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S u m m a r y
Summary
Long-term bladder catheterisation inevitably results in bacteriuria and the formation 
of biofilms on the catheters. Crystalline biofilms form when urease-producing 
bacteria infect the catheterised urinary tract. These organisms generate alkaline urine 
causing the crystallisation of calcium and magnesium phosphates and inducing the 
complication of catheter blockage. The principal organism associated with the 
formation of crystalline biofilms on urinary catheters is Proteus mirabilis. While 
several other urinary tract pathogens are capable of producing urease, there is little 
epidemiological or experimental evidence to indicate whether or not they are involved 
in the encrustation and blockage of indwelling catheters.
The aim of this study was to compare the abilities of various urease-positive species 
to encrust and block catheters with crystalline biofilm. Experiments were performed 
in laboratory models of the catheterised bladder infected with a range of urease- 
producing species. The results of these experiments allowed the classification of the 
bacteria into three groups: rapid encrusters, slow encrusters and non-encrusters. 
Rapid encrusters (Pr. mirabilis, Proteus vulgaris and Providencia rettgeri) were able 
to raise the urinary pH to 8 -  9 and cause catheter blockage within 37 h. Slow 
encrusters (Morganella morganii, Staphylococcus aureus and Staphylococcus 
saprophyticus) were able to raise the urinary pH moderately (from 6.1 to 6.89 -  7.39 
over 96 h) and cause the formation of some encrustation on the catheters. Non- 
encrusters (Providencia stuartii, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Klebsiella oxytoca, Serratia marcescens, Enterobacter cloacae, Citrobacter freundii 
and Citrobacter koseri) were not able to raise the mean urinary pH above mean levels 
of 6.45 and did not form crystalline biofilm.
Pr. mirabilis, Pr. vulgaris and Pv. rettgeri were also capable of rapidly encrusting 
silver-hydrogel coated latex catheters (Bard I.C. catheter) and nitrofurazone 
impregnated silicone catheters (Rochester NF catheter). There were no significant 
differences between the times these organisms took to block these catheters compared 
to all-silicone control catheters. The antimicrobial catheters also had no effect on the 
urinary pH generated by these organisms. The insensitivity of the three encrusting 
species to nitrofurazone (MICs 3 2 -  128 pg/ml) is clearly a major factor in the failure 
of these catheters to prevent encrustation.
The results of experiments in which the balloons of all-silicone catheters were inflated 
with solutions of triclosan (3 mg/ml in 0.1 M sodium carbonate) confirmed previous 
observations that catheter encrustation by Pr. mirabilis was prevented by this strategy. 
It also proved effective against Pr. vulgaris. In both cases, in contrast to the controls, 
the numbers of viable cells recovered from the residual urine fell steeply within 24 h, 
the pH of the urine dropped below its nucleation pH (pH 6.5) and the catheters 
drained freely for the seven day experimental period. The effect of triclosan on 
encrustation by Pv. rettgeri was minimal however, with no significant difference 
between blockage times or urinary pHs in the test and control models. While the 
Proteus sp. had MICs of triclosan of < 0.2 pg/ml, the value for Pv. rettgeri was 64 
pg/ml. Inflating catheter balloons with a solution which generated nitric oxide proved 
ineffective as a means of controlling catheter encrustation.
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S u m m a ry
Previous studies have shown that a simple cellulose acetate / bromothymol blue 
sensor is capable of signalling infection by Pr. mirabilis and the early stages of 
catheter encrustation. Placed in the drainage bag it can give early warnings to 
patients, carers and nurses that catheters need to be replaced. While the use of the 
sensor in this way could avoid the clinical crises induced by catheter blockage, it 
would be of more value if an effective strategy to inhibit encrustation could be 
deployed when the problem is signalled. In the present study it was demonstrated that 
strips of the sensor polymer placed in the drainage bags changed from yellow to blue 
signalling the rise in urinary pH induced by infection with Pr. mirabilis, Pr. vulgaris 
or Pv. rettgeri. Electron microscopy confirmed that encrustation had started on the 
catheters at the times the sensors turned blue. Triclosan (3 mg/ml) introduced into the 
catheter balloons when the signal was observed was found to halt the development of 
the Proteus crystalline biofilms. It was concluded that an integrated sensor / 
modulator strategy was feasible for the control of encrustation by these species. The 
sensor was also effective in providing early warning of blockage by the slow 
encrusting species M. morganii and Staph, saprophyticus. Experiments with the non- 
encrusting species E. coli, Ent. faecalis and K. pneumoniae in the model system 
showed that the sensors remained yellow in colour throughout the tests. Some false 
positive signals were observed however in the cases of Staph, aureus, Ps. aeruginosa 
and Pv. stuartii. Better specificity might be achieved by placing the sensor at the 
catheter / drainage tube junction since this would allow monitoring of the voided 
urine rather than the pH of urine stored in the bag.
Pr. mirabilis is generally present as part of mixed communities of organisms in the 
urine of patients undergoing long-term catheterisation. The availability of collections 
of organisms from the urine of three such patients whose catheters block very slowly 
or not at all made possible a study on the effect of the other members of the bacterial 
community on the rate at which Pr. mirabilis produced crystalline biofilm. In one of 
the cases it was found that a community of E. coli, Ps. aeruginosa and K. oxytoca had 
a profound effect on the rate of encrustation by Pr. mirabilis. While the Pr. mirabilis 
was able to block catheters in a mean time of 40 h, the community delayed blockage 
until 147 h in one replicate and in two others the catheters in models inoculated with 
all four organisms drained freely for the full 168 h test period.
The results of this study show that while a large number of urease positive species 
colonize the catheterised urinary tract, only a few species are capable of causing rapid 
encrustation. Of these Pr. mirabilis is by far the most common and it should be the 
focus of strategies to control catheter encrustation. The sensor / modulator concept 
using the cellulose acetate / bromothymol blue polymer and triclosan is clearly a 
feasible strategy for the management of catheter encrustation. Further work on the 
identification of relatively benign species that are antagonistic to Pr. mirabilis would 
be of interest. It could lead to the development of a biological interference study to 
control the problem that complicates the care of many elderly and disabled people.
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pneumoniae and Ent. faecalis and a control inoculated 
with the Pr. mirabilis isolate.
Figure 3.64: The mean pH of urine samples from models inoculated with 
a reconstituted catheter community (Patient 19) consisting 
of Pr. mirabilis, Ps. aeruginosa, E. coli and K. oxytoca, and 
a control inoculated with the Pr. mirabilis isolate alone.
Figure 3.65: The viable cell population of urine from models inoculated 
with a reconstituted catheter community (Patient 19) 
consisting of Pr. mirabilis, Ps. aeruginosa, E. coli and K. 
oxytoca, and a control inoculated with the Pr. mirabilis 
isolate alone.
Figure 3.66: Comparison of encrustation after 168 h or at blockage for 
reconstituted catheter communities against the Pr. mirabilis 
isolate from that community.
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1. Introduction
Urinary catheters are the most commonly used prosthetic device, with over 30 million 
being deployed every year in the USA alone (Darouiche, 2001). They are widely 
used for the long-term management of urinary incontinence or retention in the elderly 
and patients disabled by strokes, spinal injuries, and neuropathies such as multiple 
sclerosis. In addition urinary catheters have a number of short-term uses in 
hospitalisation, such as allowing the measurement of urine output in severely ill 
patients or facilitating repair of the urethra following surgery (Kunin, 1988). 
Although catheters provide a convenient way to drain urine from the bladder, 
unfortunately they also undermine important defence mechanisms of the bladder and 
induce vulnerability to infection. As a result they are a major cause of the infections 
that are acquired by patients in healthcare facilities (Meers et al., 1981; Jepsen et a l, 
1982; Warren et a l , 1989). It is difficult to understand why at a time when 
spectacular advances have been made in other areas of medicine, that it is still not 
possible to perform the relatively simple task of draining urine from the bladder 
without putting patients at risk. There is a clear clinical need to understand the 
processes that induce the infection-associated complications in catheter management 
and devise novel strategies to control the problems that pose severe threats to the 
health of many elderly and disabled people.
1.1 The history of the urinary catheter.
Self-retaining Foley catheters were initially designed to control bleeding following 
transurethral resectioning of the prostate (Foley, 1929). It was soon realised however
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that indwelling urinary catheters would be useful in the management of incontinence, 
allowing drainage of the bladder (Foley, 1937). The original Foley catheter was made 
of latex and consisted of a hollow tube down which the urine flows with a second 
smaller tube embedded in its wall to allow inflation of the retention balloon once the 
catheter was in place. The design of the indwelling catheter has remained essentially 
unchanged from Foley’s original.
There are two types of indwelling catheterisation used currently, urethral and 
suprapubic (Figure 1.1). Urethral catheterisation involves the insertion of the catheter 
into the bladder via the urethra. This is the most commonly used form of 
catheterisation and can be performed by health care professionals without the need for 
extensive training. In suprapubic catheterisation the catheter is inserted directly into 
the bladder through the anterior abdominal wall. This is a surgical procedure, and can 
be subject to complications resulting in bladder damage (Hamid et al., 2002; Witham 
and Martindale, 2002).
1.2 The prevalence of urinary catheterisation.
The use of indwelling urinary catheters (IUCs) is widespread throughout the world. 
Large numbers of hospital patients undergo indwelling bladder catheterisation. A 
prevalence study in hospitals in 8 European countries found that between 5 and 25 % 
of patients were catheterised (Jepsen et al., 1982). Another large scale study by 
Zimakoff et al. (1993) found that 13.2 % of hospital patients in Denmark were 
catheterised. Other smaller scale studies conducted in Europe and the USA have also 
found similar levels of catheterisation in hospital patients (Gastmeier et al., 2000;
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Figure 1.1: The placement o f urethral and suprapubic catheters.
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Saint et a l, 2000). Catheterisation in hospital patients is often short term (<28 days). 
Merle et al (2002) for example, found that the mean duration of catheterisation 
among 10,000 urologic patients over 6 years in a French hospital was 3 days, with a 
maximum of 70 days.
Catheterisation is also common in community care, particularly among patients with 
spinal cord injuries or neuropathies and in the elderly. Studies by Warren et al 
(1989), Zimakoff et al (1993) and Smith et al (2000) reported the prevalence of 
urinary catheterisation to be between 4.9 % and 7.5 % for the residents of long-term 
care facilities. Kunin et al. (1992) found that 10.5 % of patients at nursing homes 
were catheterised on entry, and that these patients tended to remain catheterised 
during the study period (1 year). In a survey of the use of catheters in nursing homes 
in England McNulty et al. (2003) found that overall 9 % of residents were 
catheterised, although there was wide variation between nursing homes with some 
having as many as 40 % of residents catheterised. Getliffe and Mulhall (1991) and 
Zimakoff et a l (1993) also found that 4 % and 3.9 % respectively of patients who 
were receiving home care were catheterised. Long-term catheterisation (> 28 days) is 
common in community care patients (Getliffe and Newton, 2006) and is most often 
used in the management of bladder dysfunction (urinary retention or chronic urinary 
incontinence (Warren, 1992)).
1.3 Catheter associated urinary tract infections (CAUTIs).
Underlying many of the complications associated with catheter management is the 
common occurrence of catheter-associated urinary tract infection (CAUTI). Patients
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often develop bacteriuria (the presence of bacteria in the urine) within a few days of 
catheterisation. Garibaldi et al. (1974) estimated risk of developing bacteriuria at 
between 3 and 10 % per day. Warren et al. (1987) found that bacteriuria was 
universal in a study on long-term catheterised women. Long-term catheterised 
patients (>28 days) will inevitably develop bacteriuria (Stickler and Zimakoff, 1994). 
An analysis of pooled data by Saint (2000) revealed that patients catheterised for 2 -  
10 days can be expected to develop bacteriuria in 26 % of cases.
While bacteriuria is normally asymptomatic, other more serious conditions such as 
bacteraemia (the presence of bacteria in the blood) (Warren et al., 1987; Jewes et al., 
1988) and pyelonephritis (acute bacterial infection of the kidney) (Warren et al., 
1988) can develop from it. In addition bacteriuria involving urease positive 
organisms is associated with catheter obstruction (Mobley and Warren, 1987) and the 
formation of infection stones in the bladder (Bichler et al., 2002). In the very long­
term (years) bladder cancer is associated with chronic catheterisation (West et a l, 
1999) (Section 1.3.3).
Nickel (1991) stated that “inserting and leaving a Foley catheter in situ is like building 
a bridge between the outside world and the sterile bladder, along which bacteria can 
travel”. Given the prevalence of bacteriuria in catheterised individuals, this statement 
would seem to be accurate. Despite this catheters remain a popular method for long­
term bladder management, largely due to a lack of suitable alternatives.
With the increased occurrence of UTIs associated with catheterisation, unnecessary 
catheterisation should be avoided. Jain et al. (1995) found in a prospective study that
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in 21 % of cases the use of an IUC was ‘unjustified5, and that in 47 % of cases 
continued catheterisation was ‘unjustified5. Saint et al. (2000) and Hazelett et al. 
(2006) also found that catheter use was ‘inappropriate5 in 31 % and 49 % of cases 
respectively. The unnecessary use of catheters in these instances is both dangerous 
and costly, not only in terms of patient health but also financially (due to the cost of 
treating additional problems).
Suprapubic catheters are sometimes used as an alternative to urethral catheterisation. 
They are inserted directly into the bladder through the anterior abdominal wall. The 
onset of bacteriuria in suprapubic catheters is slower than that in urethral catheters, 
with 50% of patients infected on day 40 as opposed to 50% infection after one week 
with urethral catheters (Ringert and Gross, 1996). In the long-term however 
bacteriuria is still inevitable. Newman and Price (1977) reported a 95% incidence of 
bacteriuria in spinal cord patients with long-term suprapubic catheterization. Sheriff 
et al. (1998) reported similar problems to those found in long-term urethral catheters 
(bacteriuria, catheter blockage, urine leakage) although they also reported that the 
general level of satisfaction with the catheters was high. Complications related to the 
insertion of suprapubic catheters in spinal cord patients, resulting in bladder damage, 
have also been reported (Hamid et al., 2002; Witham and Martindale, 2002). 
Suprapubic catheterisation has also been associated with high rates of bladder stone 
formation (Nomura et al., 2000). Suprapubic catheterisation provides an alternative 
to the urethral catheter but it is subject to additional complications.
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1.3.1 The routes of infection in IUCs.
There are three main routes of infection associated with IUCs (Figure 1.2). These are:
(a) infection due to carriage of bacteria into the bladder as the catheter is inserted, (b) 
the periurethral route (bacteria migrating along the outside of the catheter and urethral 
mucosa sheath) and (c) the intraluminal route (through the lumen of the catheter).
The bacterial flora of the urethral meatus can be introduced into the bladder on 
catheterisation and produce bacteriuria (Barnes et al., 1992; Schlager et al., 1999). A 
system bypassing the first 1.5cm of the distal urethra was found to decrease the 
incidence of CAUTIs in men with spinal cord injury (Bennett et al., 1997), indicating 
the importance of this route in CAUTIs.
Infection along the outside of the catheter and urethral mucosa sheath has also been 
shown to be an important route for catheter associated bacteriuria. Kass and 
Schneiderman (1957) found that after the application of a small amount of Serratia 
marcescens to the periurethral epithelium of 3 patients with IUCs the bacteria were 
cultured from the patients’ urine between 1 and 3 days later. Although highly 
unethical by today’s standards this study does indicate the speed with which bacteria 
are able to migrate along the outside of IUCs to the bladder. Daifuku and Stamm 
(1984) found that urethral colonization preceded bladder colonization in 12 of 18 
women and 5 of 17 men with bacteriuria.
Infection through the lumen of the catheter itself is also an important route. The 
introduction of closed collection systems in the 1960’s was responsible for delaying 
the onset of bacteriuria (Garibaldi et al., 1974). Since then contamination of the
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Routes of infection
(a) C arriage o f b acteria  into b ladder a s  ca th e ter  is in serted  ( ■ )
(b) B acteria  m igrating a lo n g  th e  o u ts id e  o f th e  ca th e ter  ( )
(c ) T hrough  th e  lum en  o f th e  c a th e ter  ( ■ )
Figure 1.2: Structure o f a urinary catheter and potential routes o f infection. The catheter is inserted into the urethra 
of the patient and the retention balloon inflated with 10 ml of sterile water via a syringe attached to the balloon 
inflation port. Once in place urine flows into the catheter through the eyehole and down the lumen to an attached 
collection bag.
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collection bag or a failure of the closed drainage system have been responsible for 
most intra-luminal infections. A study of the relative importance of infection routes 
by Tambyah et al (1999) found that where the route of entry could be determined, 34 
% of contaminants used the intra-luminal route, with extra-luminal contamination 
(along the urethra or contamination during insertion) accounting for the remaining 66 
%.
1.3.2 Pathogens associated with CAUTI.
A wide range of microorgainsms are involved in CAUTIs. In a large scale study 
carried out in 25 countries (141 hospitals) on nosocomial UTIs the major 
microorganisms isolated from urine samples were (on average), Escherichia coli (25.1 
%), Enterococcus sp. (13.2 %), Pseudomonas aeruginosa (10.5 %), Klebsiella sp. (10 
%), Proteus sp. (7.3 %), Enterobacter sp. (5 %) and Staphylococcus aureus (3.7 %) 
(Bouza et a l, 2001). A significant component of the isolates were yeast of the genus 
Candida (16.4 %). The vast majority (90.8 %) of these catheterisations were short 
term (< 30 days). The organisms isolated from long-term catheterisations are similar 
to those found in short term catheterisations, with the most common being 
Providencia stuartii (which has been particularly associated with infections in nursing 
homes (Muder et a l, 1992)), Pr. mirabilis, Morganella morganii, Enterococcus sp., 
Ps. aeruginosa, E. coli, Klebsiella sp. and Citrobacter sp. (Clayton et a l, 1982; 
Warren et a l, 1987; Kunin, 1989). E. coli has been found to be the most commonly 
isolated organism from long-term catheterised women, with Pr. mirabilis being more 
common in men (Nicolle et a l, 1996). Infections occurring in short term 
catheterisations are generally caused by a single species (Bouza et a l, 2001) while
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long-term catheterisations are often polymicrobial, consisting of two or more species 
(Clayton et al., 1982; Warren et al., 1982; Jewes et al., 1988). A study on patients 
who had acquired bacteriuria after short term catheterisation (Harding et al., 1991) 
found that younger women (< 65) were significantly more likely to have resolved the 
infection 14 days after catheter removal than older women (> 65). Other risk factors 
involved in UTIs are: female gender, duration of catheterisation, lack of systemic 
antibiotics, and violations of catheter care (Stamm, 1991).
1.3.3 The impact of CAUTIs on morbidity and mortality.
Long-term IUCs have a major effect both on patient morbidity and mortality. Kunin 
et al. (1992) found the IUC to be an independent risk factor for death in long-term 
nursing home facilities. In a prospective study they found that patients catheterised 
for more than 76 % of their days resident in the nursing homes were three times more 
likely to die within one year than non-catheterised residents. As mentioned 
previously patients with long-term IUCs will inevitably develop CAUTI (Stickler and 
Zimakoff, 1994). Although asymptomatic bacteriuria in hospitalised patients was 
found to be unrelated to bacteraemia by Tambyah and Maki (2000) a study by 
Mylotte et al. (2002) on nursing home acquired bacteraemia found that for 51 % of 
clinical episodes the source of the infecting bacteria was the urinary tract (this was 
particularly true for Pr. mirabilis infections), although only 8 % of total mortality 
during the period of hospitalisation occurred in patients with bacteraemia from this 
source, compared with 58 % of total mortality from just 11 % of clinical episodes for 
respiratory sources. Bacteraemia has been found to progress into septicaemia (sepsis 
of the blood) in 10 -  16 % of urological patients (Grabe, 1987).
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Acute and chronic pyelonephritis has been associated with long-term catheterisation 
(Warren et al., 1988; Warren et al., 1994). Autopsies carried out on elderly long-term 
catheterised nursing home patients found that acute renal inflammation was present in 
38 % of patients who died with a urinary catheter in place vs. 5 % of non-catheterised 
patients (Warren et al., 1988). A later study found that 10 % of patients catheterised 
for > 90 days during their last year of life had chronic pyelonephritis while none of 
the patients catheterised for < 90 days had chronic pyelonephritis (Warren et al., 
1994).
Chronic indwelling catheters have also been identified as an independent risk factor 
for bladder cancer in patients with spinal cord injuries (West et a l, 1999; Groah et a l, 
2002; Hess et al., 2003). Chronic infection and chronic inflammation of the bladder 
mucosa due to the presence of the catheter are thought to be important in the 
development of bladder cancer in long-term catheterised patients (Delnay et a l,
1999). The presence of nitrate reducing organisms such as E. coli or Pr. mirabilis has 
been shown to generate carcinogenic nitrosamines in the urine of paraplegic patients 
(Tricker et al., 1991). Nitrosamines have been linked to the occurrence of a wide 
range of cancers (O’Brien et a l, 1996) and so their production in the catheterised 
urinary tract may well be responsible for bladder cancer.
1.4 Bacterial biofilms.
All patients undergoing long-term catheterisation will experience bacteriuria. While 
the catheter remains in place the bacteria are extremely difficult to eliminate from the 
urine with antibiotic therapy (Clayton et a l, 1982; Warren et al., 1982). In most 
cases, for most of the time the patients do not experience symptomatic infection and it
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is common practice not to attempt treatment with antibiotic therapy (Kunin et al., 
1987a). As a result urine containing large bacterial populations flows through the 
catheter for periods of up to 12 weeks at a time (the normal duration of placement for 
a long-term catheter). Bacteria have a propensity to colonize surfaces and live as 
sessile biofilm communities rather than as planktonic cells in suspension (Costerton et 
al., 1987). In aquatic ecosystems, from rocks in streams to prosthetic devices 
implanted in the body, the vast majority of bacteria are found in biofilms on surfaces 
(Costerton et al., 1995).
Catheters provide attractive, unprotected sites for bacterial colonization, particularly 
the rims of the eyeholes and the luminal surfaces (Stickler et al., 2003b). Bathed in a 
constant gentle flow of a nutrient-sufficient medium, the sessile bacterial populations 
thrive. As a result extensive biofilm communities develop within days (Ganderton et 
al., 1992). There are several major advantages for bacteria living in biofilms, 
including protection from antibacterial chemicals, bacteriophages and predators such 
as protozoa and phagocytes (Donlan and Costerton, 2002). Donlan and Costerton
(2002) defined the biofilm as “a microbially derived sessile community characterised 
by cells that are irreversibly attached to a substratum or interface or to each other, are 
embedded in a matrix of extracellular polymeric substances that they have produced, 
and exhibit an altered phenotype with respect to growth rate and gene transcription”.
1.4.1 Biofilm structure and formation.
Biofilm formation has been studied extensively in recent years, particularly in Ps. 
aeruginosa. The initial stage of biofilm formation is the attachment of cells to the
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surface, via a conditioning layer, and the formation of dispersed monolayers. These 
monolayers then become confluent and microcolonies several cells thick then begin to 
form (Caldwell and Lawrence, 1986; Lawrence et a l, 1989). The form of mature 
biofilms is subject to some discussion. Lawrence et al (1991) used scanning confocal 
laser microscopy to examine fully hydrated mature biofilms. They found that the 
mature biofilms had a distinct ‘architecture’. The bacteria were embedded in an 
extracellular polysaccharide matrix (EPS) and channels and pores permeated the 
structure. Costerton et a l (1995) proposed a universal water-channel model of the 
mature biofilm based on the observation of Ps. aeruginosa biofilm formation (Figure 
1.3). In this model bacterial microcolonies produce large quantities of EPS and begin 
to form cone shaped structures which extend away from the colonized surface. These 
then develop into pillars and mushroom shaped structures which may fuse together, 
with the mature biofilm consisting of these structures and a network of water channels 
between them. Costerton et a l (1995) suggested that these channels comprised a 
primitive circulatory system allowing exchange of nutrients and metabolites with the 
bulk fluid phase. It is important to note that much of the work on which this model 
was based was conducted in relatively low nutrient conditions. Some biofilms, such 
as those on teeth and urinary catheters, have been observed to form more densely 
packed structures with confluent layers of cells and little evidence of the water 
channels present in the Costerton model (Nyvad and Fejersdorf, 1989; Stickler et a l, 
1993a). Wimpenny and Colasanti (1997) proposed a model of biofilm structure 
which attempted to explain these differences. Using a cellular automaton model they 
showed that the differences in biofilm structure could be explained by the availability 
of nutrients. In low nutrient environments the model predicted a structure similar to 
that of the Costerton model (see Figure 1.3) while in higher nutrient environments
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S ubstra te
Figure 1.3: The structure o f a mature biofilm as proposed by Costerton et al. (1995). The mature biofilm consists o f matrix enclosed ‘towers’ 
and ‘mushrooms’ separated by water channels. Adapted from Donlan and Costerton (2002).
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(such as the mouth or the urinary tract) the model predicted a dense biofilm with 
confluent layers of cells.
Bacteria in a biofilm show different phenotypes from those in planktonic suspension. 
Sauer et al. (2002) characterised 5 distinct stages in Ps. aeruginosa biofilm formation, 
with multiple phenotypes displayed which were distinct from the planktonic form. In 
the initial stages of biofilm formation bacteria often express specific surface contact 
factors, for example type I pili in E. coli (Pratt and Kolter, 1998). Costerton et al 
(1995) stated that surface adhesion is ‘remarkably unaffected by the physical or 
chemical nature of the surface concerned’. Studies by Downer et a l (2003) and 
Stickler et a l (2006b) however, have indicated that the properties of the surface (such 
as charge) have a significant effect on the adhesion of Pr. mirabilis. Price et al. 
(2005) also found that silane-treated silicone rubber was effective in reducing the 
adherence of Candida sp. in comparison to untreated controls. In implanted devices 
such as urinary catheters the surface of the device is often coated with a 
glycoproteinaceous film termed a ‘conditioning film’ which is formed from 
components of the surrounding body fluids (Gristina, 1987). This film has been 
shown to be important in the initial stages of biofilm formation, providing receptor 
sites for bacterial adhesion (Gristina, 1987; Lappin-Scott and Bass, 2001). While type 
I pili are important in adhesion, twitching motility, involving type IV pili rather than 
flagella (Wall and Kaiser, 1999), also appears to be associated with successful biofilm 
formation in Pseudomonas sp. (O’Toole and Kolter, 1998; Whitchurch et al., 2002b) 
allowing colonization to spread over the substrate, particularly in the initial stage of 
biofilm formation.
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The mature biofilm is composed of a hydrated EPS matrix in which the bacteria reside 
(Sutherland, 2001). Lawrence et al. (1991) determined that the biofilms they were 
studying were composed of 80 -  95 % non-cellular material (the matrix). This matrix 
often contains other compounds such as signalling molecules and DNA (Stickler et 
a l, 1998b; Whitchurch et a l, 2002a). Signalling molecules are used in bacterial 
communication know as quorum sensing. Quorum sensing is a cell density-dependant 
system which allows the coordination of behaviour (i.e. phenotype) in a bacterial 
population, for example the production of virulence factors (Parsek and Greenberg,
2000). Once a threshold concentration of the quorum sensing molecules has been 
reached a change in global cell regulation is triggered (Spoering and Gilmore 2006). 
While Gram-positive and Gram-negative bacteria use different molecules for quorum 
sensing the use of signalling molecules appears to be important for biofilm formation 
in both. The production of a competence signalling peptide in Streptococcus sp. has 
been shown to contribute to biofilm formation (Li et a l, 2002a; Petersen et a l, 2004) 
while acyl-homoserine lactones (AHLs) have been found in the biofilms formed by 
several Gram-negative species (Davies et a l, 1998; Stickler et a l, 1998b; Lehner et 
a l, 2005; Rice et a l, 2005). The disruption of biofilm formation using non-native 
acyl-homoserine lactone derivatives has been observed in Ps. aeruginosa biofilms 
(Geske et a l, 2005). Mature biofilms also show heterogeneity in physiological 
activity. Xu et al (1998) showed that physiologically active cells were restricted to 
the top 30 pm of a 130 pm deep Ps. aeruginosa biofilm. This was determined to be 
due to the limited oxygen availability in the lower layers of the biofilm.
Bacteria emigrate from an established biofilm as individual cells or as aggregates of 
cells which slough off (Donlan and Costerton, 2002). Studies by Davies et al. (1998)
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and Rice et a l (2005) showed that this may be mediated by AHLs. Detachment of 
large pieces of biofilm may aid in the development of infections in a medical setting 
(Donlan and Costerton, 2002).
1.4.2 Multi-species biofilms.
Bacterial biofilms such as in the bovine rumen, oral biofilms, and those occurring on 
urinary catheters are usually composed of several species (Stickler, 1999; Stoodley et 
a l, 2002; Li et a l, 2004). Co-aggregation, in which genetically distinct bacteria 
become attached to one another through specific molecular interactions, is thought to 
be important in the development of multi-species oral biofilms (Rickard et a l, 2003). 
This occurs either by single planktonic cells adhering to genetically distinct cells in a 
biofilm or by groups of already co-aggregated cells adhering to the biofilm (known as 
co-adhesion (Bos et a l, 1994)). Bacteria in mature oral biofilms are often seen in 
associations known as ‘corn-cobs’ such as those observed by Cobb et al (2003). The 
extent to which this occurs in multispecies urinary catheter biofilms is unknown.
1.4.3 The resistance of biofilms to anti-microbial agents.
One of the most important features associated with biofilms is their increased 
resistance to antimicrobials relative to genetically identical bacteria in a planktonic 
state. Nickel et a l (1985b) and Ladd et a l (1987) demonstrated that Ps. aeruginosa 
biofilms growing on sections of catheter material were capable of surviving 
concentrations of tobramycin as high as 1000 mg/1 for 12 h or more while planktonic 
cells were rapidly killed with just 50 -  100 mg/1. Pascual et a l (1993) also found
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increased resistance in Ps. aeruginosa catheter associated biofilms. Biofilms have 
also been shown to increase resistance in a number of other organisms such as 
Burkholderia cepacia, Staph, aureus and E. coli (Desai et al., 1998; Harrison et al., 
2004). The increased resistance of biofilms to antibiotics can be dramatic (Donlan 
and Costerton, 2002). Ceri et al. (1999) found that antibiotic resistance could be as 
much as 1000 times greater for biofilms when compared to planktonic cells.
There are a number of theories which attempt to explain the increased resistance of 
cells in biofilms to antimicrobial agents. The biofilm matrix has been proposed to 
constitute a diffusion barrier, slowing significantly the penetration of antimicrobial 
agents into the biofilm. Suci et al. (1994) found that the penetration of ciprofloxacin 
into a surface was slowed when a Ps. aeruginosa biofilm was present. A suspension 
of alginate (EPS) from Ps. aeruginosa was also able to inhibit the diffusion of 
gentamicin and tobramycin (Hatch and Schiller, 1998). The inhibition of 
antimicrobial diffusion has been linked with their binding to biofilm matrix 
constituents (Suci et al., 1994; Mah and O’Toole, 2001). Increased production of 
EPS has been observed in Ps. aeruginosa biofilms in response to imipenem (Bagge et 
al., 2004). Some biofilms however are not so effective in preventing the diffusion of 
antimicrobials (Dunne et al., 1993) so limited diffusion into the biofilm cannot fully 
explain the increased resistance observed.
The growth rate of cells in a biofilm is often slowed compared to that in the 
planktonic state (Wentland et al., 1996). It has been proposed that since the cells in a 
biofilm are growing more slowly the uptake of antibiotics will also be reduced, 
leading to increased resistance (Donlan and Costerton, 2002). Anwar et al. (1992)
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found that older Ps. aeruginosa biofilms (10 day old) were significantly less 
susceptible to antibiotics than younger biofilms (2 day old). The slowest growing 
biofilm cells have also been found to be the most resistant in E. coli (Evans et a l, 
1991). However they also found that slow growing planktonic and biofilm Ps. 
aeruginosa cells were equally resistant to ciprofloxacin while at increased growth 
rates the planktonic cells were more susceptible than the biofilm cells. This suggests 
that a property of the biofilm other than simply growth rate was responsible for the 
increased resistance, as pointed out by Mah and O’Toole (2001). Walters et al.
(2003) however found that oxygen limitation and low metabolic activity but not poor 
antibiotic penetration were associated with increased Ps. aeruginosa biofilm 
resistance to ciprofloxacin (and tobramycin).
Brown and Barker (1999) suggested that the slower growth rate seen in some biofilm 
cells might be related to a stress response rather than simply to nutrient limitation. 
The changes in gene expression result in physiological changes which may serve to 
protect the cell from antimicrobials. For example E. coli cultures at high cell density 
have been shown to produce increased levels of catalase, which would help to protect 
against hydrogen peroxide (Liu et a l, 2000). Elkins et al. (1999) observed that Ps. 
aeruginosa biofilms exposed to hydrogen peroxide produced catalase in response, 
which may indicate that the response to antimicrobials is adapted to the type of agent 
used.
A review by Lewis (2005) put forward the theory that biofilm resistance can be 
attributed to ‘persisted cells. In some of his earlier work he noted some Ps. 
aeruginosa biofilm cells were essentially ‘invulnerable’ when exposed to high levels
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of ofloxacin while the bulk of the biofilm was quite vulnerable (Brooun et al., 2000). 
These cells were thought to be phenotypic variants of the wild type rather than 
mutations since they allow the regeneration of the original population after treatment 
(Keren et al., 2004). He also argued that the presence of ‘persisters’ could explain the 
relapsing nature of biofilms in infection after antibiotic treatment, with ‘persisters’ 
being protected by the biofilm matrix from host defences and then repopulating the 
biofilm (Lewis, 2005).
The mechanism of biofilm resistance thus continues to be the subject of much 
discussion and speculation and it may well be due to a combination of the factors 
mentioned rather than to a single process.
1.4.4 Catheter associated biofilms.
The importance of biofilm formation in infections resulting from long-term 
catheterisation was first realised in the 1980’s (Nickel et al., 1985a). Nickel et al. 
(1989) found that the biofilms on the catheters they examined were composed of a 
wide range of species, some of which had not been detected using routine culture 
methods. Ganderton et al. (1992) reported that catheters removed from patients had 
biofilms present on their surfaces and that biofilms were occasionally present when 
bacteriuria had not been detected. They also reported that the biofilms observed were 
often polymicrobial and that there was a large variation in the depth of the biofilm 
which did not correspond to the time that the catheter had been indwelling. Analysis 
of catheter biofilms has shown little evidence of some of the more structured elements 
such as water channels which have been reported in biofilms found in other locations
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(Stickler et al., 1993a). Ohkawa et al. (1990) found biofilms on catheters that were 
indwelling for one week. They hypothesised that these biofilms acted as reservoirs of 
infection due to the protection given to bacteria within them from chemotherapeutic 
agents used in the treatment of urinary tract infections, as demonstrated by Pascual et 
al (1993).
Biofilms are also able to rapidly colonize other areas of urinary tract management 
devices such as catheter drainage bags. Rogers et al. (1996) found in vitro biofilm 
formation occurred rapidly when bacteria were inoculated into drainage bags.
In addition to biofilms composed of bacteria in an EPS matrix, such as those observed 
by Ganderton et al. (1992), biofilms containing large amounts of crystalline material 
commonly occur in urinary catheters (Cox et al., 1989)
1.5 Urinary catheter encrustation.
Many of the biofilms that form on long-term catheters are crystalline in nature 
(Stickler et a l, 1993b). They encrust the catheter lumen and can block the flow of 
urine. This results either in leakage of urine around the outside of the catheter, 
patients becoming incontinent, or retention of urine and painful distention of the 
bladder (Getliffe and Mulhall, 1991; Stickler and Zimakoff, 1994). Retention of urine 
due to catheter blockage is potentially dangerous, as it can cause a reflux of infected 
urine to the upper urinary tract leading to cases of pylenonephritis and septicaemia 
(Wagenlehner and Naber, 2000). Encrustations can also occur on the retention 
balloon and eye-hole of the catheter (Stickler and Zimakoff, 1994; Morris and
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Stickler, 1998a). Due to their crystalline nature, encrustations can cause trauma to the 
bladder mucosa and to the urethra (Stickler and Zimakoff, 1994).
Analysis of encrusted catheters removed from patients has shown that the crystalline 
material is composed of a combination of magnesium ammonium orthophosphate 
hexahydrate (struvite) and hydroxyapatite (calcium phosphate) (Cox et al., 1987). 
The struvite appears as large coffin-shaped crystals. The hydroxyapatite occurs as 
aggregates of microcrystals (Cox et al., 1989).
Kunin et a l (1987b) characterised patients who were subject to persistent catheter 
blockage as ‘blockers’. No significant difference was found in the makeup of urine 
from ‘blockers’ and ‘non-blockers’. This was confirmed by the studies of Choong et 
al. (2001). In both instances urinary pH was found to be significantly higher for 
‘blockers’ than ‘non-blockers’. Studies by Mobley and Warren (1987) and Kunin 
(1989) found that the urine of patients who experienced catheter blockage was often 
colonized by urease positive bacteria, particularly Pr. mirabilis.
1.6 Urease producing urinary tract pathogens.
A wide range of bacterial species colonize the catheterised urinary tract and many of 
these species are able to produce the enzyme urease (Mobley and Warren, 1987). 
Urease (urea amidohydrolase; E.C.3.5.1.5) is a cytoplasmic nickel containing 
metalloenzyme which catalyses the hydrolysis of urea. The net result of this reaction 
is the formation of two molecules of ammonia and a molecule of carbonic acid as 
shown in Figure 1.4. The equilibration of ammonia and carbonic acid with their
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respectively protonated and deprotonated forms results in an overall increase in pH 
(Mobley et al., 1995). In urine this increased pH reduces the solubility of calcium and 
magnesium phosphates (hydroxyapatite and struvite) and as a result makes crystal 
formation more likely. This makes urease the most important factor in the formation 
of encrustation on urinary catheters
(A)
O
h 2n — c — n h 2 + h 2o
(B)
urea
O
H2N — C — OH + H20  
carbamate
(C)
(D)
h 2c o 3
2 NH3 + 2 H20
Urease
O
ll
NH3 + H2N — C — OH 
ammonia carbamate
NH3 + h 2c o 3
carbonic acid
H+ + HCXV
^  2N R,+ + 2 0HT
Figure 1.4: The hydrolysis of urea. Urease hydrolyses urea to produce ammonia and carbamate 
(A). Carbamate spontaneously decomposes to form ammonia and carbonic acid (B). The carbonic 
acid and ammonia molecules equilibrate with their deprotonated (C) and protonated (D) forms. 
Adapted from Bume and Chen (2000).
1.6.1 Urease producing Pr. mirabilis in catheter encrustation and blockage.
Pr. mirabilis is the species of bacteria present most often in the urine of patients who 
block their catheters (Mobley and Warren, 1987; Kunin, 1989). It is the organism 
most commonly found on encrusted catheters (Stickler et al., 1993b). Experimental
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work in bladder models has also shown that it is the urinary pathogen most capable of 
raising the pH of urine and generating crystalline catheter biofilms (Stickler et a l, 
1998a). The urease produced by Pr. mirabilis has a relatively low substrate affinity 
(Jones and Mobley, 1987) but this is not an important factor in urine, where urea is 
present at high concentrations (up to 500mM (Gendlina et al., 2002)). The urease of 
Pr. mirabilis is particularly potent, being able to hydrolyse urea several times faster 
than ureases produced by other species (Jones and Mobley, 1987). Urease production 
in Pr. mirabilis is induced by the presence of urea (Thomas and Collins, 1999) and 
only relatively low concentrations (4 mM) are required to initiate its gene 
transcription (D’Oriazo et a l, 1996). Expression of the urease gene cluster is 
regulated by the transcriptional activator UreR (D’Oriazo and Collins, 1993b). 
Dattelbaum et al. (2003) found that a mutant Pr. mirabilis strain deficient in UreR 
was unable to produce urease and was also less able to cause kidney infections in 
mouse models of urinary tract infection. This was also found to be the case with 
urease negative Pr. mirabilis in a study by Jones et al. (1990), indicating that urease 
production has an important role in the virulence of Pr. mirabilis. Mobley et al. 
(1991) suggested that the increased pH has a deleterious effect on the renal 
epithelium.
Pr. mirabilis swarmer cells (elongated polyploid hyperflagellated cells which can 
reach over 80 pm in length (Belas, 1996)) have been found to express far larger (30 
fold) quantities of urease than normal vegetative cells (Allison et al., 1992). Sabbuba 
et al. (2002) suggested that swarmer cells of Proteus, with their substantially 
increased levels of urease (the driving force of encrustation) and their ability to 
migrate rapidly over catheters, are well adapted to initiate ascending infection of the
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catheterised urinary tract and produce catheter blocking crystalline biofilm. Swarmer 
cells also demonstrate increased expression of other virulence factors such as ZapA, 
an IgA degrading protease, which may have a role in infection (Walker et a l, 1999).
While it is quite clear that the urease enzyme of Pr. mirabilis is the main force driving 
crystalline biofilm formation, there is some evidence that the bacterial capsule has a 
role to play in the process. Experiments in vitro have demonstrated that the capsule 
produced by Pr. mirabilis forms a gel which encourages crystal growth (Clapham et 
a l, 1990). The purified exopolysaccharide from the capsule has also been shown to 
be uniquely capable of binding magnesium and accelerating struvite formation 
(Dumanski etal., 1994).
As well as causing catheter encrustation urease producing Pr. mirabilis is also 
responsible for the formation of some types of bladder stones (Naas et al., 2001). The 
stone both protects the bacteria and may serve as a reservoir of infection (Li et al., 
2002a). Sabbuba et al. (2004) found that the DNA profiles of pairs of Pr. mirabilis 
isolates taken from bladder stones and encrusted catheters from 6 patients were 
identical. This may mean that any new catheter inserted in these cases will soon 
become colonized and encrusted with bacteria from the bladder stones.
1.6.2 Urease production in urinary tract pathogens other than Pr. mirabilis.
There is strong epidemiological and experimental evidence that Pr. mirabilis is the 
main cause of catheter encrustation and blockage. While other urease producing
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species can be found quite commonly infecting the catheterised urinary tract the 
extent of their involvement in generating crystalline biofilms is uncertain.
The production of urease in these species is controlled in a variety of ways. In a 
number of species closely related to Pr. mirabilis, such as Pr. vulgaris and Pv. 
rettgeri (formerly Pr. rettgeri), urease production is induced by the presence of urea 
(Mobley et al., 1987; Mobley and Hausinger, 1989). Both of these species have been 
shown to be able to form crystalline biofilms similar to those of Pr. mirabilis on 
urinary catheters (Stickler et a l, 1998a). These two species are much less prevalent 
however in the catheterised urinary tract than Pr. mirabilis (Mobley and Warren,
1987). A study by Senior (1979) found that Pr. mirabilis accounted for 96.5 % of 
urinary tract infections by the Proteeae tribe (Proteus, Providencia and Morganella 
sp.) members while Pr. vulgaris and Pv. rettgeri accounted for less than 2 %. Senior 
and Leslie (1986) speculated that the low number of infections with Pr. vulgaris was 
related to its infrequent occurrence as a part of the gut microflora, which is often the 
source of bacteria infecting the urinary tract (Daifuku and Stamm, 1984). Urease 
producing isolates of Pv. stuartii, another member of the Proteeae tribe, have also 
been found to possess a plasmid-encoded urease similar to that of Pr. mirabilis 
(D’Oriazo and Collins, 1993a). Urease activity in these isolates was found to be 
induced by the presence of urea (D’Oriazo and Collins, 1993b). This plasmid- 
encoded urease was also found in a number of E. coli isolates.
Urease production in the commonly occurring urinary tract pathogen M. morganii 
(formerly Pr. morganii) appears to be constitutive (Rosenstein et al., 1981). The 
urease produced by M. morganii is distinct from that of other uropathogens (Hu et al.,
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1990) and has a higher substrate affinity than that of the ureases from other Proteeae 
tribe members and also a larger molecular weight (Jones and Mobley, 1987). Unlike 
the ureases of most other Gram-negative bacteria the urease of M. morganii has a low 
optimum pH of 5.5 which appears to provide protection from acidic conditions 
(Young et a l, 1996). M. morganii urease has also been reported to hydrolyse urea 
more slowly than that of Pr. mirabilis (Jones and Mobley, 1987). Stickler et al. 
(1998a) found that M. morganii was unable to raise the pH of artificial urine 
significantly over 24 h incubation periods.
There is also some evidence that Staph, saprophyticus may produce urease 
constitutively (Sissons et al., 1990). This species is not commonly found in the 
catheterised urinary tract but is regularly found to be the cause of uncomplicated UTI 
in young women (Ferry et al., 1988).
A number of urease positive urinary tract pathogens control the production of their 
urease as a part of the nitrogen regulatory system (Mobley et al., 1995). Urease 
production in Klebsiella sp. has been a particular focus of research. The production of 
urease in K. pneumoniae has been shown to be blocked by mutations of the global 
nitrogen regulation system (ntr) cascade (ntrA and ntrC) (Collins et al., 1993). In 
addition urease expression has been found to be low in K. aerogenes when grown in 
nitrogen rich media (Mulrooney et al., 1989). The expression of urease by Ps. 
aeruginosa has also been found to be regulated by available nitrogen (Totten et al., 
1990). Due to the high levels of available nitrogen present in the urinary tract, 
bacteria in which urease synthesis is controlled by the nitrogen regulatory system are 
unlikely to produce high levels of urease in this environment. However K. oxytoca
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has been reported to cause hyperammonaemia, the presence of high concentrations of 
ammonia in the blood which is usually associated with Proteus infections, in urinary 
stasis (Cheang et al., 1998).
Staph, aureus is another pathogen commonly isolated from the catheterised urinary 
tract. Isolates of Staph, aureus are occasionally found to be capable of producing 
urease, although the control mechanisms have not been investigated fully. There is 
some evidence of pH dependent expression of urease similar to that seen in 
Streptococcus salivarms, with apparent inhibition of urease synthesis at high pHs 
(Sissons et al., 1990). Resch et al. (2005) observed that the production of urease was 
one of a number of enzymes upregulated in Staph, aureus biofilms when compared to 
planktonic cells. Urease production is also characteristic of one of the two most 
important strains of epidemic methicillin-resistant Staph, aureus (EMRSA-16) 
affecting UK hospitals. EMRSA-16 accounted for 24 % of all MRS A isolates in 
England and Wales in 2000 (Murchan et al., 2004).
1.7 Factors that modulate the rate of catheter encrustation.
Although urease is the most important factor in the formation of encrustation the 
chemical composition of the urine is also significant. In particular the concentration 
of calcium ions in the urine, in conjunction with elevated urine pH, has been 
identified as a major factor in the formation of encrustation. Burr and Nuseibeh 
(1993) found that elevated calcium levels in urine combined with the presence of a 
urease producing microorganism were the most important factors in catheter 
blockage. Studies on human urine in vitro have confirmed the importance of calcium
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and also magnesium concentrations (Hugosson et a l, 1990). This is unsurprising 
given that the encrustation is formed from calcium and magnesium phosphates which 
become insoluble at elevated urine pHs. However it does not explain the wide 
variations in the rates at which catheter encrustation occurs.
It is obvious to nursing staff responsible for the care of catheterised patients that even 
among patients infected with Pr. mirabilis there is considerable variation in the times 
catheters take to block (i.e. the catheter lifespan). A recent prospective study by 
Mathur et al. (2006a) characterised the variability in the lifespan of catheters in 
patients having Pr. mirabilis in their urine. The time the catheter took to block with 
encrustation varied from 2 - 9 8  days. The rate of crystalline biofilm formation on 
catheters is clearly extremely variable. The factors that modulate the rate at which Pr. 
mirabilis encrusts catheters are poorly understood.
As mentioned previously the urine of long-term catheterised patients is often 
colonized with mixed communities of organisms. Pr. mirabilis is commonly found 
with two or three other organisms in patients’ urine (Clayton et a l,  1982; Warren et 
a l, 1987). The effect of these other species on the rate at which Pr. mirabilis is able 
to cause encrustation has not been investigated.
It has often been noted that high urinary pH is associated with catheter blockage 
(Hedelin et al., 1991; Kohler-Ockmore, 1991; Burr and Nuseibeh, 1997). As catheter 
blockage is brought about by the elevation of urinary pH, it would seem likely that the 
higher the urinary pH generated by the bacterial flora, the shorter will be the catheter 
lifespan. Some attempts have been made to identify a critical pH value above which
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encrustation and blockage will occur. Hedelin et al. (1991) suggested that crystal 
formation in urine occurs predominantly above a critical value of pH 6.8. This 
conclusion was based on their observations that very little encrustation was found on 
catheters of patients with a mean urinary pH below this value. Choong et a l (2001) 
reported that patients who blocked their catheters rapidly (within 6 weeks) had a mean 
urinary pH of 7.63. The results of the studies by Mathur et al. (2006a & b) however 
suggested a more subtle relationship between the urinary pH and the encrustation 
process. The data showed that in patients infected with Pr. mirabilis the nucleation 
pH of urine (pHn) is the important factor in predicting the rate of catheter encrustation. 
The nucleation pH of a sample of urine is defined as the pH above which calcium and 
magnesium phosphates come out of solution (Choong et al., 1999). Statistical 
analysis of data from the Mathur et al. (2006a) study showed that there was a highly 
significant (P=0.004) positive correlation between pHn and catheter lifespan. The 
higher the pHn the slower the rate of encrustation and the greater the catheter lifespan.
1.8 Strategies to control catheter encrustation and blockage.
Community nurses and continence advisors in the UK have recorded their 
uncertainties over the management of patients who suffer from recurrent catheter 
blockage (Capewell and Morris, 1993). This is a reflection of the situation that 
although several strategies have been advocated for the control of the problem, there 
is little hard evidence from controlled clinical trials that any of them are effective.
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1.8.1 Bladder washouts.
Bladder washouts with various solutions have been used for many years to try and 
deal with the problems of CAUTI and catheter encrustation. The technique involves 
the introduction of 50 -  100 ml of the solution into the bladder by injection through 
the catheter. The catheter is then clamped so that the solution is retained in the 
bladder. After 20 -  30 minutes the clamp is removed to allow the solution to drain 
into the urine collection bag.
Acidic bladder washouts have been used for a number of years in attempts to control 
the formation of encrustation on urinary catheters (Getliffe, 1996). Getliffe (1994) 
compared the effects of using washout solutions of Suby G (3.2 % citric acid), 
mandelic acid and physiological saline on the formation of encrustation by Pr. 
mirabilis in an in vitro model. Both Suby G and mandelic acid were able to reduce 
the encrustation present on the catheters after instillation while saline had no effect. 
In a second study Getliffe et al. (2000) found similar results, with Suby G and 
Solution R (6 % citric acid) being able to reduce the encrustation present on catheters 
in urine containing jack bean urease. Clinical studies on the effectiveness of bladder 
washouts however, have not conclusively shown that these strategies have any effect 
in vivo (Kennedy et al., 1992). A review of the available data (Mayes et al., 2003) for 
citric acid washout solutions (Suby G and Solution R) found that the evidence for the 
use of these solutions was weak and suggested that they should not be used routinely 
but instead evaluated on a patient by patient basis. It has also been observed that the 
acidification of urine by citric acid solutions is quickly countered by urease producing 
bacteria once the solution is removed, and that these solutions are not effective in
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removing urease producing bacteria from the urinary tract (Bibby and Hukins, 1993). 
Bladder washouts have also been linked to irritation of the bladder epithelium (Elliott 
et a l, 1989). Despite this acidic bladder washouts remain popular in the management 
of catheter encrustation (Rew, 1999; Evans and Godfrey, 2000).
Chlorhexidine is a biocide which is often used as an infection control measure in 
catheterised patients (Stickler, 2002). Chlorhexidine containing bladder washout 
solutions have been in use since the 1970’s (Guttmann, 1973). The intention of its 
use in combating encrustation is to eliminate the infecting urease producing bacteria. 
While chlorhexidine can be effective against Gram-positive bacteria, it is often less so 
against Gram-negative bacteria (this is most likely due to an intrinsic property of the 
Gram-negative cell wall (Stickler, 2002)), importantly including Pr. mirabilis 
(Stickler et al., 1971). Despite their widespread use (Stickler and Chawla, 1987) there 
is little clinical or in vitro evidence that chlorhexidine washouts are effective in either 
sterilizing urine or against the bacterial biofilms which act as a reservoir of infection 
(Davies et al., 1987; Stickler et a l, 1987 a & b; King and Stickler, 1991; Stickler et 
al., 1991). The over use of chlorhexidine can also lead to increased resistance 
amongst Gram-negative bacteria, as was shown by the experiences of the 
Southampton infection control team. They devised a comprehensive strategy to 
reduce the occurrence of CAUTI, with chlorhexidine used for disinfection of the 
urethral meatus, included in gel lubricants used to allow easier passage of the catheter 
into the bladder, and added to the urine drainage bags (Southampton Infection Control 
Team, 1982). Despite initial success in reducing the occurrence of CAUTI this 
strategy lead to the selection of drug resistant Gram-negative bacteria (Walker and
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Lowes, 1985) culminating in an outbreak of chlorhexidine and antibiotic resistant Pr. 
mirabilis infections (Dance et al., 1987).
1.8.2 Dietary acidification of urine.
The formation of catheter encrustations is inextricably linked to increased urine pH 
(Hedelin et a l, 1991). The dietary acidification of patient’s urine has as a result been 
viewed as a potentially useful strategy in combating the formation of catheter 
encrustation
McDonald and Murphy (1959) demonstrated that the administration of a daily total of
2.5 g of ascorbic acid at 4 hour intervals could significantly lower patient’s urine pH. 
A later study by Travis et a l (1965) showed that this therapy was not able to 
consistently reduce urine pH below 5.5 even when higher doses were used. An 
analysis of the results of the use of orally administered ascorbic acid on urine pH 
showed that in patients with Proteus infected urine the therapy failed to have any 
acidifying effect (Murphy et a l, 1965). This was attributed to the action of the 
ureases produced by Proteus sp.
Bibby and Hukins (1993) attempted to determine whether it was possible to prevent 
an increase in urinary pH by urinary acidification when urease was present. They 
found that in order to counter the effect of the urease, large quantities of strong acid 
would be required. This is due to the effect of Le Chatelier’s principle, since any 
acidification of urine under these conditions results in the conversion of more urea to 
ammonia to oppose the change. In fact it was determined that to prevent a rise in pH
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resulting from the complete conversion of the urea in a days supply of urine would 
require 2.7 L of strong acid. As a result it was concluded that without the removal of 
urease producing bacteria the acidification of a patient’s urine was not feasible.
Cranberry juice has often been advocated by health care practitioners to control 
catheter encrustation (Morris, 1999). While there is some evidence that cranberry 
juice is effective in combating uncomplicated UTI in young women it is unclear 
whether there is any effect in other patient groups (Jepson et al., 2004). Urine from 
volunteers who had drunk cranberry juice a few hours earlier has been shown to 
inhibit the adherence of bacteria to the uroepithelium in vitro (Schmidt and Sobota,
1988). However urine collected in a similar way showed no effect on the formation 
of crystalline biofilms by Pr. mirabilis in an in vitro model when compared to the 
urine of volunteers who had drunk the same amount of water. Both sets of urine 
extended the blockage time when compared to the urine of volunteers who had not 
increased their fluid intake, emphasising the importance of maintaining dilute urine in 
combating catheter encrustation (Morris and Stickler, 2001).
1.8.3 Increased fluid intake.
Increased fluid intake has been associated with a reduction in the occurrence of 
catheter blockage (Burr and Nuseibeh, 1995). Burr and Nuseibeh (1997) found that 
consistent fluid intake rather than excessive consumption of fluid was important in 
maintaining dilute urine over 24 h periods. Suller et al. (2005) showed that increased 
fluid intake can raise the pHn of urine significantly as well as reducing the 
concentration of calcium and magnesium ions available to form encrustations.
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The influence of citrate in limiting the formation of catheter encrustations has been 
investigated recently. Wang et al. (1994) showed the potential of increased citrate 
consumption to reduce the formation of crystals in urine in vitro. Some doubts were 
expressed about its clinical usefulness since the consumption of excess citrate raises 
urinary pH (Burr and Nuseibeh, 1997). Suller et al. (2005) however, demonstrated 
that increased citrate consumption caused the pHn of urine to be raised considerably, 
more than compensating for the increased urine pH. Stickler and Morgan (2006) 
showed that diluting urine and increasing its citrate concentration, elevated its pHn 
and prevented Pr. mirabilis from forming crystalline biofilms in an in vitro model. It 
would be interesting to see if this effect is reproducible in vivo.
1.8.4 Urease inhibitors.
Given the association of urease producing pathogens with the formation of catheter 
encrustations, inhibitors of urease activity would be useful in combating encrustation. 
Acetohydroxamic acid has been used successfully to combat bladder stone formation 
and urinaiy catheter encrustation (Bums and Gauthier, 1984; Williams et al., 1984). 
The mechanism of action of acetohydroxamic acid is shown in Table 1.1. 
Unfortunately acetohydroxamic acid has some rather unpleasant toxic side effects 
which, such as severe tiredness and unusual hair loss, have limited its clinical use 
(Williams et a l, 1984). Fluorofamide is another urease inhibitor which has the 
potential to reduce catheter encrustation. Studies in a rat model of infection and in an 
in vitro model have both shown its possible usefulness in combating encrustation 
(Millner et al., 1982; Morris and Stickler, 1998b). Fluorofamide has not as yet been
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Name Class Mode of Action
Chlorhexidine Antibacterial Disruption o f cytoplasmic membrane function
Nitrofurazone Antibacterial Targets enzymes involved in carbohydrate metabolism and DNA synthesis
Nitric Oxide Antibacterial Unknown
Silver Antibacterial Toxic metal
Triclosan Antibacterial Inhibition o f fatty acid synthesis
Acetohydroxamic Acid Urease inhibitor Binds to Nickel ion in urease inhibiting activity
Fluorofamide Urease inhibitor Unknown
Table 1.1: Antibacterial and urease inhibiting substances in use or proposed for use in CAUTI.
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fully tested and so its toxicity is unknown and as a result is not currently used in 
clinical practice.
1.8.5 Antimicrobial catheters.
Attempts to produce catheters which resist infection initially focused on producing 
catheters with surfaces designed to inhibit the initial attachment of bacteria to the 
catheter surface. Latex catheters with coatings of teflon or hydrophilic hydrogel 
however, have not been shown to be effective in preventing either biofilm formation 
or blockage (Kunin et a l , 1987b; Bull et a l, 1991; Morris et a l, 1997).
A number of silver-alloy coated catheters began to become available during the early 
1990’s. These catheters are designed to inhibit the formation of biofilm by the 
gradual release of silver ions into the urine. While a number of studies have 
suggested that silver coated catheters may be able to reduce to occurrence of 
bacteriuria in short term catheterisation (Karchmer et a l, 2000; Rupp et a l, 2004) 
other studies have shown little or no difference between standard and silver coated 
catheters (Bologna et a l, 1999; Lai and Fontecchio, 2002; Srinivasan et a l, 2006). In 
addition silver coated catheters were not effective in preventing catheter encrustation 
and blockage in an in vitro model of the catheterised urinary tract (Morris et a l, 
1997). There is no clinical evidence that silver coated catheters would be more 
effective than standard catheters in the prevention of CAUTI or blockage in long-term 
catheterised patients.
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Nitrofurazone is another antimicrobial agent which has been incorporated into urinary 
catheters. The mode of action of nitrofurazone is not well defined but it is thought to 
target bacterial enzymes including those involved in carbohydrate metabolism and 
DNA synthesis (Shah and Wade, 1989; McOsker and Fitzpatrick, 1994). It is active 
against a wide range of Gram-positive and Gram-negative bacteria. Johnson et al 
(1993) found that a nitrofurazone impregnated catheter was effective in vitro against 
many bacteria which commonly infect the catheterised urinary tract with the notable 
exception of Pseudomonas sp. and Proteus sp. Clinical trials of nitrofurazone 
impregnated catheters have shown some indications that these catheters may be 
effective in delaying the occurrence of hospital acquired CAUTI (Al-Habdan et a l, 
2003; Lee et a l, 2004).
A systematic review by Johnson et a l (2006) of studies into the use of silver coated 
and nitrofurazone impregnated catheters was not able to make any definitive 
recommendations about their clinical use. They did conclude however that there was 
some evidence for the use of these catheters in short-term catheterisation. As 
Trautner et al (2005a) pointed out even if definitive data become available for the 
effectiveness of these catheters in short-term catheterisation this does not necessarily 
mean that it will have any effect in chronic long-term catheterised patients.
Catheters incorporating chlorhexidine and combinations of chlorhexidine and silver 
and chlorhexidine, silver and triclosan are currently being developed for clinical use 
(Whalen et a l, 1997; Gaonkar et a l, 2003; Richards et a l, 2003). These catheters 
have shown some promise in in vitro studies but the widespread use of biocide
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containing catheters in long-term catheterisation may well lead to the emergence of 
resistant organisms as has already been observed with chlorhexidine (Section 1.8.1).
Chakravarti et al. (2005) reported on the in vitro effect of a catheter fitted with silver 
electrodes. Electrification of the catheter using a 9 V battery caused the steady release 
of silver ions into the urine. This method was found to extend the lifespan of 
catheters when challenged with Pr. mirabilis when compared to controls.
1.8.6 Use of the catheter retention balloon to deliver antimicrobial agents to the 
bladder.
Bibby et al. (1995) first suggested that the catheter retention balloon could be filled 
with an antimicrobial solution as a method of controlling encrustation. The balloon 
membrane might then act as an effective diffusion barrier, allowing small amounts of 
the antimicrobial to pass into the urine in the bladder over an extended period from 
the large reservoir of antimicrobial solution in the balloon. Stickler et al. (2003a) 
found that the instillation of a solution containing 10 mg/ml triclosan into the balloon 
of a standard all-silicone catheter was able to keep catheters draining freely for 7 days 
when challenged with Pr. mirabilis in an in vitro model. The control catheters 
quickly became encrusted and blockage occurred within 24 h. A later study found 
that lower concentrations of triclosan were also effective in preventing blockage by 
Pr. mirabilis (Jones et al., 2005). Jones et al. (2006) observed that while this strategy 
was effective against several other commonly occurring urinary tract pathogens a 
number of other species were able to form extensive biofilms on the surface of 
triclosan impregnated catheters. The resistant species however were not able to form
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crystalline biofilms. Research is needed into the ability of triclosan to prevent the 
formation of crystalline biofilms by species other than Pr. mirabilis which are able to 
raise urinary pH significantly.
Urinary pH testing with indicator strips is commonly used to predict catheter 
encrustation in the management of urinary catheters (McCarthy and Hunter, 2001; 
Getliffe, 2002). An inherent problem of this technique is that since the urinary pH is 
subject to some variation during the day pH testing may miss points at which the 
urine is particularly alkaline, during which encrustation is more likely to occur (Burr 
and Nuseibeh, 1997). Measurements of urinary pH also need to be taken quickly 
since samples exposed to air may show an increase in pH (Choong et al., 1999). 
Stickler et al. (2006a) developed a sensor designed to be placed in the urine collection 
bag and so provide constant monitoring of voided urinary pH. This sensor was shown 
to predict catheter blockage an average of 43 h before it occurred for in vitro models 
inoculated with Pr. mirabilis. A clinical assessment of the performance of this sensor 
showed it was able to signal both infection with Pr. mirabilis and the early stages of 
catheter encrustation, allowing time to take preventative action before the 
development of clinical crises (Stickler et al., 2006c). The use of this pH sensor 
shows promise in the management of catheter encrustation and blockage. It would be 
useful to assess its effectiveness in predicting catheter blockage for a range of urease 
producing bacteria both in vitro and in vivo in order to provide constructive data for 
recommendations on its clinical use. The use of the pH sensor in determining when 
intervention with triclosan containing solutions is appropriate could also be useful, 
since the blanket use of the triclosan solution in long-term catheterisation could lead
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to resistance problems similar to those encountered with chlorhexidine (Section 
1.8.1). This combined strategy should be examined in vitro.
Carlsson et al (2005) also used the approach of filling the catheter balloon with an 
antimicrobial solution. They evaluated the use of a solution which releases nitric 
oxide into the surrounding urine in a static model of the catheterised urinary tract. 
This approach was effective in reducing the numbers of E. coli in the model. It would 
be interesting to see what effect this approach has on species capable of causing 
encrustation in a continuous flow model of the catheterised urinary tract.
1.8.7 Bacterial interference with pathogenesis in CAUTI.
Several studies have investigated the possibility of interfering with CAUTI using non- 
pathogenic bacteria. This approach involves deliberate infection of the catheterised 
urinary tract with a non-pathogenic bacterial strain in order to prevent or reduce 
infection with pathogenic microorganisms and as a result prevent symptomatic 
infections (Darouiche and Hull, 2000). Work in this area has been carried out both in 
vitro and in vivo using a non-pathogenic E. coli strain (Darouiche et al., 2001; 
Trautner et al., 2003; Darouiche et a l , 2005). Colonization by pathogenic strains was 
shown to be reduced in vitro for pathogenic E. coli, Ent. faecalis and Pv. stuartii 
when a pre-existing non-pathogenic E. coli strain was present on catheters (Trautner 
et al., 2003). This approach has also shown some success in vivo where patients with 
bladders colonized with non-pathogenic E. coli were half as likely as controls to 
develop symptomatic UTI during the subsequent year (Darouiche et a l, 2005). Some 
in vitro work has also been carried out using a non-pathogenic E. coli strain able to
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produce bacteriocins (bacterially produced antibacterial agents, known as colicins in 
E. coli). This strain was able to completely prevent catheter colonization in vitro by 
colicin-susceptible E. coli but not by colicin-resistant E. coli (Trautner et al., 2005b).
A similar strategy has been tried using non-pathogenic Lactobacillus sp. in an attempt 
to control Pr. mirabilis ascending UTI in a mouse model of infection (Fraga et al., 
2005). Although this strategy was effective in reducing the numbers of Pr. mirabilis 
present in the bladders of the mice it did not have any significant effect on the 
occurrence of kidney colonization.
Given the interactions observed between bacteria in these studies it would be 
interesting to investigate what effects, if any, the composition of the bacterial 
community present has in modulating Pr. mirabilis associated catheter blockage.
1.9 Aims of the study.
The enzyme urease is the force driving the encrustation and blockage of Foley 
catheters. While Pr. mirabilis produces this enzyme in abundance and is clearly a 
major cause of this complication in catheter care, there are many other urinary tract 
pathogens that register as urease positive in conventional bacterial identification tests. 
The extent to which any of these species are involved in blocking catheters is 
unknown. In view of this uncertainty, the aims of the work reported in this thesis 
were:
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AIMS:
• To compare the relative abilities of a wide range of urease positive species to 
cause the formation of encrustations and blockage on urinary catheters.
• To test the ability of antimicrobial catheters to delay catheter blockage by Pr. 
mirabilis and other species found to be able to produce alkaline urine and 
crystalline bacterial biofilms.
• To examine the efficacy of delivering triclosan or nitric oxide into the bladder 
via the catheter retention balloon in preventing catheter blockage by species 
able to generate crystalline biofilm.
• To examine the feasibility of an integrated sensor/modulator strategy to detect 
the early stages of catheter encrustation and then inhibit further deposition of 
crystalline material thus preventing blockage.
• To examine the response of the sensor of catheter encrustation to bacterial 
species that are not capable of causing catheter blockage.
• To observe the effect of the other urinary tract pathogens present in the mixed 
bacterial communities that commonly infect catheterised patients on the 
encrustation and blockage of urinary catheters by Pr. mirabilis.
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2.1 Chemicals.
Most chemicals used in this study, unless otherwise stated, were purchased from 
Fisher Scientific Ltd. (Loughborough, UK).
2.2 Media.
All of the agar media and broths used in this study were purchased from Oxoid Ltd. 
(Basingstoke, UK). Chromogenic UTI agar was used in the isolation of bacteria from 
clinical catheter samples and enumeration of individual species in bladder model 
experiments performed with more than one species (Figure 2.1). Chromogenic UTI 
agar allows differentiation between bacterial species based on colony colour and / or 
morphology. This is due to chromogenic substrates incorporated into the agar, which 
allow the detection of enzymes specific to a particular genus or species. Cysteine- 
Lactose Electrolyte Deficient (CLED) agar was used for the culturing and 
enumeration of the various bacterial species used in this study (Figure 2.1). CLED 
agar inhibits or greatly reduces the swarming behaviour of several of the species used 
in this study (for example Pr. mirabilis, Pr. vulgaris), thereby allowing individual 
colonies to be counted. CLED agar supplemented with 2 ml/L Tween 80 (Sigma- 
Aldrich chemical company, Poole, UK) was used for enumeration in experiments 
involving triclosan. Tween 80 neutralizes triclosan, thereby allowing the enumeration 
of triclosan sensitive species from experiments involving triclosan. Tryptone Soya 
Agar (TSA) was used to detect swarming organisms from clinical catheter samples. 
TSA was also used for Dienes typing of Pr. mirabilis isolates (Figure 2.2). Colistin 
Inositol (Cl) agar (Clayton, 1984) was used to enumerate Pr. mirabilis in urine from
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bladder models that were inoculated with mixed bacterial communities. Cl agar 
consists of 28 g/L Nutrient Agar, 10 g/L myo-inositol (Sigma), 0.02 g/L bromothymol 
blue (BTB) (Sigma) and 0.01 g/L colistin methanesulfonate (Sigma). Urea Agar, 
containing 2 % v/w urea, was used for the detection of the enzyme urease. Hydrolysis 
of the urea by urease causes an increase in pH, resulting in the agar changing from 
straw-yellow colour to pink due to a pH indicator in the agar (Figure 2.3). Iso- 
Sensitest Agar (ISA) was used as the agar base in the determination of minimum 
inhibitory concentrations (MIC) of triclosan (CIBA speciality chemicals, Basel, 
Switzerland) and nitrofurazone (Sigma). Iso-Sensitest Broth (ISB) was used to grow 
cultures for MIC testing. Tryptone Soya Broth (TSB) was used to prepare inocula for 
use in experiments and was also used as an ingredient in the artificial urine.
2.3 Artificial urine.
Artificial urine was prepared using a method based on that described by Griffith et al 
(1976). The constituents used are listed in Table 2.1. The pH of the artificial urine 
was adjusted to 6.10 using 3 M sodium hydroxide prior to the addition of the gelatine. 
Once the gelatine had dissolved the artificial urine was sterilised using a capsule filter 
with a 0.2 pm pore size (Sartorius, Goettingen, Germany). TSB (1 g/L of urine) was 
prepared separately, sterilized by autoclaving at 121 °C for 15 minutes and added 
aseptically to the sterile artificial urine.
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Figure 2.1: Enumeration methods. A spread plate o f diluted urine with several species present is 
shown on the left and a drop count plate from urine containing one species is shown on the right.
Figure 2.2: Dienes typing o f Pr. mirabilis isolates on TSA. Different strains (left) will not swarm 
into each other leaving a gap between the swarming fronts (indicated <—  ), while isolates from the 
same strain will swarm into each other (right).
Figure 2.3: E. coli (urease -ve), left, and Pr. mirabilis (urease +ve), right, streaked onto urea agar
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Chemical name Formula grams/litre
Sodium sulphate Na2SC>4 2.30
Calcium chloride dihydrate CaCl2 . 2 H20 0.65
Magnesium chloride M gC l. 6 H20 0.651
Sodium chloride NaCl 4.60
tri-Sodium citrate Na3C6H50 7 . 2 H2 0 0.65
Sodium oxalate (COONa)2 0.02
Potassium dihydrogen 
orthophosphate k h 2p o 4 2.80
Potassium chloride KC1 1.60
Ammonium chloride NH4CI 1.00
Urea CO(NH2)2 25.00
pH to 6.10 - -
Gelatine 5.00
Table 2.1: Chemicals used in the preparation o f artificial urine. After preparation 1 g/L TSB is 
added prior to use.
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2.4 Bacterial isolates.
Bacterial isolates were collected from the catheters of long term catheterised patients. 
Sections (approximately 1 cm long) cut from the catheters were placed in 10 ml of % 
strength Ringer’s solution (Oxoid). These were then sonicated gently at 35 kHz 
continuously for 5 minutes (Camlab Transsonic T310, Camlab Ltd., Cambridge, UK) 
and vortex mixed for 2 minutes in order to dislodge and break-up the biofilm. Serial 
dilutions of the resulting cell suspensions were then made and 100 pi aliquots were 
spread plated onto Chromogenic UTI agar. A loop of the original solution was also 
streaked onto TSA in order to detect any swarming species. Colonies with different 
colours / morphologies were then Gram stained and identities confirmed using the 
appropriate BBL Crystal™ identification test kits (Becton Dickinson, Oxford, UK). 
Additional isolates were also kindly supplied by Dr N. Morris, Dr N. Sabbuba, Dr S. 
Jones, Dr M. Suller, Mr S. Morgan and Miss S. Macloed. All of these were recent 
isolates from the catheters or urine of long term catheterised patients. A single strain 
(ZEC17, Staphylococcus saprophyticus), kindly supplied by Dr Zeliha Caliskan, was 
isolated from the urine of a patient with a urostomy. The identities of these organisms 
were confirmed using Gram staining and the appropriate BBL Crystal™ kits. The 
bacterial isolates were stored in pure culture at -80 °C in a 5 % glycerol solution.
2.5 Bacterial enumeration methods.
Viable cell numbers in cell suspensions were determined using either a drop count 
method, as described by Miles and Misra (1938), or by spread plating (Figure 2.1). 
Both methods required the preparation of a dilution series of the bacterial suspension
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in % strength Ringer’s solution. In the drop count method triplicate 10 pi aliquots of 
each dilution were dropped onto pre-dried CLED agar plates. Each dilution was done 
in triplicate and dropped onto separate plates. In the spread plate method 10 pi 
aliquots of bacterial suspension were spread over the surface of pre-dried 
Chromogenic UTI agar plates. This was done for each appropriate dilution and in 
triplicate. Plates were incubated aerobically at 37 °C for 24 -  48 h.
2.6 Catheters.
All of the catheters used in experiments were size Ch 14. All-silicone and hydrogel- 
coated latex (Biocath) catheters were purchased from Bard Ltd. (Crawley, UK). 
Releen Nitrofurazone catheters were kindly provided by Coloplast (Humlebaek, 
Denmark). All of the catheters were connected to 2 L urine drainage bags (Bard) 
during experiments.
2.7 Determination of MIC’s.
The MIC of triclosan to Pr. mirabilis, Pr. vulgaris and Pv. rettgeri isolates was 
determined on ISA plates. The method used was adapted from the method described 
by Andrews (2001). Stock solutions of triclosan were made in dimethyl sulfoxide 
(DMSO). The appropriate amounts were then added to molten ISA and mixed before 
pouring, resulting in plates containing the desired concentrations of triclosan. The 
plates were then dried in a laminar flow cabinet for 20 minutes. Overnight cultures of 
the strains to be tested were grown in ISB. The cultures were then adjusted with ISB 
to contain approximately 108 cfu/ml. They were then diluted 1:10 with sterile
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deionised H2O. The prepared ISA plates were then inoculated with 1 pi aliquots o f  
the diluted cultures (approx. 104 cfu) using a Denley multipoint inoculator (Denley 
instruments Ltd., Billinghurst, UK). This was done in triplicate for each triclosan 
dilution. Control plates o f  ISA alone and ISA containing the maximum volume o f  
DMSO used (without triclosan) in the screen were also prepared and inoculated as 
above. The inoculated plates were then incubated for 18 h at 37 °C. After 18 h the 
plates were examined and the MIC o f each isolate determined as the lowest triclosan 
concentration at which no growth occurred (method as shown in Figure 2.4). For 
those isolates able to swarm the minimum swarming inhibitory concentration (MSIC) 
was also determined. This was determined as the lowest triclosan concentration at 
which no swarming occurred.
The MIC of nitrofurazone to Pr. mirabilis, Pr. vulgaris, Pv. rettgeri, M. morganii, 
Staph, aureus and Staph, saprophyticus isolates was determined using the same 
method. Nitrofurazone stock solutions were also prepared using DMSO.
Figure 2.4: ISA plate containing triclosan after 18h incubation at 37°C
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2.8 Atomic absorption spectrometry (AAS).
AAS was used to determine calcium and magnesium concentration in samples. AAS 
was carried out in an aa/ae spectrophotometer 457 (Thermo Electron Corporation, 
Waltham, Massachusetts, USA).
2.8.1 Determination of encrustation rates using AAS.
Calcium and magnesium encrustation rates (pg/min) for bacterial isolates on all­
silicone catheters were determined using AAS. The rates calculated were the mean 
accumulation over the period the experiment was conducted (96 h or blockage) and do 
not indicate when the encrustation occurred during this period. Catheters were 
removed from the models at the completion of experiments and the external surface 
wiped clean of encrustation. The catheter balloons were removed and discarded. The 
catheters were then cut into small sections (approximately 1 cm long) which were 
then all placed in 100 ml of a 4 % nitric acid solution (made with polished water). 
The solutions containing catheter sections were then sonicated at 35 kHz for 5 
minutes and vortex mixed for 2 minutes in order to dislodge and break-up the biofilm. 
Since AAS requires calcium and magnesium levels to be within a specific range, a 
series of dilutions in polished water was made in order to have a sample that fell 
within this range. The readable ranges on the spectrophotometer were between 0.5 
and 2.0 ppm for calcium (at 422.7 nm) and between 0.05 and 0.4 ppm for magnesium 
(at 285.2 nm). Prior to analysis the spectrophotometer was calibrated between these 
ranges with standards purchased from Spectosol (BDH Chemicals Ltd., Poole, UK). 
These 1000 ppm standards were diluted with 1 % w/v nitric acid. The nitric acid and
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polished water were also assayed for calcium and magnesium. Knowing the length of 
time each catheter had been in situ in the infected models, the encrustation rates were 
calculated as pg of calcium or magnesium / catheter / hour.
2.8.2 Determination of the nucleation pHs (pHn) of calcium and magnesium in 
artificial urine at 37 °C.
The nucleation pH (pHn) is defined as the pH at which calcium or magnesium 
crystallises from the urine (Choong et al., 1999). Samples of artificial urine (1L) were 
heated to 37 °C in a water bath. The pH of the urine was increased in increments of 
0.1 pH by the addition of 10 M sodium hydroxide up to a pH of 8.5. At each pH 
increment sub-samples (10 ml) were removed and centrifuged at 4000 g for 5 min to 
sediment any crystalline material. The concentrations of calcium and magnesium in 
the resulting supernatant were assayed using AAS. The pHn was defined by an abrupt 
change in the slope of the graph showing a decrease in dissolved calcium or 
magnesium caused by precipitation of crystals, as shown in the example in Figure 2.5. 
As described by Choong et al. (2001) plotting pH of urine against the values of 
calcium or magnesium in solution at each pH produces two straight lines which 
intersect at the pHn. Regression lines were calculated by least square analysis for the 
two parts of the graph and used to determine the pH at their intersection.
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To calculate pH at intersection (pHn):
4 2 0 -2 3  pH = 1709-208 pH 
pHn= 1289/185 = 6,97
Figure 2.5: An example of the method used to calculate nucleation pH (pHn). (A) The AAS data 
is plotted and the investigator puts the data into 2 groups -  data prior to the beginning o f a significant 
decline in calcium solubility (I) and data post the beginning of a significant decline in calcium 
solubility (3). (B) Linear regression analysis is conducted on both sets o f data producing two 
regression equations. (C) The pH value at the point o f intersection between the two regression lines 
is calculated (pH 6.97 in this case). This is the nucleation pH (of calcium) in this solution 
N.B. in order to use this method there must be a distinct point at which the metal ion solubility begins 
to drop
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2.9 The in vitro model of the catheterised urinary tract
An in vitro model of the catheterised urinary tract was used to study biofilm formation 
on urinary catheters. The model was described by Stickler et al (1999), and consists 
of a glass chamber surrounded by a water jacket maintained at 37 °C, representing the 
bladder (Figure 2.6). After each model was sterilised (autoclaved at 121 °C for 15 
mins) a Foley catheter was inserted aseptically through an inlet at the base of the 
bladder chamber, via a section of silicone tubing (representing the urethra). Once in 
place the retention balloon was inflated with 10 ml of sterile solution. The solution 
used to inflate the balloon was generally sterile water, but in some experiments 
solutions containing triclosan or sodium nitrite and ascorbic acid were used (see 
Sections 2.9.1 & 2.9.2). Once secured in place by the balloon the catheter was 
connected to a drainage tube and 2 L urine collection bag. The models were then 
connected to glass aspirators containing sterile artificial urine (representing the 
kidneys) via sterile silicone tubing (representing the ureters). Figure 2.7 shows a 
schematic diagram of the bladder model setup.
The models were inoculated with a 4 h logarithmic phase culture, incubated at 37 °C, 
of the isolate being tested in artificial urine containing approximately 108 cfu/ml. The 
size of the inoculum depended on the type of infection being modelled. For models of 
the heavily infected bladder an inoculum of 10 ml of culture was used, models of a 
developing infection used 100 pi of inoculum, and models of bacterial communities 
used 1 ml of inoculum for each isolate. Once inoculated, artificial urine was quickly 
supplied to the model using a peristaltic pump (503U, Watson and Marlow, Falmouth, 
UK) until the urine level in the model was just below the catheter eye-hole. The
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viable cell count and pH of the inoculum was determined. The inoculated model was 
allowed to stand for an hour in order to allow the culture to become established in the 
model. Urine was then supplied, via the peristaltic pump, to the model at a rate of 0.5 
ml/min. The viable cell count and pH level of the residual urine in the model was 
determined at the point when the pump was started and at 24 h intervals for the 
duration of the experiment. Viable cell counts and pHs were also determined from 
urine in the model at the times any catheters blocked during the experiment.
2.9.1 Preparation of Triclosan solutions used to inflate catheter balloons.
Stock solutions containing triclosan were prepared for use as an alternative to water 
for inflating catheter balloons. Stock solutions were of 3 mg/ml (or 6 mg/ml) 
triclosan in 0.1 M (or 0.2 M) Na2C0 3 . Hy-Shield SkinSure plus (Hygieia Healthcare 
Ltd., Bideford, UK) cream diluted with sterile water was also used to prepare 
solutions containing 3 or 6 mg/ml triclosan. For the Na2 CC>3 solutions 100 ml of 0.1 
M (or 0.2 M) Na2CC>3 was autoclaved at 121 °C for 15 min. Once cooled 0.3 g (or 0.6 
g) of triclosan was added and the suspension stirred using a magnetic stirrer until the 
biocide had dissolved. The 6 mg/ml triclosan in 0.2 M Na2C0 3  required some heating 
in order for the triclosan to dissolve. For experiments using 3 mg/ml triclosan in 0.1 
M Na2C0 3  control experiments using catheters were conducted, using 0.1 M Na2C0 3  
alone and sterile water for balloon inflation. For the Hy-Shield SkinSure plus cream 
solutions sterile water was added to the cream in plastic universal containers. For the 
3 mg/ml solution 14 ml of water was added to 6 ml of cream, and for the 6 mg/ml 
solutions 8 ml of water was added to 12 ml of cream. The cream and water were then 
mixed by vigorous shaking.
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2.9.2 Preparation of nitric oxide producing solutions used to inflate catheter balloons.
Stock solutions capable of producing nitric oxide when combined were prepared for 
use as an alternative to water for inflating catheter balloons. Stock solutions of 
ascorbic acid (20 mM) and sodium nitrite (10 mM) were prepared in sterile saline (0.9 
% w/v) and the pHs adjusted to 2.5 with conc. HC1. Immediately prior to inoculation 
of the model equal volumes of these stock solutions and 10 ml of the resulting 
solution (10 mM ascorbic acid, 5 mM sodium nitrite) were used to inflate catheter 
balloons.
2.9.3 The pH sensor.
A number of bladder models were run with sections of pH sensor placed in the 
drainage bag. The sensors were made using the method described in Stickler et al. 
(2006a). The sensors were kindly provided by Dr G. Adusei (Cardiff School of 
Dentistry). Sensors were prepared by dissolving cellulose acetate (Acordis Ltd., 
Coventry, United Kingdom) in acetone and adding a mixture of Bromothymol blue 
(BTB) and sulphuric acid. Under these conditions, the BTB becomes covalently 
bound to the cellulose acetate. Polyethylene glycol was added as a plasticizer and to 
control the rate of movement of ions through the matrix, thus controlling the response 
rate of the material to changes in pH. The mixture was spread over a glass plate to 
allow the polymer mixture to set. Strips (5 cm long by 2 cm wide by 1 mm thick) of 
the calcium acetate-BTB polymer were then prepared, washed in water to remove 
residual acid, and stored at 4 °C. Strips of sensor approximately 1 cm long by 2 mm 
wide by 1 mm thick were cut for insertion into drainage bags. The sensors were
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inserted aseptically into the drainage bags through the outlet tap. Digital photographs 
of the sensor were taken at the point when urine began to be pumped at 0.5 ml/min 
and at 24 h intervals afterwards. The pH of the urine in the drainage bag was also 
determined at these points. For some experiments additional photographs and pH 
readings were taken at 2,4 and 12 h after the start of the experiments.
2.9.4 Production of pH sensor colour chart.
A chart showing the colour of the pH sensor at urinary pHs of between 6.1 and 9.4 
was produced to allow comparison with pH sensors placed in catheter drainage bags. 
This was done by adjusting the pH of 500 ml of artificial urine at room temperature 
(approx. 25 °C) from pH 6.1 to pH 6.2 and then to pH 9 in 0.2 pH increments using 3 
M NaOH. Samples (10 ml) of artificial urine were taken at each point and a section 
of pH sensor added. After 24 h at room temperature the sensor strips were removed 
from the urine, blotted to remove excess liquid, and then digital photographs taken. 
The pictures of the sensor were then combined to produce a colour chart (see Figure 
3.41).
2.10 Electron microscopy and digital photography.
Electron microscopy and digital photography were used to allow visual comparison of 
biofilm formation and encrustation levels. Sections of catheter were cut as indicated 
in Figure 2.8. The sections (1 cm long) were taken from the catheter eyehole (section 
1), immediately below the catheter eyehole (section 2), immediately below the 
catheter balloon (section 3), and 15 cm below the base of the balloon (section 4). In
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Figure 2.8: Catheter sections used for SEM and digital photos
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some experiments electron microscopy and digital photography were also used to 
examine pH sensor strips removed from the catheter drainage bag.
2.10.1 Digital photography and Low vacuum scanning electron microscopy (XV- 
SEML
Catheters for photography and LV-SEM were carefully removed from the bladder 
model and sections cut. If required the pH sensor was also removed from the 
drainage bag. Excess fluid was carefully drained by blotting before either 
photography or LV-SEM was carried out. A Canon IXUS 500 digital camera (Canon 
UK Ltd, Reigate, UK) was used for digital photography. LV-SEM was carried out 
using a JEOL JSM 5200 lv SEM (JEOL (UK) Ltd., Welwyn Garden City, UK) on low 
vacuum mode (3 %) at 20 kv. Images of section 1 were taken looking onto the 
eyehole, while for the other catheter sections images were taken looking down the 
catheter lumen.
2.10.2 Environmental scanning electron microscopy (ESEM).
ESEM combined with X-ray analysis was used to determine the composition of 
crystals forming on the surface of catheter eyeholes. The ESEM was carried out using 
a Veeco FEI (Philips) XL30 ESEM Field Emission Gun (FEI UK Ltd., Cambridge, 
UK) with an INCA ENERGY (EDX) X-ray analysis system (Oxford Instruments, 
High Wycombe, UK), and was operated by Mr P. Fisher (School of Earth Sciences, 
Cardiff University). The eyehole section was dried overnight in a 37 °C incubator 
before the analysis was carried out. Samples were carbon coated and analysed in high
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vacuum SEM mode. An example of the use of ESEM combined with X-ray analysis 
in the identification of apatite microcrystals is shown in Figure 2.9. The morphology 
of struvite crystals in urine, identified by fourier transform infrared microscopy by 
Daudon et a l (1991), is shown in Figure 2.10.
2.10.3 High vacuum scanning electron microscopy (HV-SEM).
Catheters for HV-SEM were carefully removed from the bladder model and sections 
cut. Sections 2, 3, and 4 were cut in half longitudinally. The sections were then 
placed in a 2.5 % glutaraldehyde solution in 0.1 M Sorensen phosphate buffer 
(adjusted to the pH of the urine in the bladder model from which the catheter was 
removed by altering the proportions of monobasic (Na^PCU) and dibasic (T^HPCU) 
sodium phosphate used to make the buffer) and left to fix at 4 °C overnight. The 
samples were then washed in 0.1 M pH adjusted Sorensen phosphate buffer for 15 
minutes. The samples were then post-fixed by immersion in 1 % osmium tetroxide in 
0.1 M Sorensen phosphate buffer for 1 h. The osmium was then removed and the 
samples washed by immersion in deionised water for 15 minutes. The samples were 
then dehydrated using a series of ethanol solutions. The samples were first immersed 
in a 70 % ethanol solution for 15 minutes. This was then replaced with a 90 % 
ethanol solution for 15 minutes, followed by 2 washes in 100 % ethanol for 15 
minutes each. Silicone based catheters were then dried using a critical point dryer 
(Blazers CPD 030 critical point dryer, Bal-Tec AG, Blazers, Liechtenstein). Latex 
based catheters were dried using Hexamethyldisilazane (HMDS) (Agar Scientific), in 
a fume cupboard. After the final 100 % ethanol wash the sections were immersed in a
-62-
Materials and Methods
Ful Scale 6332 cts Cursor 7.425 keV (45 cts)
Figure 2.9: An example of the use o f X-ray microanalysis in identifying calcium phosphate microcrystals 
using ESEM. Scanning microscopy is used to identify an area o f interest (A). X-ray microanalysis o f the sample 
area results in the emission of x-rays with energies characteristic to the elements being ionised. The spectrum 
obtained (B) can be used to construct a table o f element abundance from the area analysed, as shown in Figure 
3.8. The spectrum shown in (B) is from the area surrounded by red lines in (A). The electron micrograph and 
spectrum were kindly provided by Mr S. Morgan (Cardiff School of Biosciences).
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Figure 2.10: Examples o f struvite and calcium phosphate microcrystals in infected human urine. Fourier transform infrared microscopy was used 
to obtain both image (A) and the spectra (B & C). The spectrum obtained from the crystal labeled 1 in (A) is shown in (B). Comparison with 
reference spectra indicated that this crystal is composed of struvite. Similarly the spectrum obtained from the crystal labeled 5 in (A) is shown in (C) 
and indicates that it is composed of calcium phosphate microcrystals. These examples are adapted from Daudon et al. (1991).
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1:1 solution of ethanol : HMDS for 15 minutes. This was followed by 2 washes in 
HMDS alone for 15 minutes each. The final wash was not removed, but was left 
partially covered in the fume cupboard to evaporate slowly over 1 - 2  days. Once 
dried, using critical point drying or HMDS, the catheter sections were attached to 
aluminium stubs using adhesive black carbon disks. Eyehole sections were attached 
so that micrographs could be taken looking onto the eyehole and the other sections 
attached so that the length of the lumen section was visible. The catheter sections 
attached to stubs were then sputter coated with gold (Edwards sputter coater S150B). 
HV-SEM images were taken using a Philips XL-20 HV-SEM (FEI UK Ltd., 
Cambridge, UK).
2.11 Assay of urease production.
Test strains were streaked out for single colonies (from freezer stocks) to CLED agar 
and incubated overnight at 37 °C. Artificial urine (50 ml) was then inoculated with a 
loop full of the bacterial culture and incubated with aeration for 4 h at 37 °C. The 
cultures were centrifuged at 4000 rpm for 30 seconds to remove crystals from the 
suspension, then the supernatant was poured into another container and centrifuged at 
4000 rpm for 5 minutes and the cells resuspended in 25 ml of ice cold 0.1 M sodium 
phosphate buffer (pH 7.3) 10 mM EDTA (0.01 M). A urease assay based on the 
modified Bertholt reaction (Creno et a l , 1970) was then used to determine the 
enzyme activity of the whole cell suspension. 200 pi of culture extract was then 
added to a reaction mixture containing 50 mM urea and 100 mM sodium phosphate 
buffer (pH 7.3) and incubated in test tubes at 37 °C for 10 minutes. The reaction was 
terminated by addition of phenol (0.5 %) sodium nitroprusside (0.0025 %) solution (2
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ml). 2 ml o f  0.25 % sodium hydroxide 0.21 % sodium hypochlorite solution was then 
added. Colour development was initiated by incubation for 6 minutes at 56 °C 
(Figure 2.11). The solution was then placed in a spectrophotometer and read at 600 
nm against a reagent blank. The amount o f ammonia present in the solution (and 
therefore the amount o f  urea hydrolysed) was then calculated by comparison to a 
standard curve created using ammonium chloride solutions substituted for culture 
extract (example shown in Figure 2.12). Protein levels in the cell resuspensions in 0.1 
M sodium phosphate buffer (pH 7.3) 10 mM EDTA were assayed using a commercial 
protein determination test kit (Sigma). The amount o f urea hydrolysed per mg protein 
was then calculated (pmoles o f urea hydrolysed / min / mg protein).
Figure 2.11: Solutions containing increasing amounts o f ammonia (left to right) after colour 
development.
2.12 Statistical analysis.
Unless otherwise stated experiments were performed three times independently and 
where appropriate the standard error (SE) o f the mean was indicated. ANOVA  
(analysis o f  variance) carried out at 95 % confidence interval was the statistical test o f
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Figure 2.12: Example o f a calibration curve used to determine the amount o f urea hydrolysed in samples from 
the urease assay. Known concentrations of NH4 were used in place o f bacterial culture extract in the urease assay to 
obtain this data.
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choice for all the experiments. This was carried out using Minitab® release 14 
software (Minitab Inc., State College, Pennsylvania, USA). In order to use ANOVA 
the data analysed had to conform to the normal distribution and have homogeneity of 
variance. This was checked using Minitab, and if these assumption were violated and 
after transformation of the data they still did not fit, then the non-parametric Kruskal- 
Wallis test was used instead, again at a 95 % confidence interval. When only two sets 
of data were to be compared a two sample t-test (parametric) or Mann-Whitney test 
(non-parametric) were used.
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3.1 Comparison of the ability of urease producing species to encrust and block 
all-silicone catheters.
There is substantial epidemiological and experimental evidence that the major cause 
of catheter encrustation is Proteus mirabilis (Mobley and Warren, 1987; Kunin, 1989; 
Stickler et al. 1993b; Morris and Stickler, 1998a; Stickler et al., 1998a). The extent to 
which other urinary tract pathogens capable of producing urease are involved in the 
encrustation and blockage of patients’ catheters is not clear. In view of this 
uncertainty, a wide range of bacterial species that had been isolated from catheter- 
associated urinary tract infections was examined for their ability to produce the 
enzyme urease in standard laboratory bacteriological identification tests. The ability 
of a collection of urease positive isolates to produce crystalline biofilms on catheters 
was then examined in the bladder models.
3.1.1 The ability of urease producing urinary tract bacteria to cause catheter 
encrustation and blockage.
Bladder models were inoculated with 10 ml of a 4 h mid-logarithmic culture 
(inoculated with a loopful of test organism grown from freezer culture overnight on 
agar) of test organism in artificial urine (approximately 108 cfu/ml). At 24 h intervals, 
up to a maximum of 96 h, or at blockage if it occurred, urine samples were taken from 
the bladder chamber. The pHs of the urine samples were measured and the viable 
bacterial cell populations determined by the drop count method. The extent of 
encrustation present on catheter sections was visualised using digital photography and 
HV-SEM. The amount of calcium and magnesium present on the catheters was 
determined by AAS and the rate of encrustation calculated. The urease activity of the
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4 h logarithmic cultures in artificial urine was also assayed. Statistical analysis 
(ANOVA) was used to determine if there was any significant difference between the 
mean blockage times, urinary pHs, encrustation rates, and urease activity for the 
different test species.
Figure 3.1 shows the urinary pHs recorded for the experiments for nine urease 
producing species in comparison to a urease negative control (E. coli). The blockage 
time and final urinary pH (96 h or blockage) is shown in Table 3.1. Three urease 
producing species (Pr. mirabilis, Pr. vulgaris and Pv. rettgeri) caused catheter 
blockage within 96 h. In models inoculated with the six remaining urease producing 
species (Pv. stuartii, M. morganii, Staph, aureus, Staph, saprophyticus, Ps. 
aeruginosa and K. pneumoniae) the catheters drained freely for the full 96 h test 
period. There was no significant difference (P=0.059) between the mean blockage 
times for Pr. mirabilis, Pr. vulgaris and Pv. rettgeri. The mean urinary pH at 96 h 
was compared to that of the E. coli control for those species which did not block. In 
the case of M. morganii, Staph, aureus and Staph, saprophyticus the final mean 
urinary pHs were significantly different (P<0.05) from that of the urine in the E. coli 
control. The final mean urinary pHs produced by these three species were not 
however significantly different (P>0.05) from each other. The final mean urinary pHs 
recorded at 96 h in models inoculated with Pv. stuartii, Ps. aeruginosa and K. 
pneumoniae were not significantly different from each other or from that of the E. coli 
control (P>0.05). The final mean urinary pH for those species which blocked was 
significantly different from the control (P<0.05). All three of the species which 
caused catheter blockage produced final mean urinary pHs which were significantly 
different from those of M. morganii, Staph, aureus and Staph, saprophyticus
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Figure 3.1: The mean* pHs recorded for urine from the bladder chamber o f models infected with a range o f urease producing species. Experiments were stopped at 96 h if  
blockage had not occurred by this point. A urease negative E. coli isolate was used as a control. * The mean values ±SE were calculated for the results of triplicate experiments.
Results
Species (isolate)
Mean blockage time, if 
applicable (h) 
(±SE)
Final urinary pH 
(at blockage or 4 days) 
(±SE)
Proteus mirabilis (RB6) 19.8 (±2.91) 8.34 (±0.19) A
Proteus vulgaris (SDM2) 36.4 (± 3.85) 8.42 (±0.21)
Providencia rettgeri (SDM1) 32.2 (± 6.19) 8.36 (±0.19) A
Providencia stuartii (RB14) - 6.44 (± 0.06) •
Morganella morganii (RB15) - 7.39 (± 0.08) 1
Staphylococcus aureus (P10 6/9) 
(urease +ve)
- 6.89 (± 0.06) H
Staphylococcus saprophyticus 
(ZEC17) - 7.14 (±0.09) ■
Pseudomonas aeruginosa 
(RB16) - 6.32 (± 0.05) •
Klebsiella pneumoniae (SDM17) - 6.31 (±0.05) •
Escherichia coli (RB13) 
(urease -ve control)
- 6.15 (±0.02) #
Staphylococcus aureus (W112) 
(urease -ve control)
- 6.09 (± 0.01)
Uninoculated control - 6.11 (±0.01)
Table 3.1: The mean* times catheters took to block and urinary pHs in models infected with a range o f urinary 
pathogens. * mean values ±SE were calculated from the results o f three replicate experiments. - indicates catheters 
drained freely for the 96 h experimental period.
^  Indicates that the mean final urinary pHs for this group of species were not significantly different from the 
urease negative control E. coli or from each other (P>0.05).
_  Indicates that the mean final urinary pHs for this group of species were significantly greater than the urease 
negative control E. coli (P<0.05) but were not significantly different from each other (P>0.05).
▲
Indicates that the mean final urinary pHs for this group o f species were significantly greater than the |  group 
(P<0.05) but were not significantly different from each other (P>0.05).
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(^<0.05). There was no significant difference between the final mean urinary pHs 
produced by the species that blocked catheters (P>0.05).
Figure 3.2 shows the encrustation rates for calcium and magnesium. Catheters were 
removed from the model at blockage or 96 h and the amounts of calcium and 
magnesium present were determined using AAS. The data were then related to the 
time the catheter had been in the model to determine the encrustation rate. There was 
no significant difference (P>0.05) between the calcium encrustation rates for Pr. 
mirabilis, Pr. vulgaris, Pv. rettgeri and M. morganii while they were all significantly 
different (P<0.05) from the E. coli control. The calcium encrustation rates of Staph, 
aureus, Pv. stuartii, Ps. aeruginosa and K. pneumoniae were not significantly 
different (P>0.05) from each other or the control E. coli. There was also no 
significant difference (R>0.05) between the encrustation rates of M. morganii, Ps. 
aeruginosa and Pv. stuartii. The magnesium encrustation rates of M. morganii, 
Staph, aureus, Pv. stuartii, Ps. aeruginosa and K. pneumoniae were not significantly 
different (P>0.05) from each other or the control E. coli. Magnesium encrustation 
rates for Pr. mirabilis, Pr. vulgaris and Pv. rettgeri were not significantly different 
(P>0.05) from each other but were significantly different (R<0.05) from the other 
species and the control.
3.1.2 The effect of pH on the solubility of calcium and magnesium in artificial urine.
The pH at which calcium and magnesium phosphate crystals form in urine (the 
nucleation pH, pHn) is characteristic of a particular urine. The more dilute the urine, 
the higher the pHn (Suller et al., 2005). The pHn of the artificial urine used in these
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Figure 3.2: Mean* ±SE rates of calcium and magnesium accumulation on catheters in bladder models infected with various bacterial species. Experiments were stopped at 96 h 
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experiments was determined as described in Section 2.8.2. The concentration of 
calcium and magnesium remaining in solution as the urinary pH was increased are 
presented in Figure 3.3. Using the method described by Choong et al. (1999) (Figure 
2.5) the mean pHn ±SE for calcium was calculated to be 6.54 ±0.01. The pHn for 
magnesium was clearly higher than this figure but could not be calculated since there 
was no distinct point where the concentration began to drop steeply.
3.1.3 The urease activity of the test species.
The urease activity produced by the test species when growing in the artificial urine 
was determined using 4 h logarithmic phase cultures. The results presented in Figure
3.4 show that many of the species that produce detectable urease in bacteriological 
identification tests, produce relatively low amounts of the enzyme when grown in 
urine. In fact the rate of hydrolysis of urea was not significantly different from the 
urease negative controls for Pv. stuartii, K. pneumoniae, K. oxytoca, Serratia 
marcescens, Citrobacter freundii, C. koseri, Enterobacter cloacae and Ps. aeruginosa 
(P=O.270) or for Staph, aureus from the Staph, aureus urease negative control 
(P>0.05). The activities of Pr. mirabilis, Pr. vulgaris, Pv. rettgeri, M. morganii were 
all significantly greater (/M).05) than Staph, aureus and the Staph, aureus urease 
negative control. There was no significant difference (P>0.05) between Pr. mirabilis, 
Pr. vulgaris and Pv. rettgeri, while the rate for M. morganii was significantly 
different (P<0.05) to both Proteus species but not significantly different (P>0.05) 
from Pv. rettgeri.
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Calcium
Magnesium
Figure 3.3: Calcium and magnesium concentrations in artificial urine at each pH after removal o f  
crystals by centrifugation. Each data point is the mean o f 3 replicates (SE indicated). The green lines show 
the regression lines used to calculate the nucleation pH of calcium in artificial urine (the urine pH at their 
point of intersection, pH 6.54). The data for magnesium was not suited to this analysis due to a lack of a 
distinct point where its solubility began to drop rapidly (such as can be seen for calcium at pH 6.6).
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negative controls
^  - Mean urease activity not significantly different from each other but significantly different from 
the urease negative Staph, aureus control and urease producing Staph, aureus.
■  - Mean urease activity not significantly different (P>0.05) from the urease negative Staph, 
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M. morganii.
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Figure 3.4: Rates o f urea hydrolysis for urease producing urinary tract bacteria grown in artificial urine (4 h shake flask cultures). Urease negative Staph, aureus and E. coli 5? 
isolates were used as controls.
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3.1.4 Visualization of the catheter biofilms.
Digital photographs were taken of catheters removed from the bladder model at 96 h 
or blockage for nine urease producing species and a urease negative E. coli control 
(Figures 3.5 & 3.6). The 3 species which caused blockage {Pr. mirabilis, Pr. vulgaris 
and Pv. rettgeri) all show large amounts of encrustation, particularly on the eyehole 
and lumen sections nearest the eyehole (Figure 3.5). The images of M. morganii 
show that some encrustation is present after 96 h (Figure 3.5) while Staph, aureus and 
Staph, saprophyticus also show signs of encrustation (Figure 3.6). Ps. aeruginosa and 
K. pneumoniae produced little biofilm at the eyehole or immediately below it. 
Extensive biofilms were found however, lower down the catheter lumen (Figure 3.6). 
Pv. stuartii failed to generate biofilm, the catheter appeared similar to those removed 
from E. coli infected models (Figure 3.5).
HV-SEM carried out on catheter sections confirmed the crystalline nature of some of 
the biofilms. Figure 3.7 shows HV-SEM of Pr. mirabilis, Pr. vulgaris and Pv. 
rettgeri biofilms at blockage. All three catheters show heavy encrustation consisting 
of microcrystals typical of apatite. The biofilms produced by M. morganii, Staph, 
aureus and Staph, saprophyticus also contained large crystalline forms (Figure 3.8). 
X-ray micro-analysis of the large crystalline arrays produced by Staph, aureus 
indicated that these structures were composed of calcium phosphate (Figure 3.9). No 
crystalline material was observed in the biofilms formed by Pv. stuartii, K. 
pneumoniae or Ps. aeruginosa (Figure 3.10). The biofilms formed by the urease 
negative controls E. coli and Staph, aureus are clearly non-crystalline (Figure 3.1 la &
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A & B: Encrusted Pr. mirabilis biofilm on an all-silicone catheter (removed from the bladder model at 
blockage). The biofilm can be seen to be heavily encrusted (A). Microcrystals typical o f apatite can be seen at 
high magnification (B).
C & D: Encrusted Pr. vulgaris biofilm on an all-silicone catheter (removed from the bladder model at blockage). 
Crystalline material typical of struvite and apatite can be seen (C). Bacterial cells and apatite are visible at high 
magnification (D).
^  * n r  J v  J£ v
. f _ i r  - l a ,, »»
n V T  •
i c t V  Spot Magn Det WO V----------------------------I 10 pm
?0 0 kV 4 0 ISOOx SE- E4S1 4a P rettgeri
E & F: Encrusted Pv. rettgeri biofilm on an all-silicone catheter (removed from the bladder model at blockage). 
The extensive crystalline biofilm (E) when visualised at high magnification is composed o f bacterial cells and 
microcrystals (F).
Figure 3.7: HV-SEM images o f Pr. mirabilis, Pr. vulgaris and Pv. rettgeri biofilms on all-silicone catheters 
removed from bladder models at blockage.
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A & B: The crystalline nature of an M morganii biofilm on an all-silicone catheter (removed from the bladder 
model after 4 days).
C & D: Staph, aureus biofilm on an all-silicone catheter (removed from the bladder model after 4 days). A 
variety o f crystalline forms can be seen together with large numbers o f cocci.
E & F: Staph, saprophyticus biofilm on an all-silicone catheter (removed from the bladder model after 4 days). 
Crystalline structures are clearly present in the bacterial biofilm
Figure 3.8: HV-SEM images o f M. morganii, Staph, aureus and Staph, saprophyticus biofilms on all-silicone 
catheters removed from bladder models after 4 days.
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200pm 100pm
Element Atomic % Weight %
Carbon 7.46 4.38
Oxygen 68.51 53.6
Sodium 0.14 0.16
Magnesium 0.06 0.08
Silicone 0.13 0.18
Phosphorous 10.86 16.45
Calcium 12.83 25.15
Element Atomic % Weight %
Carbon 6.88 3.77
Oxygen 63.11 46.1
Phosphorous 11.49 16.25
Calcium 18.52 33.88
u>
Figure 3.9: X-ray microanalysis data for large crystal formations on a urease positive Staph, aureus biofilm. The element abundance data presented in the 
tables is taken from the areas labeled in green on the electron micrographs.
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Figure 3.10: HV-SEM images o f Pv. stuartii (A), Ps. aeruginosa (B) and K. pneumoniae (C) 
biofilms on all-silicone catheters removed from bladder models after 4 days.
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Figure 3.11: HV-SEM images o f control catheters removed from the bladder model 
after 4 days. Controls were performed using urease negative E. coli (A) and Staph, aureus 
(B) isolates, and also an uninoculated model (C). The surface o f the uninoculated catheter 
is quite bare, although some small pieces o f debris are visible.
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b). Examination of the uninoculated control catheter shows the nature of the catheter 
surface (Figure 3.1 lc).
3.1.5 An assessment of the abilities of three isolates of each urease producing species 
to raise urinary pH and cause catheter encrustation.
To examine whether the results obtained from the independently replicated 
experiments with just one isolate of each test species were typical for that species, the 
abilities of a further three isolates of each species to produce crystalline biofilms was 
tested in the bladder models. The isolates of any given species were all obtained from 
different patients. In the case of Pr. mirabilis, Dienes typing confirmed that the three 
isolates chosen were distinct strains (Figure 3.12). The experiments were performed 
once for each isolate and samples were collected as described in Section 3.1.1. 
Statistical analysis (Two sample t-test) was used to determine if there was any 
significant difference between the blockage times and final bladder model pHs for the 
isolates tested in Section 3.1.1 and the pooled data from the three isolates of the same 
species.
Table 3.2 shows a summary of the data obtained. For those species which blocked 
within 96 h (Pr. mirabilis, Pr. vulgaris and Pv. rettgeri) there was no significant 
difference (P>0.05) between the mean blockage times of the original and pooled 
alternative isolates. With the exception of Staph, aureus none of the species tested 
showed a significant difference between the original and pooled alternative isolates 
for the mean final pH values.
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RB6 (top) vs. RB6 (bottom)
HI4320 (top) vs. B2 (bottom) NSM6 (top) vs. B2 (bottom) HI4320 (top) vs. NSM6 (bottom)
00 Figure 3.12: Dienes typing of swarming Pr. mirabilis isolates on TSA. Combinations o f the four Pr. mirabilis isolates tested all show the characteristic gap between the
swarming fronts (indicated <----- ), and are therefore considered to be different strains. No gap is evident at the point the swarming fronts meet for the control o f a single isolate
swarming towards itself.
R
esults
Species
Data from triplicate experiments on 
original test isolates of urease 
producing species
Pooled data from single experiments with 
three alternative isolates of each urease 
producing species
Result of 5 
analy
(Two sam
statistical
rsis*
pie t-test)
Isolate
code
Mean blockage 
time, if 
applicable (h) 
(±SE)
Final urinary 
pH
(at blockage or 
4 days) (1SE)
Isolate codes
Mean blockage 
time, if 
applicable (h) 
(±SE)
Final urinary pH 
(at blockage or 4 
days) (±SE)
Blockage 
time (if 
applicable)
Final 
urinary pH
Proteus
mirabilis RB6 19.8 (± 2.91) 8.34 (± 0.19)
B2, NSM6, 
HI4320 22.0  (±2.00) 7.95 (± 0.06)
NSD
(P=0.614)
NSD
(P=0.185)
Proteus
vulgaris SDM2 36.4 (± 3.85) 8.42 (± 0.21)
NSM19, H2V, 
W
28.7 (±2.85) 8.44 (± 0.27)
NSD
(P=0.213)
NSD
(P=0.972)
Providencia
rettgeri SDM1 32.2 (±6.19) 8.36 (±0.19)
NSM26, 
RE12, AAAAG 26.0 (±8.19) 8.35 (± 0.28)
NSD
(P=0.565)
NSD
(P=0.963)
Providencia
stuartii RB14 - 6.44 (± 0.06)
NSM71, 
SM53, SM72 - 6.27 (± 0.04) -
NSD
(P=0.108)
Morganella
morganii RB15 - 7.14 (± 0.12)
NSM63, 
SM18, SM40 - 7.28 (± 0.05) -
NSD
(P=0.575)
Staphylococcus
aureus P10 6/9 - 6.89 (± 0.06)
NSM5, NSM7, 
N49 - 6.27 (± 0.06) -
HSD
(P<0.001)
Pseudomonas
aeruginosa RB16 - 6.32 (± 0.05)
RB4, SM10, 
SDM5 - 6.29 (± 0.03) -
NSD
(P=0.723)
Klebsiella
pneumoniae SDM17 - 6.31 (±0.05)
NSM22, 
SM28, RB8 - 6.27 (± 0.02) -
NSD
(P=0.568)
Table 3.2: Comparison between blockage time (if appropriate) and final urinary pH (at blockage or 96 h) recorded in triplicate experiments on original test 
isolates and single experiments on three alternative isolates of each species.
* - indicates catheters drained freely for the 96 h experimental period; NSD: No significant difference; HSD: Highly significant difference
Results
Digital photographs taken of catheters removed from the bladder model at blockage or 
after 96 h are presented in Figures 3.13 -  3.20. The isolates of Pr. mirabilis, Pr. 
vulgaris and Pv. rettgeri tested all show large amounts of encrustation to be present 
on the catheter sections, in particular the eyehole sections (Figures 3.13 -  3.15). The 
M. morganii isolates showed some variation (Figure 3.16), with some alternative 
isolates (NSM63 & SMI8) apparently less encrusted than the original isolate (RBI5) 
after 96 h. There was also a difference between the original isolate and the alternative 
isolates for Staph, aureus (Figure 3.17). While the main isolate (P10 6/9) showed 
some encrustation little sign of crystalline material is apparent on the alternative 
isolates (N49, NSM5 & NSM7) after 96 h. Figure 3.21 shows that, while the mean 
urinaiy pH at 96 h of the original Staph, aureus isolate is significantly greater 
(P<0.001) than that of the alternative isolates, the mean cfu/ml of the original isolate 
is significantly less (PO.OOl) than that of the alternative isolates. For Ps. aeruginosa 
there was no apparent difference between any of the isolates after 96 h, with little 
biofilm present on the top two sections and very thick mucoid biofilm present on the 
third section (Figure 3.18). The images of Pv. stuartii (Figures 3.19) show little 
evidence of biofilm produced by any of the isolates. In the case of K. pneumoniae 
two of the four isolates appeared to form biofilm on section 3 of the catheters (Figure 
3.20).
3.1.6 An assessment of the ability of less commonly occurring urease producing 
bacteria to raise urinary pH.
The collection of bacteria that has been built up in the Cardiff laboratory over the 
years contains several other urease producing species that although not common, have
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Figure 3.20: Comparison of biofilm formation after four days for four K. pneumoniae isolates
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Figure 3.21: Variation in urine pH and viable cell numbers vs. time for Staph, aureus (P10 6/9) and 
three alternative urease producing Staph, aureus isolates (NSM5, NSM7, N49) in the bladder model over 
four days. Experiments using the alternative isolates were performed once for each isolate and the data 
combined. Statistical analysis indicates that the means of viable cell numbers and urinary pH for Staph, 
aureus PI 0 6/9 at 96 h are significantly different (PO.OOl) than those o f the alternative isolates.
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Results
been isolated from time to time from catheter associated UTIs. Nine isolates of five 
such species (Ser. marcescens, K. oxytoca, Enterobacter cloacae, C. freundii and C. 
koseri) were also tested in the bladder model for their ability to produce crystalline 
biofilms.
The results obtained with three isolates of Ser. marcescens are presented in Figure 
3.22. There was little evidence of biofilm on the catheter sections (Figure 3.22a). 
The urinary pH remained stable at approximately 6.2 over 96 h, while the numbers of 
bacteria also remained stable at just above 108 cfu/ml (Figure 3.22b). This was also 
true for the other isolates tested {K. oxytoca, Enterobacter cloacae, C. freundii and C. 
koseri), with the urinary pH remaining stable at approximately 6.2 and the bacterial 
numbers remaining stable at just above 108 cfu/ml (Figures 3.23 -  3.25).
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Figure 3.22a: Sections of catheter removed from Ser. marcescens infected bladder models
after four days.
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Figure 3.22b: The pHs and viable cell populations of the residual urine 
over a 96 h test period in bladder models inoculated with Ser. marcescens 
isolates. Experiments were performed once for each isolate. The mean 
values from the three isolates combined (±SE) is also shown.
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Figure 3.23a: Sections o f catheter removed from K. oxytoca
infected bladder models after four days.
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Figure 3.23b: The pHs and viable cell populations o f the residual urine over a 96
h test period in bladder models inoculated with K. oxytoca isolates. Experiments
were performed once for each isolate.
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Figure 3.24b: The pHs and viable cell populations of the residual urine over a 96
h test period in bladder models inoculated with Enterobacter cloacae isolates.
Experiments were performed once for each isolate.
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Figure 3.25a: Sections of catheter removed from C. freundii
(SM45) and C. koseri (RBI2) infected bladder models after four
days.
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Figure 3.25b: The pHs and viable cell populations of the residual urine over a 96
h test period in bladder models inoculated with C. freundii (SM45) and C. koseri
(RBI2). Experiments were performed once for each isolate.
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3.2 The development of crystalline biofilm on silver-hydrogel and nitrofurazone 
catheters.
Antimicrobial catheters (silver-hydrogel coated latex (Bard IC catheter) and the 
nitrofurazone impregnated all-silicone catheter (Rochester Medical NF catheter)) have 
recently been introduced into clinical practice. In view of the controversy 
surrounding their efficacy in preventing catheter-associated UTI (Trautner et al., 
2005a; Johnson et al., 2006) it was decided to examine their ability to resist 
encrustation by crystalline biofilm. Experiments were performed in the bladder 
models with five of the urease producing species that had been shown to be capable of 
forming crystalline biofilm in urine (Section 3.1).
A summary of the results indicating the mean times catheters took to block, calculated 
from three replicate experiments, is presented in Table 3.3. The experiments were 
conducted as stated in Section 3.1.1, until 168 h or blockage, with an all-silicone 
catheter inoculated as a control. The results show that the three most active urease 
producers Pr. mirabilis, Pr. vulgaris and Pv. rettgeri blocked the silicone control, the 
silver and the nitrofurazone catheters within mean times of 30 h. There was no 
significant difference in mean times to blockage for these species for the silicone and 
nitrofurazone catheters (P>0.05). Pr. mirabilis and Pv. rettgeri however blocked the 
silver catheters significantly more rapidly than Pr. vulgaris (P<0.05). M. morganii 
took significantly longer to block the silicone and nitrofurazone catheters, 149 and 
131 h respectively, (P<0.05) and failed to block the silver catheters within the 168 h 
experimental period. All three types of catheter drained freely for 168 h in models 
infected with Staph, aureus.
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C a t h e t e r
t y p e
M e a n  b l o c k a g e  t i m e  ( h )  ( ± S E )
S ta t is t ic a l  
a n a ly s i s  o f  
b lo c k a g e  
t im e s  
(A N O V A )
P r .  m i r a b i l i s  
(R B 6)
P r .  v u l g a r i s  
(SD M 2)
P v .  r e t t g e r i  
(SD M 1)
M .  m o r g a n i i  
(R B 1 5 )
S t a p h ,  a u r e u s  
(P 1 0  6 /9 )
A ll- s i l ic o n e 2 0 .0  (±2.6) 2 5 .0  (±2.0) 2 6 .7  (±7.9) 1 4 9  (±13.0)
Did not block  
after 1 6 8  h
HSD
(P < 0 .0 0 1 )
S ilv e r -  
h y d r o g e l  
c o a t e d  la te x
1 5 .7  (±2.0) 2 3 .7  (±1.3) 1 5 .3  (±0.9)
Did not block  
after 1 6 8  h
Did not b lock  
after 1 6 8  h
S D
(P = 0 .0 1 2 )
N itr o fu r a z o n e 2 6 .7  (±3.2) 2 7 .0  (±2.5) 2 9 .7  (±6.1) 1 3 1 .3  (±12.2)
Did not block  
after 1 6 8  h
HSD
(P < 0 .0 0 1 )
S ta t is t ic a l  
a n a ly s i s  o f  
b lo c k a g e  
t im e s  
(AN O V A )
N S D  
(P = 0 .0 6 8 )
N S D
(P = 0 .4 4 4 )
N S D  
(P = 0 .2 5 6 )
N S D
(P = 0 .3 7 9 )  
(between all­
silicone and 
nitrofurazone)
-
Table 3.3: Blockage times (±SE) for five urease producing species on all-silicone, silver-hydrogel and nitrofurazone catheters recorded in triplicate experiments. 
Statistical analysis was carried out on the blockage times between the different species on each catheter type and for each species on the three catheter types
*NSD: No significant difference; SD: Significant difference; HSD: Highly significant difference; - indicates no statistical analysis attempted
Results
Figure 3.26 shows the variation in urinary pH for the five test species during the 
experimental period for each of the catheters tested. For all-silicone catheters (Figure 
3.26a) there was no significant difference CP>0.05) between the mean final urinary 
pHs of Pr. mirabilis, Pr. vulgaris and Pv. rettgeri, while all three species were 
significantly different (P<0.05) from the mean final urinary pHs of M. morganii and 
Staph, aureus. There was no significant difference (P>0.05) between the mean final 
urinary pHs of M. morganii and Staph, aureus. The silver-hydrogel catheters (Figure 
3.26b) showed a similar pattern, with no significant difference (P>0.05) between the 
mean final urinary pHs of Pr. mirabilis, Pr. vulgaris and Pv. rettgeri, while all three 
species were significantly different (P<0.05) from the mean final urinary pH of Staph, 
aureus. The mean final urinary pH of M. morganii was not significantly different 
(P>0.05) from that of Pr. vulgaris and Pv. rettgeri but was significantly different 
(^<0.05) from those of Pr. mirabilis and Staph, aureus. For nitrofurazone catheters 
(Figure 3.26c) there was no significant difference (i^O.05) between the mean final 
urinary pHs of Pr. mirabilis, Pr. vulgaris, Pv. rettgeri and M. morganii while all four 
species were significantly different (P<0.05) from the mean final urinary pH of Staph, 
aureus (Figure 3.26c).
The mean urinary viable cell counts are presented in Figure 3.27. Each of the species 
shows a consistent pattern irrespective of the catheter type being tested. Both Proteus 
species show a similar pattern, with an initial cfu/ml of just above 108, falling slightly 
at blockage. For models inoculated with Pv. rettgeri the cell numbers present 
remained stable at approximately 107 cfu/ml for the duration of the experiment. M. 
morganii numbers fell in the first 24 h from an initial cfu/ml of above 108 to below 
107, before recovering steadily back to around 108 cfu/ml. The numbers of Staph.
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Figure 3.26a: Variation in urinary pH vs. time for five urease producing species until blockage or 
168 h on all-silicone catheters.
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Figure 3.26b: Variation in urinary pH vs. time for five urease producing species until blockage or 
168 h on silver-hydrogel coated latex catheters.
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Figure 3.26c: Variation in urinary pH vs. time for five urease producing species until blockage or 
168 h on nitrofurazone impregnated all-silicone catheters.
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Figure 3.27a: Variation in viable cell numbers vs. time for five urease producing species until 
blockage or 168 h on all-silicone catheters.
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Figure 3.27b: Variation in viable cell numbers vs. time for five urease producing species until 
blockage or 168 h on silver-hydrogel coated latex catheters.
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Figure 3.27c: Variation in viable cell numbers vs. time for five urease producing species until 
blockage or 168 h on nitrofurazone impregnated all-silicone catheters.
Results
aureus cells present show a steady fall from around 108 cfu/ml initially to below 107 
cfu/ml after 168 h.
Digital photography, LV-SEM and HV-SEM were used to visualise the biofilms 
present on catheters at blockage or after 168 h. The images of all-silicone catheters 
were similar to those present in Section 3.1.
3.2.1 Visualisation of the encrustation present on silver-hydrogel catheters.
Digital photographs and LV-SEM images of silver-hydrogel catheters removed from 
the model at blockage or after 168 h are presented in Figures 3.28 & 3.29. The 
catheters infected with Pr. mirabilis, Pr. vulgaris, Pv. rettgeri and M. morganii are 
heavily encrusted, in particular around and below the catheter eyehole, while very 
little encrustation is present on the un-blocked Staph, aureus catheter. HV-SEM 
images of Pr. mirabilis, Pr. vulgaris and Pv. rettgeri biofilms at blockage (Figure 
3.30) show that the encrustation present on the catheters was mostly composed of 
apatite microcrystals, with a few struvite crystals also observed in the Pr. vulgaris 
biofilm on the eyehole section. Images of the M. morganii biofilm (Figure 3.31) 
showed that while the encrustation was mostly composed of apatite microcrystals 
some large calcium phosphate crystals were also present. HV-SEM of the Staph, 
aureus biofilm after 168 h showed that the encrustation present on the eyehole section 
was mostly composed of large calcium phosphate crystals (Figure 3.31). In the 
catheter lumen the encrustation was mainly composed of apatite microcrystals with 
some large calcium phosphate crystals also present.
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Figure 3.28: Digital camera images o f silver hydrogel catheters removed from the model at blockage or after 168 h.
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Figure 3.29: LV-SEM images of silver-hydrogel catheters removed from the model at blockage or after 168 h.
Results
K :c  V  Spot Magn 
10 0 kV 3 0, 11039x vulgaris. S ^ td tjw te r  (blockade)
A & B: Encrusted Pr. mirabilis biofilm on a silver-hydrogel catheter. Biofilm heavily encrusted with apatite 
microcrystals is shown in A. No struvite crystals were observed in the biofilm. A close-up image of the biofilm 
is shown in B, showing Pr. mirabilis rods in association with apatite microcrystals.
C & D: Encrusted Pr. vulgaris biofilm on a silver-hydrogel catheter. A large struvite crystal is present (indicated
, ^ ------, C), surrounded by apatite microcrystals . Few struvite crystals were observed in the biofilm. Pr.
vulgaris cells were seen in association with apatite microcrystals at higher magnification (D).
E & F: Encrusted Pv. rettgeri biofilm on a silver-hydrogel catheter. Biofilm heavily encrusted with apatite 
microcrystals is shown in E. No struvite crystals were observed in the biofilm. A high magnification image of 
the biofilm is shown in F, showing Pv. rettgeri rods in association with apatite microcrystals.
Figure 3.30: HV-SEM images of Pr. mirabilis, Pr. vulgaris and Pv. rettgeri biofilms on silver-hydrogel coated 
latex catheters removed from bladder models at blockage.
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A & B: M  morganii biofilm on a silver-hydrogel catheter. Some arrays o f large calcium phosphate crystals are 
present around the eyehole (A). The biofilm was also encrusted with apatite microcrystals crystals (B).
,Acc V Spot Magn Det WD I----------------------1 5  pm
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C & D: Staph. aureus biofilm on a silver-hydrogel catheter. Many arrays o f large calcium phosphate crystals 
are present, in particular around the eyehole (C). Further down the catheter the biofilm was encrusted with 
apatite microcrystals in addition to some large calcium phosphate crystals (D).
Figure 3.31: HV-SEM images of M. morganii and Staph, aureus biofilms on silver-hydrogel coated latex 
catheters removed from bladder models after 168 h.
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3.2.2 Visualisation of the encrustation present on nitrofurazone catheters.
Digital photographs and LV-SEM images of nitrofurazone catheters removed from 
the model at blockage or after 168 h are presented in Figures 3.32 & 3.33. The 
catheters infected with Pr. mirabilis, Pr. vulgaris, Pv. rettgeri and M. morganii are 
heavily encrusted, in particular around and below the catheter eyehole, while very 
little encrustation is present on the un-blocked Staph, aureus catheter. HV-SEM 
images of Pr. mirabilis, Pr. vulgaris, Pv. rettgeri and M. morganii biofilms at 
blockage (Figures 3.34 & 3.35) show that the encrustation present on the catheters 
was mostly composed of apatite microcrystals, with a few struvite crystals also 
observed in the Pr. mirabilis, Pr. vulgaris and Pv. rettgeri biofilms on the eyehole 
sections. HV-SEM of the Staph, aureus biofilm after 168 h showed that the 
encrustation present on the eyehole section was mostly composed of apatite 
microcrystals, with some large calcium phosphate crystals also present (Figure 3.35). 
In the catheter lumen the encrustation was composed of apatite microcrystals.
3.2.3 The MIC of nitrofurazone for encrusting species used in experiments with 
nitrofurazone catheters.
The MIC of nitrofurazone for four of isolates of each of the species tested on the 
nitrofurazone catheters was determined using the method described in Section 2.7. 
The highest concentration tested was 128 pg/ml, since this is approaching the limit of 
solubility for nitrofurazone in agar. The results are displayed in Table 3.4. The MIC 
was greatest for Pv. rettgeri isolates (64 -  128 pg/ml), with Pr. mirabilis (64 pg/ml), 
M. morganii (32 -  64 pg/ml) and Pr. vulgaris (32 -  64 pg/ml) isolates exhibiting high
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Figure 3.32: Digital camera images o f nitrofurazone catheters removed from the model at blockage or after 168 h.
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Figure 3.33: LV-SEM images of nitrofurazone catheters removed from the model at blockage or after 168 h.
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A & B: Encrusted Pr. mirabilis biofilm on a nitrofurazone catheter. Several large struvite crystals are present
(indicated,^ , A), surrounded by apatite microcrystals. A relatively large number of struvite crystals were
observed in the biofilm. Biofilm heavily encrusted with apatite microcrystals is shown in B, with some bacterial 
cells present (indicated,^ ).
-------- ( 100 |im
arts. NF catheter (blockage)
C & D: Encrusted Pr. vulgaris biofilm on a nitrofurazone catheter. A relatively large number o f struvite crystals
were present (indicated, ------, C), surrounded by apatite microcrystals. Few struvite crystals were observed in
the biofilm. Biofilm heavily encrusted with apatite microcrystals is shown in D.
E & F: Encrusted Pv. rettgeri biofilm on a nitrofurazone catheter. A number o f large struvite crystals are
present (indicated, ^ -------, E), surrounded by apatite microcrystals. Few struvite crystals were observed in the
biofilm. Biofilm heavily encrusted with apatite microcrystals is shown in F.
Figure 3.34: HV-SEM images of Pr. mirabilis, Pr. vulgaris and Pv. rettgeri biofilms on nitrofurazone 
catheters removed from bladder models at blockage.
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A & B: M. morganii biofilm on a nitrofurazone catheter. The biofilm is heavily encrusted with apatite 
microcrystals (A). A close-up image o f the biofilm is shown in B, showing M. morganii rods in association with 
apatite microcrystals.
C & D: Staph, aureus biofilm on a nitrofurazone catheter. Some arrays o f large calcium phosphate crystals are 
present around the eyehole together with apatite microcrystals (C). Further down the catheter the biofilm was 
encrusted with apatite microcrystals (D).
Figure 3.35: HV-SEM images o f M. morganii and Staph, aureus biofilms on nitrofurazone catheters removed 
from bladder models at blockage (M morganii) or after 168 h {Staph, aureus).
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Species Isolate Nitrofurazone MIC (pg/ml)
Nitrofurazone 
MSIC (pg/ml) 
(if appropriate)
E. coli 
(control)
NCTC 10418 4 -
Staph, aureus 
(control) NCTC 6571 8 -
Pr. mirabilis RB6 64 16
Pr. mirabilis NSM6 64 16
Pr. mirabilis B2 64 4
Pr. mirabilis HI4320 wild type 64 16
Pr. vulgaris SDM2 32 -
Pr. vulgaris H2V 32 -
Pr. vulgaris NSM19 64 -
Pr. vulgaris W 32 -
Pv. rettgeri SDMI 64 -
Pv. rettgeri RE12 128 -
Pv. rettgeri NSM26 128 -
Pv. rettgeri AAAAG 128 -
M. morganii RBI 5 64 -
M. morganii SM18 64 ;
M. morganii SM40 32 -
M. morganii NSM63 64 -
Staph, aureus P10 6/9 16 -
Staph, aureus NSM5 16 -
Staph, aureus NSM7 16 -
Staph, aureus N49 8 -
Staph, saprophyticus ZEC17 4 -
Table 3.4: MIC o f nitrofurazone (and if  appropriate MSIC) for selected isolates. Control plates containing the 
largest levels o f solvent used (DMSO) and agar only plates all showed growth for all isolates.
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MICs in comparison to the E. coli NCTC 10418 (4 pg/ml) and Staph, aureus NCTC 
6571 (8 pg/ml) controls. Staph, aureus isolates exhibited MICs similar to that of the 
control Staph, aureus ( 8 - 1 6  pg/ml). A single isolate of Staph, saprophyticus was 
also included in the screen, as this isolate was also identified as being capable of 
causing encrustation. Since this species is rarely isolated from long-term catheterised 
patients only one isolate was available for testing. The isolate was found to be quite 
sensitive to nitrofurazone (MIC 4 pg/ml).
It is clear that the four main urease producers have (Pr. mirabilis, Pr. vulgaris, Pv. 
rettgeri and M. morganii) have relatively high MICs for nitrofurazone. This lack of 
sensitivity could well explain why there was no significant difference between the 
mean times to blockage recorded for the all-silicone and nitrofurazone impregnated 
silicone catheters (P>0.05), as shown in Table 3.3.
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3.3 The control of catheter encrustation by the delivery of antimicrobial agents 
through the retention balloon.
A strategy to control catheter encrustation by inflating the retention balloons with 
solutions of antimicrobial agents rather than with water was first suggested by Bibby 
et al. (1995). The idea was that the balloon would constitute a large reservoir from 
which antimicrobials could be delivered to the urine and thus inhibit the encrustation 
process. It was also suggested that the membrane of the balloon might provide a 
diffusion barrier that could control the rate of release of agents into the residual urine 
over protracted periods. Subsequent experimental work in laboratory models of the 
catheterised bladder showed that the biocide triclosan, which is extremely active 
against Pr. mirabilis, can diffuse through the balloons of silicone and latex catheters 
and inhibit encrustation (Stickler et a l, 2003a; Jones et a l, 2005). Unfortunately the 
formulation of triclosan used in this in vitro work (10 mg/ml in 5 % aqueous 
polyethylene glycol) is not suitable for producing the sterile solutions that would be 
necessary for use with patients. Because of the possibility of the degradation of 
triclosan by heating, sterilization by autoclaving is not a possibility. The polyethylene 
glycol formulation produces an emulsion rather than a solution and on membrane 
filtration, the phases separate and the filtrate is an aqueous solution containing very 
little triclosan. Williams (2006) investigated various ways of producing sterile stable 
solutions of triclosan and found that solutions containing up to 3 mg/ml can be 
prepared in 0.1 M sodium carbonate. It was decided to examine the ability of this 
formulation to inhibit catheter encrustation by the three species previously shown to 
be capable of rapidly blocking catheters.
Results
3.3.1 The ability of triclosan 3 mg/ml in 0.1 M sodium carbonate to inhibit crystalline 
biofilm formation bv species capable of causing rapid catheter blockage.
Bladder models were inoculated with 10 ml of a 4 h logarithmic culture of Pr. 
mirabilis (RB6), Pr. vulgaris (SDM2) or Pv. rettgeri (SDMI) in artificial urine. The 
catheter retention balloons of the test catheters were inflated using 10 ml of a 3 mg/ml 
triclosan solution in 0.1 M Na2 CC>3 (pH 11) prepared as described in Section 2.9.1. 
Catheters with retention balloons inflated with 0.1 M Na2 CC>3 or sterile water were 
used as controls. At 24 h intervals, up to a maximum of 168 h, or at blockage if it 
occurred, urine samples were taken from the bladder chamber. The pH values of the 
urine samples were measured and the viable bacterial cell populations were 
determined. The experiments were all carried out as three independent replicates and 
a summary of the data on the time the catheters took to block is presented in Table 
3.5.
Figure 3.36 shows the urinary pH and viable bacterial cell population data collected 
for models inoculated with Pr. mirabilis RB6. The catheters with retention balloons 
inflated with control solutions (0.1 M Na2CC>3 or water) all blocked within 40 h, with 
no significant difference between the mean blockage times (^=0.467). In contrast 
urine was still flowing freely through the catheters with balloons inflated with 
triclosan in 0.1 M Na2CC>3 after 168 h. Statistical analysis revealed that there was no 
significant difference between the means of the initial urinary pHs (7MX783) and 
initial cell populations (7MX288) of the test and control models. Inflation of the 
balloons with the triclosan solution clearly had a profound effect, significantly 
reducing the pH (P=0.04) and viable cell population (F*<0.05) of the residual urine.
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Species
(isolate)
Mean blockage time (h) (±SE)
W a ter
c o n tr o l
0.1 M N a 2C 0 3 
c o n tr o l
T r ic lo sa n  
(3  m g /m l)
P r .  m i r a b i l i s  
(R B 6)
2 3 .7  (±6.9) 1 8 .0  (±1.5)
Did not block  
after 1 6 8  h
P r .  v u l g a r i s  
(S D M 2)
2 7 .0  (±2.0) 3 8 .7  (±7.7)
Did not block  
after 1 6 8  h
P v .  r e t t g e r i  
(S D M 1)
3 0 .7  (±0.3) 3 2 .3  (±6.0) 4 1 .7  (±8.5)
Table 3.5: The effect o f inflating catheter retention balloons with triclosan (3 mg/ml in 0.1 M NajCO-j) on catheter blockage times in 
models infected with Pr. mirabilis, Pr. vulgaris or Pv. rettgeri.
Results
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Figure 3.36: Variation in urinary pH and cell population vs. time for models inoculated with Pr. 
mirabilis RB6 until catheter blockage or 168 h. The catheter retention balloons were inflated with 
either 10ml of 3 mg/ml triclosan in 0.1 M Na^C^ or a control solution (0.1 M Na^C^ or sterile water).
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A very similar set of data was produced from the experiments with Pr. vulgaris 
SDM2 (Figure 3.37). None of the test catheters blocked within the 168 h test period. 
The control catheters all blocked within 60 h and showed no significant difference 
(P=0.216) between mean blockage times. There was no significant difference 
(P=0.255) between the mean initial urinary pHs of the test and control models. The 
median final urinary pH of the Na2CC>3 control was significantly greater (iM).04) than 
that of the test model. The means of the initial and final cell populations of the 
control models were not significantly different (P>0.05) from each other while the 
mean initial and final cell populations of the test model were significantly different 
(P<0.05) to both of the controls.
While the triclosan formulation controlled the generation of alkaline urine and 
catheter encrustation by both Pr. mirabilis and Pr. vulgaris it had little effect on the 
process in models infected with Pv. rettgeri SDMI (Figure 3.38). Catheter blockage 
occurred in all of the test and control models. There was no significant difference 
between the median blockage times (P=0.575), mean initial urinary pHs (P=0.887), 
mean final pHs (P=0.844) and mean final cell populations (7MX102) of the test and 
control models. The mean initial cell population of the control models was 
significantly different (PO.05) from that of the test models while the control models 
were not significantly different (P>0.05) from each other.
The MIC of triclosan for four of isolates of each of the three species was determined 
using the method described in Section 2.7. The lowest concentration tested was 0.05 
pg/ml and the highest concentration tested was 128 pg/ml, since this is approaching 
the limit of solubility for triclosan in agar. The results (Table 3.6) confirm the
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Figure 3.37: Variation in urinary pH and cell population vs. time for models inoculated with Pr. 
vulgaris SDM2 until catheter blockage or 168 h. The catheter retention balloons were inflated with 
either 10ml o f 3 mg/ml triclosan in 0.1 M Na^C^ or a control solution (0.1 M Na^C^ or sterile water).
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Figure 3.38: Variation in urinary pH and cell population vs. time for models inoculated with Pv. 
rettgeri SDMI until catheter blockage. The catheter retention balloons were inflated with either 10ml 
o f 3 mg/ml triclosan in 0.1 M Na2C03 or a control solution (0.1 M NajCC^ or sterile water).
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Species Isolate
Triclosan 
MIC (pg/ml)
Triclosan 
MSIC (pg/ml) 
(if appropriate)
E. coli 
(control)
NCTC 10418 0.1 -
Staph, aureus 
(control) NCTC 6571 0.05
-
Pr. mirabilis RB6 0.1 0.1
Pr. mirabilis NSM6 0.2 0.1
Pr. mirabilis B2 0.1 0.1
Pr. mirabilis HI4320 wild type 0.1 0.1
Pr. vulgaris SDM2 0.1 -
Pr. vulgaris H2V 0.05 -
Pr. vulgaris NSM19 0.1 -
Pr. vulgaris W 0.1 -
Pv. rettgeri SDMI 64 -
Pv. rettgeri RE12 64 -
Pv. rettgeri NSM26 64 -
Pv. rettgeri AAAAG 64 -
Table 3.6: MIC and, if appropriate, MSIC o f triclosan for selected isolates. Control plates containing the largest 
levels of solvent used (DMSO) and agar only plates all showed growth for all isolates.
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extreme sensitivity of Pr. mirabilis and Pr. vulgaris to this biocide. Pv. rettgeri is 
much more resistant to triclosan (MIC 64 fig/ml) and this clearly explains the failure 
of the triclosan formulation to prevent catheter encrustation by this organism.
3.3.2 The effect of a nitric oxide generating solution on catheter encrustation by Pr. 
mirabilis.
A recent study by Carlsson et al. (2005) showed that filling catheter retention balloons 
with a solution that generated nitric oxide significantly reduced the number of E. coli 
present in the residual urine, in a static model of the catheterised urinary tract. As 
nitric oxide has a broad spectrum of antimicrobial activity and readily diffuses 
through silicone it was decided to test this strategy against Pr. mirabilis using our 
continuous flow model.
The nitric oxide generating solution used was 10 mM ascorbic acid, 5 mM sodium 
nitrite in physiological saline at pH 2.5, as described by Carlsson et al. (2005). 
Immediately prior to inoculation of the bladder model equal volumes of stock 
solutions of pH 2.5 20 mM ascorbic acid in physiological saline and pH 2.5 10 mM 
sodium nitrite in physiological saline were mixed and the resulting solution used to 
inflate the retention balloon. Catheters with balloons inflated with pH 2.5 10 mM 
ascorbic acid in physiological saline, pH 2.5 5 mM sodium nitrite in physiological 
saline, pH 2.5 physiological saline only, and sterile water were used as controls. 
Bladder models were inoculated with 100 pi of a 4 h logarithmic culture of Pr. 
mirabilis RB6 in artificial urine. At 24 h intervals until blockage urine samples were 
taken from the bladder chamber. The pHs of the urine samples were measured and
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the viable bacterial cell populations determined. The extent of encrustation present on 
catheter sections was visualised using digital photography.
Figure 3.39 shows the blockage times and variation in bladder chamber urine pH for 
test and control models inoculated with Pr. mirabilis RB6. There was no significant 
difference (P=0.109) between the mean blockage times or the mean final urine pHs 
(P=0.182) of the test and control catheters. Statistical analysis also showed no 
significant difference in the mean initial urinary cell populations (7MX266) and mean 
final urinary cell populations (P=0.378) of the test and control models (data not 
shown).
Digital photographs of test and control catheters removed from the model at blockage 
are shown in Figure 3.40. All of the catheters show large amounts of encrustation, 
particularly on the eyehole and lumen sections nearest the eyehole. It is clear that the 
nitric oxide generating solution had little effect on the formation of crystalline biofilm 
by Pr. mirabilis.
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Figure 3.39a: Mean blockage times for catheters with retention balloons filled with a nitric oxide 
generating solution or one o f four controls. All bladder models were inoculated with 100 |il o f a 4 h 
logarithmic phase culture o f Pr. mirabilis RB6 in artificial urine. The mean values ±SE were 
calculated from the results o f three replicate experiments.
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Figure 3.39b: Variation in urine pH in the bladder model until blockage for catheters with retention 
balloons filled with a nitric oxide generating solution or one o f four control solutions. All bladder 
models were inoculated with 100 pi o f a 4 h logarithmic phase culture o f Pr. mirabilis RB6 in artificial 
urine.
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Figure 3.40: Digital camera images comparing encrustation at blockage for all-silicone catheters with retention balloons filled with either a nitric oxide 
producing solution or a control solution. All bladder models were inoculated with 100 pi o f a 4 h logarithmic phase Pr. mirabilis (RB6) culture.
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3.4 An integrated sensor/modulator strategy for the control of catheter 
encrustation.
The complication of catheter blockage and encrustation is unpredictable and 
commonly results in emergency referrals of patients with urinary retention or 
incontinence owing to obstruction of the flow of urine (Kohler-Ockmore and Feneley, 
1996). Stickler et al. (2006a) developed a simple sensor to detect the early stages in 
the formation of crystalline biofilm on catheters and thus give early warning of an 
impending clinical crisis. The sensor is composed of cellulose acetate to which the 
pH indicator bromothymol blue is covalently bound. It is a simple strip of yellow 
plastic that can be located in the urine collection bag. In laboratory and clinical 
studies (Stickler et al., 2006a; Stickler et al., 2006c) it has been shown to change from 
yellow to blue in response to infection by urease producing organisms such as Pr. 
mirabilis. It has also been demonstrated that when the sensor changes colour, 
crystalline biofilm has started to form on the catheter. The idea is that when the 
sensor in the bag turns blue, the triclosan strategy (Section 3.3) will be implemented.
An important practical question is; when the sensor gives the signal, will the emptying 
of the water from the balloon of the current catheter and refilling with the triclosan be 
effective in preventing catheter blockage? In other words will the triclosan strategy 
be effective in stopping additional encrustation forming on the catheter? On the other 
hand will it be necessary to replace the existing catheter with one inflated with 
triclosan in order to prevent blockage? A programme of work was performed in the 
bladder models in order to resolve these issues. The experiments involved the three 
species that had been shown to encrust catheters rapidly. The triclosan was prepared
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from a proprietary handwash solution (Hy-Shield SkinSure plus, Hygieia Healthcare 
Ltd.) diluted to 3 mg/ml or a solution at 3 mg/ml in 0.1 M sodium carbonate.
Bladder models were inoculated with 100 pi of a 4 h logarithmic phase culture of Pr. 
mirabilis RB6, Pr. vulgaris SDM2, or Pv. rettgeri SDMI in artificial urine. The 
catheter retention balloons of the test and control catheters were inflated with 10 ml of 
sterile water. The pH sensor was placed aseptically into the urine collection bag and 
its appearance monitored until it corresponded to pH 8 on a sensor colour chart 
(Figure 3.41). At this point 5 ml of water was removed from the balloon of the test 
catheter and replaced with 5 ml of either Hy-Shield Skinsure plus cream diluted with 
sterile water to contain 6 mg/ml triclosan or 6 mg/ml triclosan in 0.2 M Na2CC>3 . The 
water remaining in the balloon was mixed with the triclosan solution by removing 5 
ml of solution and then re-inflating the balloon several times. Urine samples were 
taken from the bladder chamber and urine collection bag at the start of the experiment, 
at the point the sensor became positive, 8 h after triclosan intervention and at 24 h 
intervals post triclosan intervention until 96 h or blockage. Additional urine samples 
were taken from the urine collection bag at 2, 4 and 12 h (and 18 h if the sensor had 
not become positive by that point) after the start of the experiment. The pHs of all the 
urine samples were measured and the viable bacterial cell populations of urine 
samples from the bladder chamber determined. Digital photographs of the pH sensors 
were taken at each point the urine collection bag pH was measured. Digital 
photography and HV-SEM were used to assess the extent of encrustation on catheters 
and sensors at the point the sensor became positive and at blockage or 96 h post 
triclosan intervention for the control and test catheters. Statistical analysis was used 
where appropriate to determine if  there was any significant difference between the
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Figure 3.41: The appearance o f the pH sensor over the pH range 6.1 -  9.4 in artificial urine. The colour chart was used for comparison to pH sensors inserted 
into urine collection bags. The pH sensor was considered to be ‘positive’ when the colour corresponded to pH 8 on the pH sensor colour chart (indicated ).
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mean (Two Sample t-test) or median (Mann-Whitney) blockage times and urinary 
pHs of the test and control catheters.
Figure 3.42 shows the variation in urinary pH in the bladder chamber and urine 
collection bag for models inoculated with Pr. mirabilis with triclosan intervention 
(Hy-Shield) applied at the time the sensor became positive. Blockage occurred in the 
test catheters of two of the replicates while one model drained freely for the duration 
of the experiment. In all three test catheters the urine pH in the collection bags 
remained above 8.5 after triclosan intervention while the urine pH in the bladder 
model quickly fell to below 7.5. The pH of the residual urine in the test model which 
drained freely for the duration of the experiment remained around pH 7 after 
intervention, although the final reading showed a sharp rise in urinary pH (up to 8.5).
The data from the experiments with Pr. vulgaris are shown in Figure 3.43. Blockage 
occurred in the test catheter of one of the replicates while two models drained freely 
for the duration of the experiment. For the test catheter in which blockage occurred 
the time of blockage was three times that of the control catheter. In all three test 
catheters the urine pH in the collection bags remained above 8 after triclosan 
intervention while the urine pH in the bladder model quickly fell to below 7. The pH 
of the residual urine in all three test models remained below pH 7 after intervention.
In experiments with Pv. rettgeri blockage of all three test catheters occurred within 24 
h of the sensor becoming positive (Figure 3.44). There was no significant difference 
between the mean blockage times of the test and control catheters (P=0.509). 
Statistical analysis also revealed no significant difference between the median final
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Figure 3.42: Variation in urinary pH vs. time for models inoculated with Pr. mirabilis RB6 until blockage or 
96 h post triclosan intervention. 3 individual replicates are shown. When the sensor gave the positive signal the 
water in the test catheter balloons was replaced with triclosan at 3 mg/ml (diluted Hy-Shield). The appearance of  
the pH sensors placed in the catheter bag is also shown. Selected reduced size images o f the sensors are shown at 
the appropriate time points on the graphs (border colour indicates which line they correspond to).
* *  indicates that the catheter was draining freely at the end o f the experiment.
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Figure 3.43: Variation in urinary pH vs. time for models inoculated with Pr. vulgaris SDM2 until blockage 
or 96 h post triclosan intervention. 3 individual replicates are shown. When the sensor gave the positive signal 
the water in the test catheter balloons was replaced with triclosan (3 mg/ml). The colour o f pH sensors placed 
in the catheter bag is also shown. Selected reduced size images o f the sensors are shown at the appropriate time 
points on the graphs (border colour indicates which line they correspond to).
* 4  indicates that the catheter was draining freely at the end of the experiment.
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Figure 3.44: Variation in urinary pH vs. time for models inoculated with Pv. rettgeri SDMI until blockage. 
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urinary pH in the collection bags (P=0.663) and mean final urinary pH in the bladder 
chamber (75=0.543) of the test and control models.
A repeat set of experiments was performed with Pr. mirabilis using triclosan at 3 
mg/ml in 0.1 M Na2 CC>3 . The results (Figure 3.45) show that while the control 
catheters all blocked within 24 h of the positive sensor signal, none of the test 
catheters had blocked 96 h post triclosan intervention. The urinary pH in the bladder 
chamber fell to around pH 6.5 (24 h after triclosan intervention) in all of the test 
models and remained around pH 6.5 for the remainder of the experiment. The urinary 
pH in the collection bags initially rose to above pH 8.5 (8 h after triclosan 
intervention) before falling below pH 8 (24 h after triclosan intervention) but then 
rose back to above pH 8.5 for the remainder of the experiment.
The pH sensors (Figures 3.42 -  3.45) appear in general to have reflected the pH of the 
urine in the collection bag. It is important to note however that even in those cases 
where the triclosan reduced the pH of the residual urine in the bladder, the pH of the 
urine in the collection bag remained around 8 to 9 and the sensor stayed blue. These 
observations suggest that to monitor catheter encrustation effectively after the 
triclosan intervention it will be necessary to replace the urine collection bag with one 
containing a new sensor.
Digital photographs of catheters removed from the model at the times the sensors 
became positive, at blockage or at 96 h post triclosan intervention are shown in 
Figures 3.46 & 3.47. All of the catheters removed from the model at the times the 
sensor gave positive signals show some encrustation on both the catheter eyehole and
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Figure 3.45: Variation in urinary pH vs. time for models inoculated with Pr mirabilis RB6 until blockage or 
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pH sensors placed in the catheter bag is also shown. Selected reduced size images o f the sensors are shown at the 
appropriate time points on the graphs (border colour indicates which line they correspond to).
* 4  indicates that the catheter was draining freely at the end o f the experiment.
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Figure 3.46: Comparison of encrustation on catheter removal at various times for test and control models inoculated with Pr. mirabilis RB6.
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Figure 3.47: Comparison of encrustation on catheter removal at various times for test and control models inoculated with Pr. vulgaris SDM2 and Pv. rettgeri SDMI.
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luminal sections. Those catheters which blocked show large amounts of encrustation, 
particularly on the eyehole sections, while those which drained freely for the duration 
of the experiment show little difference in encrustation to the sections of catheter 
removed from the model when the sensor turned blue.
HV-SEM was carried out on catheters and sensors removed from the model system at 
the point the sensor became positive and at blockage or 96 h post triclosan 
intervention in experiments using diluted Hy-Shield cream as the triclosan 
intervention solution. A film of what appears to be EPS was seen on the biofilms 
formed by all three test species on catheter sections removed from the model at 
positive sensor (Figures 3.48 -  3.50). Crystalline biofilms consisting of apatite 
microcrystals were observed on all of the catheter sections examined at the point the 
sensor became positive. Little evidence of biofilm was seen on the surface of sensors 
removed from the bag at the point the sensor became positive or on the sensor from 
the Pv. rettgeri triclosan intervention test model (Figures 3.48 -  3.50). The sensors 
removed from the collection bags of Pr. mirabilis and Pr. vulgaris triclosan 
intervention test models (neither of which blocked during the experiment) showed 
heavy encrustation on the sensor surface which was composed of apatite microcrystals 
(Figures 3.48 & 3.49).
The results of the experiments show that the sensor is able to give early warning of 
encrustation for all of the three species tested. The Hy-Shield formulation however is 
not effective in stopping encrustation once it has begun. In contrast triclosan in 
Na2CC>3 was effective in preventing Pr. mirabilis from forming further encrustation 
on the catheter during the remainder of the experiment. This suggests that
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A & B: Encrusted Pr. mirabilis biofilm on an all-silicone catheter at the point the sensor became positive. Some 
EPS can be seen on the biofilm surface, overlaying the encrustation composed of apatite microcrystals (A). 
Closer examination o f the biofilm shows bacterial cells in association with apatite microcrystals (B).
C & D: The surface o f a pH sensor from the catheter bag o f a bladder model inoculated with Pr. mirabilis at the 
point the sensor became positive. Little encrustation or biofilm can be seen on the sensor (C). Some small 
pieces o f biofilm encrusted with apatite microcrystals were present (D).
2 Pr nut {Trtcirit a t blockage}
E & F: The surface o f a pH sensor from the catheter bag o f a bladder model inoculated with Pr. mirabilis 96 h 
after triclosan intervention. The surface of the sensor was heavily encrusted (E). Closer examination of the 
encrusted biofilm showed the encrustation was composed o f apatite microcrystals (F).
Figure 3.48: HV-SEM images o f catheters and pH sensors, from the urine collection bags, from bladder 
models inoculated with Pr. mirabilis. Images A -  D are o f a catheter and its corresponding pH sensor from an 
experiment stopped at the point the sensor became positive. Images E & F are o f a sensor from an experiment 
stopped 96 h after the introduction o f triclosan into the catheter balloon.
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A & B: Encrusted Pr. vulgaris biofilm on an all-silicone catheter at the point the sensor became positive. Some 
EPS can be seen on the biofilm surface, overlaying the encrustation composed of apatite microcrystals (A). 
Bacterial cells in association with apatite microcrystals are shown in B.
BOkV*3iU>
C & D: The surface o f a pH sensor from the catheter bag o f a bladder model inoculated with Pr. vulgaris at the 
point the sensor became positive. Some biofilm can be seen on the sensor (C). Small pieces of biofilm encrusted 
with apatite microcrystals were present (D).
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E & F: The surface o f  a pH sensor from the catheter bag o f a bladder model inoculated with Pr. vulgaris 96 h 
after triclosan intervention. The surface o f the sensor was heavily encrusted (E). Closer examination of the 
encrusted biofilm showed the encrustation was composed o f apatite microcrystals (F).
Figure 3.49: HV-SEM images o f catheters and pH sensors, from the urine collection bags, from bladder 
models inoculated with Pr. vulgaris. Images A -  D are o f a catheter and its corresponding pH sensor from an 
experiment stopped at the point the sensor became positive. Images E & F are o f  a sensor from an experiment 
stopped 96 h after the introduction o f triclosan into the catheter balloon.
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A & B: Encrusted Pv. rettgeri biofilm on an all-silicone catheter at the point the sensor became positive. Some 
EPS can be seen on the biofilm surface, overlaying the encrustation composed of apatite microcrystals (A). 
Closer examination of the biofilm shows bacterial cells in association with apatite microcrystals (B).
C & D: The surface o f  a pH sensor from the catheter bag o f a bladder model inoculated with Pv. rettgeri at the 
point the sensor became positive. Little encrustation or biofilm can be seen on the sensor (C). Closer 
examination o f the sensor shows some biofilm encrusted with apatite microcrystals (D).
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E & F: The surface o f a pH sensor from the catheter bag of a bladder model inoculated with Pv. rettgeri at 
catheter blockage (triclosan intervention). Little encrustation or biofilm is present on the sensor (E). Thin 
biofilm with some apatite microcrystal encrustation is shown in F.
Figure 3.50: HV-SEM images o f catheters and pH sensors, from the urine collection bags, from bladder 
models inoculated with Pv. rettgeri. Images A -  D are o f  a catheter and its corresponding pH sensor from an 
experiment stopped at the point the sensor became positive. Images E & F are o f  a sensor removed the urine 
collection bag at catheter blockage from an experiment in which triclosan was introduced into the catheter balloon.
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intervention with triclosan in Na2 C0 3  could allow the catheter to remain in place after 
a positive sensor signal when infection is due to triclosan sensitive species such as Pr. 
mirabilis or Pr. vulgaris (but not Pv. rettgeri).
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3.5 The effectiveness of the pH sensor in predicting catheter blockage by species 
that encrust catheters slowly.
Experiments were performed to test the ability of the pH sensor to predict catheter 
blockage by M. morganii, Staph, aureus and Staph, saprophyticus. These species had 
been previously identified as able to encrust catheters but more slowly than those 
tested in Section 3.4. Bladder models were inoculated with 100 pi of a 4 h 
logarithmic phase culture of each test organism in artificial urine. Urine samples were 
taken from the bladder chamber and urine collection bag at 24 h intervals until 168 h 
or blockage. The pHs of all the urine samples were measured and the viable bacterial 
cell populations of urine samples determined. Digital photographs of the pH sensors 
in the urine bags were taken each time point the urine pH was measured. Digital 
photography was also used to assess the extent of encrustation on catheters at 
blockage or 168 h.
Figure 3.51 shows the variation in urinary pH in the bladder chamber and collection 
bag of models infected with M. morganii RBI5. It can be seen that the pH of the 
urine in the collection bag was more alkaline than the urine in the bladder chamber for 
the duration of the experiment. All three catheters blocked and the mean time to 
blockage was 149.3 h. The sensor became positive prior to blockage in all three 
replicates. The mean time (±SE) of the interval between the positive signal and 
catheter blockage was 37.3 h (±2.85 h).
The urinary pH data recorded from models inoculated with Staph, aureus P10 6/9 is 
displayed in Figure 3.52. None of the three replicate catheters blocked during the 168
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Figure 3.51: Urinary pH variation in the bladder and urine collection bag of models inoculated with M. morganii RBI 5 until blockage (149.3 h ±5.2). The colour variation o f S? 
a pH sensor placed in the urine collection bag is also shown. *Each data point is the mean o f 3 replicates, with the standard error indicated. The sensor signal was considered to 
be positive at 96 h.
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Figure 3.52: Urinary pH variation in the bladder and urine collection bag of models inoculated with Staph, aureus P10 6/9 over 168 h. The colour variation of a pH sensor 
placed in the urine collection bag is also shown. *Each data point is the mean of 3 replicates, with the standard error indicated.
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h experimental period. The sensors in two of the three replicates became positive 
during the experiment, although the signal intensity reduced as the urinary pH in the 
collection bag fell towards the end of the experiment. One sensor eventually became 
negative again.
Figure 3.53 shows the urinary pH data recorded for models infected with Staph, 
saprophyticus ZEC17. All three catheters blocked with a mean time of 137 h. The 
sensor became positive prior to blockage in all three replicates, with the mean time 
(±SE) interval between the sensor judged to be positive and the catheter blocking 
being 41.0 h (±15.0 h).
Digital photographs taken of catheters removed from the model at blockage or after 
168 h are shown in Figure 3.54. Extensive encrustation is visible on the blocked M. 
morganii and Staph, saprophyticus catheters, particularly on the eyehole and lumen 
sections nearest the eyehole. The images of catheters from models inoculated with 
Staph, aureus show that although the catheters were not blocked at 168 h, crystalline 
biofilm was close to occluding the catheter lumen.
3.5.1 The reaction of the pH sensor to commonly occurring urinary tract pathogens 
that do not produce crystalline biofilms.
The colour of pH sensors placed in the urine collection bags of models infected with 
five commonly occurring urinary tract pathogens (E. coli, Ent. faecal is, Ps. 
aeruginosa, Pv. stuartii and K. pneumoniae) that had previously been shown not to 
generate catheter encrustation was monitored over 120 h. The experiments were
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Figure 3.53: Urinary pH variation in the bladder and urine collection bag of models inoculated with Staph, saprophyticus ZEC17 until blockage (137.0 h ±15.0). The colour 
variation of a pH sensor placed in the urine collection bag is also shown. *Each data point is the mean of 3 replicates, with the standard error indicated. The signal from the 
sensor was judged to be positive at 96 h.
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Figure 3.54: Digital photographs of catheters removed from the bladder model at blockage or after 168 h.
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performed in triplicate for each species and samples were collected as described in 
Section 3.5. Three replicate models were operated for each species for 120 h.
The results of the experiments involving urease negative E. coli RBI3 and Ent. 
faecalis RB5 are shown in Figures 3.55 & 3.56. For both species the pH of the urine 
remained below 6.2 in both the bladder and collection bag for the duration of the 
experiments. The sensor remained negative, with little difference in colour 
throughout the experiments.
In the experiments involving Ps. aeruginosa RBI6, Pv. stuartii RBI4 and K. 
pneumoniae SDM17 (Figures 3.57 -  3.59) the urine pH in the bladder chamber did 
not exceed 6.4 during the experiment. The pHs recorded for the urine in the 
collection bags were higher and this was reflected in the colour of the pH sensors. 
The sensors of one of the three replicates of both the Ps. aeruginosa and Pv. stuartii 
infected models became positive during the experiments. None of the sensors in the 
K. pneumoniae infected models became positive, although colour change from yellow 
to green was observed.
Digital photographs taken of catheters removed from the model after 120 h are shown 
in Figure 3.60. No encrustation was present on any of the catheters and little biofilm 
was observed on or immediately below the catheter eyehole. Extensive mucoid 
biofilm was observed on catheter sections from further down the lumen of catheters 
from Ps. aeruginosa and K. pneumoniae infected models.
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Figure 3.55: Urinary pH variation in the bladder and urine collection bag of models inoculated with E. coli RBI 3 over 120 h. The colour variation o f a pH sensor placed 
in the urine collection bag is also shown. *Each data point is the mean of 3 replicates, with the standard error indicated.
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Figure 3.56: Urinary pH variation in the bladder and urine collection bag o f models inoculated with Ent. faecalis RB5 over 120 h. The colour variation of a pH sensor 
placed in the urine collection bag is also shown. *Each data point is the mean o f 3 replicates, with the standard error indicated.
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Figure 3.57: Urinary pH variation in the bladder and urine collection bag of models inoculated with Ps. aeruginosa RBI 6 over 120 h. The colour variation of a pH sensor 
placed in the urine collection bag is also shown. *Each data point is the mean o f 3 replicates, with the standard error indicated. The sensor was considered to be positive at 120 h.
7.40
Urine pH (B ag) (±se)
VO
Urine pH (Bag) 
Urine pH (Bladder)
6.00
0 24 48 72
Time (h)
96
MM
T im e (h)
7.18 (±0.13)
7.07 (±0.18)
6.76 (±0.08) o.a>
6.64 (±0.02)
6.32 (±0.01) 6.40
6 .12  (±0.01)
120
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Figure 3.59: Urinary pH variation in the bladder and urine collection bag o f models inoculated with K. pneumoniae SDMI 7 over 120 h. The colour variation of a pH sensor 
placed in the urine collection bag is also shown. *Each data point is the mean of 3 replicates, with the standard error indicated. The sensor was judged to be negative throughout 
the experimental period.
70o
C/1E
Ent. faecal is E. coli Pv. stuartii Ps. aeruginosa K. pneumoniae
Os
Section
Section
WAL
Section 
3
AL
Section
4
Figure 3.60: Digital photographs o f catheters removed from the bladder model after 120 h.
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3.6 The modulation of Pr. mirabilis induced catheter blockage in multi-species 
catheter communities.
The microbial communities isolated from the urine of long-term catheterised patients 
are often composed of several species (Clayton et al., 1982; Warren et al., 1982; 
Jewes et al., 1988). A recent study by Mathur et al. (2006a) on a group of long-term 
catheterised patients with a history of Proteus infection found that the presence of Pr. 
mirabilis in the catheterised urinary tract did not necessarily lead to catheter blockage. 
The life-spans of the catheters ranged from 2 - 9 8  days and in some cases catheters 
did not block and were changed on schedule. In view of these observations, it was 
decided to examine the possibility that the other species present in the mixed 
communities infecting these patients can moderate the rate at which Pr. mirabilis 
blocks catheters. Communities from patients with Pr. mirabilis who did not 
experience frequent catheter blockage were reconstituted in the bladder model and 
blockage times compared to those of the Pr. mirabilis isolate alone.
The microbial communities used in these experiments were collected during the 
prospective study conducted by Mathur et al. (2006a). These authors had taken urine 
samples on a weekly basis, subjected them to routine bacteriological analysis and 
stored the isolates at -80 °C. It was thus possible to reconstitute the urinary flora 
(except for non-culturables) of these patients and examine their ability to block 
catheters in vitro. Experiments were conducted in bladder models on the reconstituted 
communities from three patients.
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Bladder models were inoculated with 1 ml of a 4 h logarithmic culture in artificial 
urine of each isolate from the reconstituted community. Control models were 
inoculated with just the Pr. mirabilis isolate from each community (1 ml). At 24 h 
intervals, up to a maximum of 168 h, or at blockage if it occurred, urine samples were 
taken from the bladder chamber. The pHs of the urine samples were measured and 
the viable bacterial cell populations of each isolate determined. The extent of 
encrustation present on catheter sections was visualised using digital photography and 
LV-SEM. Statistical analysis (Two Sample t-test) was used to determine if there was 
any significant difference between the mean blockage times of the test and control 
catheters.
The data collected from models inoculated with the reconstituted community from 
patient 6 {Pr. mirabilis (AK) and Ent. faecalis (O)) are shown in Figures 3.61 & 3.62. 
Blockage occurred in all three replicates but the mean blockage time of the test 
catheters (55 h) was significantly greater (P=0.037) than that of the control (25 h). 
There was no significant difference between the mean urine pH initially (P=0.659), 
after 24 h (iM).120) and at blockage (P=0.270) for the test and control models and 
this was also true for the mean numbers of Pr. mirabilis (AK) cells present initially 
(P=0.613), after 24 h (P=0.413) and at blockage (P=0. 136).
Figure 3.63 shows the data from experiments using the reconstituted community from 
patient 9 {Pr. mirabilis (AO), E. coli (AM), K. pneumoniae (AN) and Ent. faecalis 
(AAC)). All of the catheters blocked and there was no significant difference 
(P=0.643) between the mean blockage times of the test (40 h) and control (35 h)
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Figure 3.61: The pH of urine samples from models inoculated with a reconstituted community (Patient 6) consisting of Pr. mirabilis and Ent. 
faecalis, and a control inoculated with the Pr. mirabilis isolate. The means ±SE were calculated from three replicated experiments.
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Figure 3.62: The viable cell populations (log10 cfii/ml) o f urine from models inoculated with a 
reconstituted community (Patient 6) consisting o f Pr. mirabilis and Ent. faecalis, and a control inoculated 
with the Pr. mirabilis isolate alone. The data shown is for each individual replicate.
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Figure 3.63a: The pH of urine samples from models inoculated with a reconstituted community 
(Patient 9) consisting of Pr. mirabilis, E. coli, K. pneumoniae and Ent. faecalis and a control inoculated 
with the Pr. mirabilis isolate. The means ±SE were calculated from three replicated experiments.
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Figure 3.63b: The viable cell population (log10 cfu/ml) of urine from models inoculated with a 
reconstituted catheter community (Patient 9) consisting o f Pr. mirabilis, E. coli, K. pneumoniae and 
Ent. faecalis and a control inoculated with the Pr. mirabilis isolate. The means ±SE were calculated 
from three replicated experiments.
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models. There was no significant difference between the mean initial urine pH 
(P=0.071), mean urine pH at blockage (/MX540) and the mean numbers of Pr. 
mirabilis (AO) cells present at blockage (/>=(). 800) for the test and control 
experiments. There was however, a significant difference (P=0.019) between the 
mean numbers of Pr. mirabilis cells present at the start of the experiment.
Figures 3.64 & 3.65 show the data collected for the reconstituted community from 
patient 19, consisting of Pr. mirabilis (AAAX), Ps. aeruginosa (AAAY), E. coli 
(AAAZ), and K. oxytoca (AAAAA). Blockage occurred in all of the control catheters 
(mean 40 h) and one of the test catheters (147 h) but two of the test catheters drained 
freely until the experiment was stopped (168 h). There was no significant difference 
between the mean initial urine pH (/MX398) of the test and control models. The 
other three organisms however clearly affected the ability of the Pr. mirabilis isolate 
to produce alkaline conditions and by 24 h the mean pH of the urine in the control 
models (pH 7.68 ±0.19) was significantly higher than that in the test models (pH 6.41 
±0.02) (P=0.021). There was also a significant difference (P=0.009) between the 
mean final urine pH of the test models which did not block and the controls. Analysis 
of the viable cell count data showed no significant difference (7MX530) between the 
mean initial Pr. mirabilis cfu/ml of the test and control catheters. By 24 h however, 
the mean viable cell count of Pr. mirabilis in the test models was significantly 
reduced compared to that in the controls (P=0.004). The inhibitory effect of the 
mixed community on the population of Pr. mirabilis seemed to persist throughout the 
experimental period. The other three species were obviously growing well in the 
models as each maintained cell populations around 107 -  108 cfu/ml.
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Figure 3.64: The mean pH of urine samples from models inoculated with a reconstituted catheter community (Patient 19) consisting o f Pr. 
i mirabilis, Ps. aeruginosa, E. coli and K. oxytoca, and a control inoculated with the Pr. mirabilis isolate alone.
On *The data for the reconstituted community is shown as the mean of three replicates (±SE) for data points up to 96 h and thereafter as the individual
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Figure 3.65: The viable cell population (log10 cfu/ml) o f urine from models inoculated with a 
reconstituted catheter community (Patient 19) consisting o f Pr. mirabilis, Ps. aeruginosa, E. coli 
and K. oxytoca, and a control inoculated with the Pr. mirabilis isolate alone. The data shown is 
for each individual replicate.
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Digital photographs of catheters removed from the model at blockage or after 168 h 
are shown in Figure 3.66. Both the test and control catheters show heavy encrustation 
for models inoculated with the communities from patients 6 and 9. The control 
catheter for the reconstituted patient 19 community also shows heavy encrustation, 
but the test catheter shows an unusual biofilm formation which is distinct from any of 
those seen in the previous sections, appearing to consist of both crystalline and 
mucoid material.
LV-SEM of the test and control catheters for patients 6 and 19 are presented in Figure 
3.67. The micrographs confirm that in the case of patient 6, the Ent. faecalis did not 
prevent catheter blockage by crystalline biofilm. The community of Ps. aeruginosa, 
E. coli and K. oxytoca from the urine of patient 19 however, clearly reduced the extent 
of crystalline material deposited on the catheter by Pr. mirabilis.
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Figure 3.66: Comparison o f encrustation after 168 h or at blockage for reconstituted catheter communities against the Pr. mirabilis isolate from that community.
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4. Discussion.
It is clear from the literature that a diverse bacterial flora develops in the urine of 
patients undergoing long-term catheterisation (Clayton et a l , 1982; Warren et a l, 
1982; Muder et a l, 1992). The biofilms that colonize the catheters also reflect this 
diversity. When Pr. mirabilis is a component of the biofilm community then 
crystalline deposits will form and cause serious complications in catheter care 
(Stickler et a l, 1993b). The urease produced by this species is the driving force of the 
crystallization process. While several other urinary tract pathogens are capable of 
producing this enzyme, there is little epidemiological or experimental evidence to 
indicate whether or not they are involved in the encrustation and blockage of patient’s 
catheters. If we are to devise a comprehensive strategy to deal with this troublesome 
complication it is important to identify all the urinary tract pathogens that are capable 
of producing crystalline biofilm in urine.
4.1. Which urease producing species are able to cause catheter encrustation and 
blockage?
Over the years successive workers in the catheter research group in the Cardiff School 
of Biosciences have built up a collection of isolates from biofilms on patients 
catheters. In an initial set of experiments the ability of isolates of nine urease 
producing species to encrust and block catheters were examined in the bladder model. 
The results presented in Figures 3.1 — 3.11 and Table 3.1 are summaries of the data 
collected from triplicate experiments on single isolates of each species.
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On the basis of the final urine pH data, the times catheters took to block, encrustation 
rates, urease activity, digital photographs and HV-SEM images, the urease positive 
species tested can be divided into three groups:
Group 1: Rapid encrusters (Pr. mirabilis, Pr. vulgaris and Pv. rettgeri).
These species were able to raise urinary pH above mean values of 8.2, produce 
relatively high urease activity, and cause the deposition of large quantities of Ca and 
Mg on catheters, leading to the blockage of catheters by crystalline biofilms 
consisting of apatite microcrystals and struvite (Figure 3.7) within mean times of 37 h 
(Table 3.1).
Group 2: Slow encrusters (M. morganii, Staph, aureus and Staph,
saprophyticus).
These species were able to raise urinary pH to mean levels of 6.89 -  7.39, sufficient to 
cause the formation of some encrustation on the catheter surface after 96 h, but with 
final urine pHs significantly less than those of group 1 but significantly greater than 
the controls (PO.05). The crystals present in the biofilms are mainly large calcium 
phosphate crystals (Figures 3.8 & 3.9), with some microcrystals present in the M. 
morganii biofilm (Figure 3.8).
Group 3: Non-encrusters (Pv. stuartii, Ps. aeruginosa and K. pneumoniae).
These species were unable to raise urinary pH above mean levels of 6.45 which was 
insufficient to cause the formation of encrustation on the catheters (Figure 3.10), with 
final urine pHs not significantly different (P>0.05) from those produced by the urease 
negative control but significantly less (P<0.05) than those of group 2 and unable to
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cause the hydrolysis of significantly more urea than the urease negative controls in the 
urease assay (Figure 3.4). Although both Ps. aeruginosa and K. pneumoniae were 
able to form thick mucoid biofilms (Figure 3.6) no evidence of encrustation was 
found (Figure 3.10).
In order to check that the isolates tested in the bladder models (Table 3.1) were 
representative, three additional urease positive catheter isolates of each species were 
examined for their ability to cause catheter blockage. For the Pr. mirabilis isolates 
Dienes typing was used to confirm that the isolates used were distinct strains (Figure 
3.12). Experiments were performed once for each of the alternative isolates and the 
data for each species pooled (Table 3.2). For the isolates of the three species which 
were able to cause blockage (Pr. mirabilis, Pr. vulgaris and Pv. rettgeri) there was no 
significant difference between the mean blockage times or final urine pHs of the 
original and pooled alternative isolates. With the exception of Staph, aureus (Figure 
3.21) none of the other species tested showed a significant difference between the 
mean final urine pHs of the original and pooled alternative isolates. Digital 
photographs of catheters removed from the model show little difference between the 
original and alternative isolates for most of the species tested. The exception to this is 
again Staph, aureus, which while showing some encrustation on the original isolate 
showed none on any of the alternative isolates (Figure 3.17). Interestingly while the 
urine pH after 96 h was significantly higher for the original isolate than for the pooled 
alternative isolates (P<0.001) the mean viable cells present were significantly lower 
(PO.OOl) (Figure 3.21). The results presented in Table 3.2 essentially confirm the 
classification of the species into the three categories. The only exception to this is
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that the data for Staph, aureus suggest that most urease producing isolates of this 
species belong to group 3, the non-encrusters.
A number of urease positive isolates from species not commonly isolated from the 
catheterised urinary tract (Ser. marcescens, K. oxytoca, Enterobacter cloacae, C. 
freundii and C. koseri) were also tested in the model of the catheterised urinary tract. 
These species all performed in a similar way to the group 3 species (Pv. stuartii, K. 
pneumoniae and Ps. aeruginosa), being unable to raise the pH of the urine above pH 
6.4 in the model, unable to block catheters and showing no signs of encrustation 
(Figures 3.22 -  3.25). This data supports the inclusion of these species in group 3 
(non-encrusters).
The experiments performed in the bladder models used large inocula (10 ml of urine 
cultures containing approximately 108 cfu/ml). A relatively concentrated urine with a 
pHn of 6.54 was supplied to the bladder chamber at a flow rate of 0.5 ml/min. These 
conditions were intended to simulate conditions which can apply particularly in 
elderly catheterised patients who have low fluid intakes and heavily infected urines. 
They can be considered as representing the worst case scenario. The experimental 
conditions were thus highly favourable to crystalline biofilm formation. Therefore if 
organisms fail to produce encrustation under these experimental conditions it is 
unlikely that they will do so in patients. Group 3 species (Pv. stuartii, Ps. aeruginosa, 
K. pneumoniae, K. oxytoca, Ser. marcescens, Enterobacter cloacae, C. freundii and 
C. koseri) are thus not likely to be appropriate targets for control strategies.
Those species classified as group 2 (M. morganii, Staph, aureus and Staph.
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saprophyticus) were able to raise the pH of the urine (means 6.89 -  7.39) sufficiently 
to cause the formation of encrustation on the catheter surface in the model, but the pH 
increase was far less than for the group 1 species. The pHn of the urine used in these 
experiments was 6.54 (Figure 3.3). This is somewhat lower than that found in the 
majority of patients during the studies of Choong et a l (1999; 2001) and Mathur et al 
(2006a) who determined the mean pHn of the majority of patients to be in the range 
7.3 -  8.1. Given the moderate increases in urinary pH caused by infection with group 
2 species, these patients would not be expected to show an increase in catheter 
blockage as a result of infection with these species. Choong et a l (1999; 2001) 
identified a small group of patients termed ‘urease negative blockers’ in which 
catheter blockage occurred without urease positive bacteriuria. The six patients (from 
35) identified by Choong et a l (1999) and eight (from 64) by Choong et al (2001) 
had mean pHnS of 6.45 and 6.49 respectively. Mathur et a l (2006b) also showed that 
a small number of patients have very low pHn levels. This small group of patients 
with low pHns might be expected to be vulnerable to catheter encrustation by group 2 
species (as well as group 1 species) while the majority of patients are unlikely to be 
affected.
The mean urinary pHs reached by the group 1 species in this series of experiments 
were above 8.2. This is greater than the mean urinary pHn of patients recorded by 
both Choong et a l  (1999; 2001) and Mathur et a l (2006a) (mean pHn range 7.3 -  
8.1). As a result infection with any of these species is likely to lead to the formation 
of encrustation and catheter blockage in most patients. Some patients however have 
an extremely high pHn, and as a result do not experience catheter blockages even 
when infected with group 1 species, as observed by Mathur et a l (2006a).
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The results presented in this section are generally consistent with the laboratory and 
clinical data available in the literature. The association of Pr. mirabilis with catheter 
encrustation and blockage is well documented (Mobley and Warren, 1987; Kunin, 
1989; Stickler et al. 1993b). The other species classified as group 1, Pr. vulgaris and 
Pv. rettgeri, have not been significantly associated with the formation of catheter 
encrustation in clinical studies (Mobley and Warren, 1987; Kunin, 1989), although 
Stickler et al. (1998a) found that their encrusting ability was similar to that of Pr. 
mirabilis when tested in vitro. Mobley and Warren (1987) found that Pr. vulgaris and 
Pv. rettgeri were present in 1 % and 4 % of urine samples respectively during their 
study while Pr. mirabilis was present in 58 %.
The results of the urease assay (Figure 3.4) show that the isolates tested of these three 
species were able to produce relatively high rates of urea hydrolysis in artificial urine, 
and there was no significant difference between the group 1 species in the time taken 
to cause catheter blockage, urine pH at blockage or rates of calcium and magnesium 
encrustation (Table 3.1, Figures 3.1 & 3.2). Images of the blocked catheters also 
showed no differences in the manner of encrustation (Figures 3.5 & 3.7). Why then 
has no clinical association been found between catheter encrustation and Pr. vulgaris 
or Pv. rettgeri? The answer to this question is most likely to be due to the fact that 
these two species are isolated far less frequently from the catheterised urinary tract 
than Pr. mirabilis (Mobley and Warren, 1987). Senior et al. (1979) reported that Pr. 
mirabilis was responsible for 96.5 % of urinary tract infections by the Proteeae tribe 
(Proteus, Providencia and Morganella sp.) members while Pr. vulgaris and Pv. 
rettgeri accounted for less than 2 %. The isolate collection available in the Cardiff
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catheter laboratory from patient catheters over a number of years also reflects this. 
While the collection contains many isolates of Pr. mirabilis and several other species 
such as Ps. aeruginosa, there were only four isolates each of Pr. vulgaris and Pv. 
rettgeri. Senior and Leslie (1986) speculated that the low number of infections with 
Pr. vulgaris was related to its infrequent occurrence as a part of the gut microflora, 
which is often the source of bacteria infecting the urinary tract (Daifuku and Stamm, 
1984). Any attempts to control the formation of encrustation would be wise to 
examine its effects on these two species however, since it is conceivable that a 
strategy which is effective against Pr. mirabilis but not Pr. vulgaris or Pv. rettgeri 
may simply select for them.
Those organisms classified as group 2 (M. morganii, Staph, aureus and Staph, 
saprophyticus) were all capable of causing some encrustation after 96 h. This group 
is less clear-cut than either group 1 or group 3, with some variation in the data 
collected between the species. All three species shared an ability to raise the urine pH 
above the nucleation pH of the urine and to cause the deposition of encrustation 
consisting of large calcium phosphate crystals on the catheter surface (Figure 3.8). 
Some apatite microcrystals were also present in the M. morganii biofilm (Figure 3.8). 
Stickler et al. (1998a) did not find any evidence of encrustation with M. morganii 40 
h after inoculation in the model. This finding is consistent with the results reported 
here however, as the pH of the urine in the models inoculated with M. morganii did 
not rise above the pHn (Figure 3.3) until after 48 h incubation (Figure 3.1).
The differences seen between the M. morganii and Staph, aureus isolates in the 
calcium encrustation rate data (Figure 3.2) are likely to be due to the relative
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differences between the calcium pHn of the artificial urine (6.54) and the final urine 
pH of the models. For M. morganii the difference is 0.85 of a pH unit (7.39) while for 
the Staph, aureus isolate it is 0.35 (6.89). The calcium precipitation profile (Figure
3.3) shows that more calcium will precipitate in the M. morganii model compared to 
the Staph, aureus model. Relatively little encrustation was apparent in the Staph, 
aureus biofilm compared to that of M. morganii (Figures 3.5 & 3.6). The occurrence 
of microcrystals in the M. morganii biofilm in addition to large calcium phosphate 
crystals (Figure 3.8) may also be linked to the greater difference between the final and 
nucleation pHs.
The urease assay data also show differences between the M. morganii and Staph, 
aureus isolates. This is most likely to be due to the mode of regulation of urease 
synthesis in these species. Urease production in M. morganii is constitutive 
(Rosenstein et al., 1981) and so high expression of urease would be expected (Figure
3.4). However there is some evidence that urease production in Staph, aureus is 
upregulated in biofilms (Resch et al., 2005). This would mean that an assay of urease 
production in suspension, such as the one used in this study, would be likely to under 
represent the expression of urease in a biofilm. The data from the bladder models, 
showing urine pH exceeding that of the group 3 organisms, would seem to suggest 
that this is the case although the assay appears to have accurately predicted biofilm 
urease expression for the other (Gram-negative) species tested.
There is some clinical data which suggests that M. morganii may serve to protect 
catheters from encrustation (Mobley and Warren, 1987). Other studies however have 
found no such association (Kunin, 1989). Both of these studies concentrated on
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patients experiencing rapid catheter blockage, while the data collected in this study 
suggests that M. morganii (in common with Staph, aureus and Staph, saprophyticus) 
is only likely to encrust catheters slowly and in patients whose urine has a low pHn. 
The analysis used in the studies by Mobley and Warren (1987) and Kunin (1989) 
make it unlikely that such a link would be detected. The Staph, aureus isolate tested 
was unusual in its ability to raise urinary pH when compared to other urease positive 
Staph, aureus isolates in our collection (Figures 3.17 & 3.21). This combined with its 
relatively low occurrence in CAUTI (Mobley and Warren, 1987; Kunin, 1989) means 
that it is also unlikely to be associated with catheter blockage clinically. The low 
occurrence of Staph, saprophyticus in CAUTI, exemplified by the fact that despite the 
large collection of isolates from catheters in our lab the one isolate found was from a 
patient with a urostomy, also means it is unlikely to be associated clinically with 
catheter blockage.
Those organisms classified as group 3 (non-encrusting) include a number of urease 
positive organisms which have not been associated with catheter encrustation, both in 
clinical and laboratory studies, such as K. pneumoniae, K. oxytoca and Ps. aeruginosa 
(Mobley and Warren, 1987; Kunin 1989; Stickler et al., 1998a). These organisms 
control urease synthesis using the nitrogen regulatory system and as a result would 
not be expected to produce significant quantities of urease in the nitrogen rich 
environment of the urinary tract (Totten et al., 1990; Collins et al., 1993). Although 
not subjected to as rigorous testing as K. pneumoniae, Ps. aeruginosa and Pv. stuartii 
the bladder model and urease assay data collected for the remaining species in this 
group (K. oxytoca, Ser. marcescens, Enterobacter cloacae, C. freundii and C. koseri) 
strongly indicates that they should be included (Figures 3.4 & 3.22 -  3.25). The
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classification of these species as urease positive may cause confusion when 
comparisons are made between patients with urease positive and urease negative 
bacteriuria, such as in the study by Choong et al. (2001).
While the majority of the group 3 species were unable to form thick biofilms on the 
catheters in the model, Ps. aeruginosa and K. pneumoniae formed thick mucoid 
biofilms (Figure 3.6). Despite this the flow of urine through the catheters was not 
impeded, indicating that these biofilms are extremely hydrated and likely to possess 
the water channels present in the Costerton biofilm model (Costerton et a l , 1995) 
which is based on the observation of Ps. aeruginosa biofilms. K. oxytoca also formed 
thick biofilms (further down the catheter than shown in Figure 3.23) which were 
similar to those formed by K. pneumoniae.
The inclusion of Pv. stuartii in this group is something of a surprise, given both the 
published data on urease production for this organism (D’Oriazo and Collins, 1993a; 
D’Oriazo and Collins, 1993b) and its reported clinical association with the formation 
of catheter encrustation (Kunin, 1989). D’Oriazo and Collins (1993a; 1993b) found 
that the plasmid borne urease of Pv. stuartii was induced by the presence of urea and 
was similar to that of Pr. mirabilis. Bladder models inoculated with four different 
isolates of Pv. stuartii in this study however, were unable to raise urine pH and 
catheters removed from the models showed no sign of encrustation (Figure 3.19). 
The isolate tested in the urease assay was also unable to produce significantly more 
urea hydrolysis than the urease negative control (Figure 3.4). It is possible that the 
regulation of urease synthesis in these isolates may be related to nitrogen starvation, 
as with K. pneumoniae, or that the induced urease operon is unable to produce
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sufficient urease to cause the hydrolysis of significant quantities of urea. Macleod 
(2006) found that Pv. stuartii often occurred together with Pr. mirabilis in catheter 
biofilms. This association with Pr. mirabilis may be the reason for the observation by 
Kunin (1989) that Pv. stuartii is associated with catheter blockage, rather than Pv. 
stuartii itself forming the encrustation.
Even under conditions highly favourable to crystalline biofilm formation group 3 
species (Pv. stuartii, Ps. aeruginosa, K. pneumoniae, K. oxytoca, Ser. marcescens, 
Enterobacter cloacae, C. freundii and C. koseri) were incapable of causing catheter 
encrustation. Group 2 species (M. morganii, Staph, aureus and Staph, saprophyticus) 
were able to cause slow encrustation under these conditions, but are only likely to 
cause encrustation in a small sub-set of patients with a low fluid intake and pHn of 
less than 7.3. The three species capable of rapid encrustation were Pr. mirabilis, Pr. 
vulgaris and Pv. rettgeri. They were capable of raising the urinary pH to mean values 
of around 8.3 -  8.4 and therefore would be capable of encrusting catheters even in 
urine with a pHn of up to 8.2. This group should be the target for strategies to control 
catheter encrustation.
4.2 The development of crystalline biofilm on silver-hydrogel and nitrofurazone 
catheters.
The ability of the antimicrobial catheters recently introduced into clinical practice to 
prevent CAUTI is the subject of some controversy (Trautner et a l, 2005a; Johnson et 
a l, 2006). Little work has been undertaken into their effectiveness at preventing the 
formation of crystalline biofilms which commonly occur during long-term
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catheterisation (Cools and Van der Meer, 1986). The aim of this part of the study was 
to assess the ability of two antimicrobial catheters (silver-hydrogel coated latex, Bard 
IC catheter and the nitrofiirazone impregnated all-silicone catheter, Rochester Medical 
NF catheter) to resist the formation of encrustation in the bladder model by five of the 
species previously identified as able to form encrustation on all-silicone catheters. 
All-silicone catheters were used as controls.
The three species previously classified as group 1 (Pr. mirabilis, Pr. vulgaris and Pv. 
rettgeri) were all able to rapidly cause catheter blockage by crystalline biofilm on 
both the silver-hydrogel and nitrofurazone catheters (Table 3.3). There was no 
significant difference between the mean blockage times of the three species on all­
silicone and nitrofurazone catheters. Pr. mirabilis and Pv. rettgeri had mean blockage 
times which were significantly faster than that of Pr. vulgaris on the silver-hydrogel 
catheters. No significant difference was seen between the mean times to blockage for 
each particular species on the three catheter types. Visual assessment of the 
crystalline biofilms using digital photography, LV-SEM and HV-SEM showed little 
difference between either the three species or the three catheter types, with extensive 
crystalline biofilms seen on all the catheters examined (Figures 3.28 -  3.30 & 3.32 -  
3.34). The three species all showed urinary pHs > 8.0 throughout the experiment 
(Figure 3.26) and each species grew well in the urine in the models irrespective of the 
catheter type (Figure 3.27). All three group 1 species also showed relatively high 
MICs of nitrofurazone (Table 3.4), particularly Pv. rettgeri (64 -  128 pg/ml).
For the group 2 species tested (M. morganii and Staph, aureus) only M. morganii was 
able to cause catheter blockage in the all-silicone and nitrofurazone catheters, while
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neither species caused blockage in the silver-hydrogel catheters (Table 3.3). The 
mean blockage times of the M  morganii infected models were significantly greater 
than those of the group 1 species for both the all-silicone and nitrofurazone catheters. 
There was no significant difference between the mean blockage times recorded for M. 
morganii on the all-silicone and nitrofurazone catheters. Visual assessment of the 
crystalline biofilms formed by M. morganii using digital photography, LV-SEM and 
HV-SEM showed that both the nitrofurazone and silver-hydrogel catheters were 
heavily encrusted (Figures 3.28 & 3.29, 3.31 -  3.33 & 3.35). The encrustation 
consisted of apatite microcrystals, with some large calcium phosphate crystals present 
on the silver-hydrogel catheter. In contrast the crystalline biofilms formed by Staph, 
aureus on both antimicrobial catheters were far less extensive, with little encrustation 
present. Examination of the Staph, aureus biofilms using HV-SEM showed the 
presence of both apatite microcrystals and large calcium phosphate crystals.
Both M. morganii and Staph, aureus showed a consistent pattern of mean urinary 
viable cell counts and mean urinary pH during the experiments irrespective of the 
catheter type (Figures 3.26 & 3.27). The pH of the urine infected with Staph, aureus 
generally remained stable between 6.5 -  7.0 for the 168 h of the experimental period. 
M. morganii however, after the first 48 h, was able to produce a gradual increase in 
the urinary pH to around 7.5 in the presence of all three catheter types. The M. 
morganii mean urinary viable cell counts fell in the first 24 h from an initial cfu/ml of 
above 108 to below 107, before recovering steadily back to around 108 cfu/ml. The 
numbers of Staph, aureus cells present show a steady fall from around 108 cfu/ml 
initially to below 107 cfu/ml after 168 h.
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The MICs of nitrofurazone for the M. morganii isolates were relatively high (32 -  64 
pg/ml) and comparable with those of the group 1 species (Table 3.4). The MICs of 
nitrofurazone for the Staph, aureus isolates however were lower ( 8 - 1 6  pg/ml) and 
similar to that of the Staph. aureus control. The single isolate of Staph, saprophyticus 
tested was quite sensitive to nitrofurazone (MIC 4 fig/ml).
This section of the study shows that both the silver-hydrogel and nitrofurazone 
catheters tested are not effective in extending catheter lifespan in vitro in comparison 
to all-silicone controls for those species capable of causing rapid catheter blockage 
(group 1 -  Pr. mirabilis, Pr. vulgaris and Pv. rettgeri). The antimicrobial catheters 
had no observable effect on the urinary pH, mean numbers of viable cells recovered 
from the urine or the nature of the crystalline biofilms generated when compared to 
the all-silicone controls for these species (Figures 3.26 -  3.30 & 3.32 -  3.34).
The data presented in Table 3.3 shows that the silver-hydrogel were consistently the 
first to block. Previous work in the bladder models inoculated with Pr. mirabilis had 
shown that latex based catheters, including the silver-hydrogel variety, blocked more 
rapidly than all-silicone devices (Morris et al., 1997; Morris and Stickler, 1998a). 
These authors suggested that the thicker walls and narrower central channels of the 
latex catheters make them particularly vulnerable to rapid blockage by crystalline 
biofilm. Kunin et al. (1987b) also reported that in their clinical experience silicone 
catheters were significantly less likely to be encrusted or blocked than latex catheters. 
The reported MICs of silver for bacteria are subject to some variation due to a lack of 
standardisation and difficulties relating to the bioavailablity of silver in some media 
(Silver, 2003). The data available for Pr. mirabilis is reported for isolates termed
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‘resistant5 to silver, with the MIC of silver being between 27 and 65 pg/ml (Hendry 
and Stewart, 1979; Filali et al., 2000). Slawson et al. (1994) reported that a 
‘sensitive5 strain of Ps. stutzeri had a MIC of silver of 5.4 pg/ml. The in vitro work 
conducted by Chakravarti et al. (2005) using a catheter fitted with silver electrodes 
which was shown to release sliver ions at 0.25 -  0.1 pg/ml into the urine and 
significantly delayed catheter encrustation demonstrates that silver can be effective in 
extending catheter lifespan when challenged by Pr. mirabilis. The fact that Pr. 
mirabilis persisted, albeit in significantly reduced numbers, indicates that this level of 
silver release may be below the MIC of silver for this isolate. Morgan (personal 
communication, 2007) determined the levels of silver ions present in human urine 
from bladder models using silver-hydrogel catheters to be lower than in the 
experiments performed by Chakravarti et al. (2005) at 0.01 -  0.02 pg/ml. The data 
presented in Figures 3.26 & 3.27 indicates that this lower quantity of silver ions 
released into the urine by the silver-hydrogel catheters is not sufficient to affect the 
growth or activity of any of the group 1 species.
The results from the experiments using nitrofurazone catheters also show that they are 
not effective in delaying catheter blockage by the group 1 species (Table 3.3). As 
with the silver-hydrogel catheters there was no difference between the mean numbers 
of bacteria recovered or the urinary pH between the nitrofurazone catheters and the 
all-silicone controls (Figures 3.26 & 3.27). This is not surprising when the relatively 
high MICs of nitrofurazone for the group 1 species are taken into account (Table 3.4). 
The MIC of nitrofurazone for Pr. mirabilis found in this study (64 pg/ml, Table 3.4) 
is in agreement with that found by Johnson et al. (1993) (32 -  64 pg/ml). Johnson et 
al. (1993) reported that sections of nitrofurazone catheter were not able to cause
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inhibition zones in lawns of the majority of Proteus sp. isolates tested on agar plates. 
Inhibition zones were produced however, against several other commonly occurring 
urinary tract pathogens such as E. coli. This raises an important question -  would the 
use of nitrofurazone catheters in long-term catheterisation select for species which 
cause catheter encrustation and blockage? If so the use of these catheters would be 
potentially dangerous for the patients involved, given the complications associated 
with catheter blockage.
The data presented in Table 3.3 demonstrates that M. morganii was able to cause 
catheter blockage in both the nitrofurazone and all-silicone control catheters, clearly a 
reflection of the relative resistance of this organism to nitrofurazone (Table 3.4). 
Blockage did not occur within 168 h in any of the experiments using silver-hydrogel 
catheters. The presence of extensive of encrustation (Figures 3.28 & 3.29) and the 
mean urinary pH being well above the pHn at 168 h (Figure 3.26) however, both 
indicate that catheter blockage was imminent. The nature of the crystalline biofilms 
also seems relatively unaffected by the catheter type, with no evidence of struvite 
crystals on any of the catheters (Figures 3.31 & 3.35). It is interesting that the latex 
based silver-hydrogel catheters performed better than both silicone based catheters, 
given the reduced lumen size of latex based catheters. While this may suggest that 
this isolate is more sensitive to silver than the group 1 species tested there is little 
evidence to support this in Figure 3.27b.
The Staph, aureus isolate tested was unable to cause blockage in any of the catheters 
tested after 168 h (Table 3.3). Although Staph, aureus was the organism most 
sensitive to nitrofurazone (Table 3.4) there was no evidence that the concentration of
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antibacterial agent diffusing from the catheter into the urine had any adverse effect on 
the population present in the bladder chamber (Figure 3.27).
This section of the study provides strong evidence that the antimicrobial catheters 
tested (silver-hydrogel and nitrofurazone) are unlikely to be able to either prevent or 
delay catheter blockage by Pr. mirabilis, Pr. vulgaris and Pv. rettgeri. Given the lack 
of convincing evidence for their effectiveness in preventing bacteriuria even in short­
term catheterisation (Brosnahan et al., 2004; Trautner et al., 2005a; Johnson et al., 
2006) the use of these catheters in long-term catheterisation is unnecessary, costly, 
and in the case of nitrofurazone catheters potentially counter productive.
4.3 The control of catheter encrustation by the delivery of antimicrobial agents 
through the retention balloon.
Previous workers have shown in studies in the bladder model that the retention 
balloon of catheters could be used to deliver the biocide triclosan to the residual urine 
and prevent encrustation by Pr. mirabilis. At concentrations of 1 -  10 mg/ml 
triclosan in the balloon, the rise in urinary pH was prevented, the bacterial populations 
in the urine significantly reduced and crystalline biofilm formation inhibited (Stickler 
et al., 2003a; Jones et a l, 2005; Jones et a l, 2006). Unfortunately the formulations 
used in these experiments were not suitable for use in clinical studies because of 
difficulties in stability and sterilization. Williams (2006) found that solutions 
containing up to 3 mg/ml of triclosan could be prepared in 0.1 M sodium carbonate 
and that these solutions were stable and could be sterilized by membrane filtration. 
He further demonstrated that inflating the balloon with 3 mg/ml triclosan in 0.1 M
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sodium carbonate was effective in preventing encrustation by Pr. mirabilis. The 
results presented in Table 3.5 confirm this activity and that this formulation was also 
effective against Pr. vulgaris. In both these cases in contrast to the controls the 
numbers of viable cells recovered from the urine fell steeply within 24 h. The pH of 
the urine in the bladder chamber fell below that of its pHn (6.5) and the catheters 
drained freely for the 7 day experimental period (Figures 3.36 & 3.37). The effect on 
Pv. rettgeri was minimal however, with no significant difference between the 
blockage times or urine pHs recorded for the test and control models (Table 3.5, 
Figure 3.38). Both Proteus sp. tested had MICs of triclosan of < 0.2 pg/ml while the 
MIC of Pv. rettgeri isolates was 64 pg/ml (Table 3.6).
Jones et a l, (2006) demonstrated that triclosan (10 mg/ml in 5% polyethylene glycol) 
in the retention balloon was able to inhibit biofilm formation on catheters by Pr. 
mirabilis, Pv. stuartii, K. pneumoniae and Staph, aureus. These organisms were also 
shown to have MICs of triclosan ranging from 0.2 -  0.6 pg/ml. In contrast species 
with MICs of > 100 pg/ml (Ser. marcescens, M. morganii and Ps. aeruginosa) were 
able to produce extensive biofilms on catheters inflated with the triclosan formulation. 
The results presented in Table 3.5 and Figures 3.36 -  3.38 adds Pr. vulgaris to the list 
of organisms that should be inhibited by triclosan and Pv. rettgeri to the list of those 
that will resist the treatment.
The picture that is emerging from these laboratory studies is that triclosan at 3 mg/ml 
in the catheter balloon should be effective in preventing encrustations by Pr. mirabilis 
and Pr. vulgaris but will have no effect on encrustation produced by Pv. rettgeri or M. 
morganii. An important consideration is how does this picture relate to the incidence
-190-
D iscuss ion
of these species in the catheterised urinary tract? Mobley and Warren (1987) recorded 
the frequency of the occurrence of urease positive bacteria in urine samples. Pr. 
mirabilis and M. morganii were the most commonly occurring, being present in 58 
and 54 % of 1,135 samples respectively, with Pv. rettgeri (4 %) and Pr. vulgaris (1 
%) occurring far less frequently. Kunin (1989) found a similar pattern, with Pr. 
mirabilis being present in 34 % of 214 urine samples and M. morganii in 12 %. Pv. 
rettgeri and Pr. vulgaris were not isolated at all in this study. Ohkawa et al. (1990) 
and Matsukawa et al. (2005) examined the relationship between organisms present in 
urine samples and catheter biofilms in short-term catheterisation. In both studies the 
occurrence of all four species was relatively low. Ohkawa et al. (1990) found that for 
57 paired cultures of urine and catheter surface M. morganii was present in 5 (9 %) 
urine cultures, 3 (5 %) catheters and once (2 %) on both. Pr. mirabilis and Pr. 
vulgaris were present less often, being isolated in 2 (4 %) urine cultures each, 5 (9 %) 
and 4 (7 %) catheters respectively and on both twice (4 %) each. Pv. rettgeri was not 
isolated. Matsukawa et al. (2005) also found that these species occurred infrequently, 
with M. morganii and Pr. vulgaris only occurring twice each and Pv. rettgeri once, 
with Pr. mirabilis not occurring at all. Macleod (2006) examined the bacterial flora 
of 106 catheter biofilms (both crystalline and non-crystalline) and reported that the 
numbers (%) of catheters colonized by these species was Pr. mirabilis 31 (30.2 %), 
Pr. vulgaris 3 (2.8 %), Pv. rettgeri 5 (4.7 %) andM morganii 14 (13.2 %).
The evidence thus suggests that the triclosan strategy should prevent encrustation in 
most patients prone to this complication. Encrustation induced by Pv. rettgeri and M. 
morganii is likely to continue however if such a control strategy is used. It should be 
noted that encrustation by M. morganii will be a slow process and will only occur in
-191 -
D iscussion
patients with low urinary pHn values (< 7.3). There is of course the possibility that 
the widespread use of the triclosan strategy could select for the intrinsically resistant 
species. In addition acquired resistance to triclosan could also develop in sensitive 
species such as Pr. mirabilis.
Triclosan is widely used as an antibacterial agent in soaps, handwashes, deodorants, 
cosmetics, toothpaste and mouthwashes. There has been concern expressed that its 
overexploitation might result in the selection of resistant organisms (Levy, 2001; 
Schweizer, 2001). Despite extensive use for over 30 years however there has been 
little sign that its use in clinical, domestic or industrial situations has led to significant 
resistance. An important current application of triclosan is in the disinfection of 
patients colonized with MRSA (Coia et al., 2006). There have been some reports of 
increased MICs of triclosan in MRSA up to 4 pg/ml (Cookson et al., 1991; Brenwald 
and Fraise, 2003; Bayston et al., 2007). Strains of bacteria exhibiting this level of 
resistance are still killed by ‘in use’ concentrations which are generally well in excess 
of the MIC (Lear et al., 2002).
Jones et al. (2006) found that the amount of triclosan released into the urine from 
catheter balloons inflated with 10 mg/ml triclosan in 5 % aqueous polyethylene glycol 
over 48 h remained quite stable at approximately 0.1 pg/ml. This concentration of 
triclosan is close to its MIC for Pr. mirabilis (Table 3.6). Any increase in the MICs of 
triclosan found in Pr. mirabilis would thus be of concern in this context.
Experiments by Jones (2005) on triclosan resistant mutants created in the laboratory 
showed that some of the mutants were able to produce crystalline biofilm and block
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catheters had been inflated with triclosan (10 mg/ml). These mutants had MICs of 
triclosan of 40 fig/ml compared to the parent strains in which the MIC was around 0.1 
pg/ml. The development of similar resistance in clinical situations would render the 
triclosan strategy ineffective. For this reason the clinical use of the triclosan strategy 
should be limited strictly to those situations in which catheter blockage is being 
caused by sensitive species (Pr. mirabilis or Pr. vulgaris) and not used as a general 
anti-infection strategy for long-term catheterised patients. In addition there are some 
indications that triclosan resistance may also lead to antibiotic resistance (Cookson et 
al., 1991). Some authors have also suggested that the occurrence of stable low-level 
triclosan resistant mutants in the environment might encourage the preferential 
survival of mutants resistant to other antimicrobial agents (Heath et a l, 1998; 
McMurry et a l, 1998). Other authors have cast doubts on this, but nonetheless 
emphasize that the use of triclosan should be limited to clinically useful situations 
(Gilbert and McBain, 2001; Russell, 2003). In view of this speculation it will be 
important in any subsequent clinical trial of the triclosan strategy to perform careful 
monitoring of urine samples to check for changes in the bacterial flora and its 
sensitivity to triclosan and antibiotics.
The catheter balloon has also been used to deliver antibacterials to the bladder by 
Carlsson et al. (2005). These authors developed a formulation which generated nitric 
oxide in the balloon. This agent then diffused through the balloon to the surrounding 
medium. A batch culture model of the catheterised urinary tract was used in these 
experiments. It consisted of long-necked 50 ml flasks containing 25 ml of urine 
inoculated with E. coli to a final population density of 106 cfu/ml. The urinary 
catheter was then inserted into the flask and the balloon inflated with the nitric oxide
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generating solution. The solution (10 mM ascorbic acid 5 mM sodium nitrite in 
physiological saline at pH 2.5) was produced by mixing equal quantities of pH 2.5 20 
mM ascorbic acid in physiological saline and pH 2.5 10 mM sodium nitrite in 
physiological saline immediately prior to inflation of the catheter balloon. Once the 
balloon had been inflated the catheter was pulled up to seal the neck of the flask. The 
flask was then inverted and incubated at 37 °C for 24 h.
The data presented in Figure 3.39 show that when the mixture used by Carlsson et al. 
(2005) was used to inflate catheter balloons in models there was no inhibition of Pr. 
mirabilis crystalline biofilm formation. The results of triplicate experiments showed 
no differences between the mean urinary pHs, mean urinary viable cell numbers and 
mean times to catheter blockage in the test and control models (Figure 3.39). Visual 
examination of catheters removed from the models at blockage also showed no 
differences between the test and control catheters, with all of the catheters showing 
large amounts of encrustation (Figure 3.40).
Nitric oxide has been shown to be important in the intracellular killing of 
microorganisms by macrophages (MacMicking et al., 1997). The acidification of 
inorganic nitrite results in the production of a variety of reactive nitrogen species 
(RNSs) such as nitric oxide (NO) (Weitzberg and Lundberg, 1998). Carlsson et al. 
(2005) speculated that the combination of nitrite and ascorbic acid in acidic conditions 
with which they inflated the catheter balloon resulted in the formation of RNSs in the 
surrounding urine, which accounted for the antibacterial effect observed. They 
attributed the bactericidal effects observed to NO on the basis that (1) only small 
uncharged molecules such as NO would be expected to pass though the silicone
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balloon membrane freely, (2) the use of ascorbic acid strongly favours the formation 
of NO from acidified nitrate over the formation of other RNSs and (3) that the NO 
donor DETE NONOate, which is believed to be a pure NO donor with minimal 
formation of other RNSs (Feelisch, 1998), also had bacteriostatic effects. They also 
suggested that once NO has passed through the membrane it might be able to form 
other uncharacterised compounds with antimicrobial activity. From the data provided 
by Carlsson et al. (2005) it can be seen that the formation of NO from the solution in 
the balloon is rapid, and that the amount of NO in the urine quickly became 
undetectable (within 3 h). This pulse of NO production was suggested by the authors 
to be responsible for the bactericidal effects observed. The longer lasting effects were 
attributed to the formation of more long-lived antibacterial compounds in the urine.
Why then was this strategy not effective in extending the life-span of catheters when 
challenged by Pr. mirabilis? Given the fact that NO is active against such a wide 
range of pathogens including fungi, protozoa and bacteria as part of the human 
immune response (Fang, 1997) it seems unlikely that resistance to NO the cause. The 
model system used by Carlsson et al. (2005) was a batch culture model. In the 
catheterised urinary tract the urine in the bladder is being constantly replaced by urine 
from the kidneys and is a continuous flow system. The pulse of NO generated by the 
solution used by Carlsson et al. (2005) must as a result quickly eliminate the infecting 
bacteria since the production of NO occurs over such a short time period. The 
formation of more long-lived antibacterial compounds in the urine by NO would not 
be relevant since they would also be washed out with the urine from the bladder. 
Observation of the models in the early stages of incubation suggested that the NO 
strategy had an initial effect. The urine in the test models was distinctly less turbid
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than in the controls. On further incubation however, the turbidity of the culture in the 
test unne soon matched that in the controls. This series of experiments shows that 
even with a modest flow rate of 0.5 ml/min of urine the strategy was unable to 
eliminate the infecting bacteria and as a result had no effect on the time taken for the 
catheters to block. If this strategy is to be effective it will be necessary to prolong the 
generation of NO in the catheter balloon.
4.4 The effectiveness of an integrated sensor/modulator strategy for the control 
of catheter encrustation.
The simple bromothymol blue / cellulose acetate sensor developed by Stickler et al 
(2006a) is capable of signalling the early stages of catheter encrustation. Placed in the 
urine drainage bag it can warn patients, carers or nurses in good time that the catheter 
needs to be replaced (Stickler et al., 2006c). In this way the use of the sensor could 
avoid the clinical crises induced by catheter blockage. The sensor would be of even 
more value if there was an effective strategy that could be deployed to inhibit 
encrustation when the problem is signalled. It was decided therefore to test the sensor 
/ modulator concept using triclosan as a means of blocking crystalline biofilm 
development.
The 0.1 M Na2C0 3  solution used as a solvent for triclosan in Section 3.3 has a pH of 
11. If the catheter balloon were to burst inside the bladder the release of 10 ml of this 
alkaline solution would be of concern. Other triclosan containing solutions have been 
investigated for their effect on Pr. mirabilis biofilm formation in vitro (Williams, 
2006). Williams (2006) found that a diluted solution of Hy-shield handcream was
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effective against Pr. mirabilis when tested in the bladder model and at this stage the 
preparation was being considered for use in the clinical trials of the strategy. It was 
decided therefore to use the Hy-shield handcream for the triclosan intervention, with 
triclosan in Na2 CC>3 as a comparison.
In the previous study using Hy-shield (Williams, 2006) catheters were placed in the 
models, inflated with the antiseptic (diluted to 3 mg/ml triclosan) and then the residual 
urine in the bladder chamber was inoculated with Pr. mirabilis. Under these 
circumstances encrustation was prevented and the catheters drained freely for the 
experimental period. The results presented in Figure 3.42 show that when the 
introduction of the Hy-shield was delayed until the sensor signalled, the intervention 
was less successful at inhibiting encrustation. In two of the replicated experiments the 
test catheters blocked soon after their respective controls. In the third replicate the 
triclosan treated catheter drained for 96 h post-intervention period but by 108 h the pH 
of the urine in the bladder had risen to 8.5 suggesting that encrustation was occurring 
on this catheter. The results presented in Figure 3.43 suggest that the Hy-shield was 
slightly more effective against Pr. vulgaris. While in one of the replicate experiments 
the treated catheters blocked, it drained for 92 h compared to 29 h for the control. In 
the other two replicates, the catheter drained freely for 112 and 117 h and the pH of 
the urine was maintained at about 6.5 throughout the experimental period. As 
expected in models inoculated with Pv. rettgeri the test and control catheters all 
blocked (Figure 3.44). There was no significant difference between the blockage 
times of the test and control catheters.
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In the models inoculated with Pr. mirabilis where the balloon was inflated with 3 
mg/ml triclosan in Na2CC>3 , blockage did not occur within 96 h post triclosan 
intervention for any of the test models (Figure 3.45). All control models blocked 
within 30 h of inoculation. The pH of the urine in the test models was maintained at 
or just below pH 6.5. These results indicate that triclosan in Na2 CC>3 is more effective 
than Hy-shield. Hy-shield cream has a complex formulation and it is possible that 
some of the ingredients inactivate or cause a reduction of the diffusion of triclosan 
through the membrane of the catheter balloon.
The sensors used in this study were able to signal the rise in urine pH caused by the 
infecting urease producing organisms {Pr. mirabilis, Pr. vulgaris and Pv. rettgeri) 
(Figures 3.42 -  3.45). Encrustation was observed on catheters removed from models 
stopped when the sensor became blue (Figures 3.46 -  3.50), confirming the 
observations of Stickler et al. (2006a) that the sensor signalled the early stages of 
catheter encrustation. The scanning electron micrographs (Figures 3.48 -  3.50) also 
show that the sensors became colonized by crystalline biofilm, though not as heavily 
as the catheters.
The urine in the collection bags remained alkaline even when the bladder urine pH 
was reduced (Figures 3.42 -  3.45). Thus the sensors continued to give a positive 
signal for the duration of the experiments. It is clear therefore that for the sensor to 
accurately reflect the pH of urine in the bladder after triclosan intervention both the 
collection bag and sensor need to be replaced. This raises the question of whether the 
catheter will have to be changed when the triclosan strategy is initiated. The results 
presented in Figures 3.42 and 3.43 show that if Hy-shield is to be used to supply
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triclosan then it would probably be prudent to remove the catheter that had started to 
encrust and replace it with one inflated with the antiseptic solutions. In the case of the 
triclosan in Na2CC>3 this would probably not be necessary.
Overall the data presented in Section 3.4 shows that a combined sensor/modulator 
strategy can be effective in preventing catheter blockage by Proteus sp. (but not by 
Pv. rettgeri) in vitro.
4.5 The response of the pH sensor to slow-encrusting and non-encrusting 
bacterial species.
In clinical practice the sensor will o f course be exposed to the wide range of bacterial 
species that infect the catheterised urinary tract. It is of interest therefore to 
investigate its response to slow-encrusting and non-encrusting bacterial species.
The results of the 168 h long experiments with the three slow encrusting species 
(Figures 3.51 -  3.54) show that catheter blockage by crystalline biofilm was induced 
by M. morganii and Staph, saprophyticus but not by Staph, aureus. The colour shown 
by the sensors reflected the pH of the urine in the collection bags well during the 
experiments. For the models inoculated with M. morganii and Staph, saprophyticus 
the mean times between the sensor becoming positive and catheter blockage were 
37.3 h (±2.85 h) and 41.0 h (±15.0 h) respectively. For the Staph, aureus inoculated 
models the sensors in two of the three replicates became positive during the 
experiment, although the signal intensity reduced as the urinary pH in the collection 
bag fell towards the end of the experiment. One sensor eventually became negative
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again. Digital photographs taken of catheters removed from the model (Figure 3.54) 
show the extensive crystalline biofilms on the blocked M. morganii and Staph, 
saprophyticus catheters. The catheter removed from the Staph, aureus infected model 
after 168 h shows that while it had not blocked it was heavily encrusted. These three 
species were designated as slow encrusters as a result of experiments performed in the 
bladder model over 96 h (Section 3.1). The extensive encrustation and catheter 
blockage observed in the 168 h long experiments confirm this classification.
The data collected from experiments with urease negative E. coli and Ent. faecalis 
(Figures 3.55 & 3.56) show that the urine pH remained low (< 6.2) in both the bladder 
and collection bag for these species. This was reflected in the lack of colour change 
shown by the sensors, which remained yellow for the duration of the experiments. No 
encrustation can be seen in digital images of catheters removed from models 
inoculated with these species after 120 h (Figure 3.60).
For models inoculated with Ps. aeruginosa, Pv. stuartii and K. pneumoniae the urine 
pH in the bladder chamber did not exceed 6.4 during the experiment (Figures 3.57 -  
3.59). The urine pH in the collection bag however was higher, and this was reflected 
in the colour of the sensor. The sensors of one of the three replicates of both the Ps. 
aeruginosa and Pv. stuartii infected models became positive during the experiments. 
None of the sensors in the K. pneumoniae infected models became positive, although 
colour change from yellow to pale green was observed. Digital photography showed 
no encrustation on catheters removed from models infected with these three species 
after 120 h, though thick mucoid biofilm was present on some catheter sections from 
Ps. aeruginosa and K. pneumoniae infected models (Figure 3.60).
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The data for the slow-encrusting species show that the sensor is capable of providing 
early warning of blockage in M. morganii and Staph, saprophyticus infected models. 
The results for Staph, aureus were not so clear cut. The sensor gave a positive signal 
at 72 h reflecting an increase in the pH of the urine in the bag to 8 and a pH of 7 in the 
urine in the bladder. The intensity of the signal reduced with time however as the pH 
of the urine dropped to 7.3 in the bag and 6.7 in the bladder. The catheters were 
heavily encrusted and would therefore probably have blocked if the experiment had 
been extended. In this case however, it is less convincing to state that the sensor gave 
a clear warning of catheter encrustation.
The response of the sensors to Ps. aeruginosa and Pv. stuartii was also interesting in 
that they gave positive signals and yet the catheters drained freely and no evidence of 
crystalline biofilm was seen. These reactions have therefore to be considered as false 
positives. The results with all the test species show that the pH of the urine in the bag 
was consistently higher than that of the urine in the bladder. This is understandable as 
the storage of the urine in the bag for periods of up to 18 h prior to emptying allows 
the urease producing bacteria to generate more ammonia. It was decided to place the 
sensor in the drainage bag rather than between the catheter and drainage tube as it was 
shown to produce a more rapid response to Pr. mirabilis at that site (Stickler et a l, 
2006a). The results presented in Figures 3.51 -  3.60 suggest that perhaps the 
specificity of the sensor would be improved if it was located in a connector between 
the catheter and drainage tube. At this site it would register the pH of urine flowing 
from the bladder and thus in the cases of Ps. aeruginosa and Pv. stuartii should not 
give a signal. It is interesting however that when the sensor was tested in the urine
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bags of patients (Stickler et al., 2006c) it did not give positive signals in the presence 
of Ps. aeruginosa, Pv. stuartii or K. pneumoniae. It might also be interesting to see 
how a sensor at the catheter / drainage tube junction responded to Staph, aureus.
4.6 Are other urinary tract pathogens capable of modulating crystalline biofilm 
formation by Pr. mirabilis?
Mathur et al. (2006a) showed that in patients infected with Pr. mirabilis the rates at 
which catheters block vary considerably. In their study mixed communities of 
organisms were isolated from the urines of all the patients. The availability of the 
collection of organisms from these patients made it possible to investigate the effect 
of the bacterial communities on the ability of the Pr. mirabilis strains to encrust 
catheters in the laboratory model.
In the case of patient 6, while the Pr. mirabilis and Ent. faecalis were colonizing the 
urine, the catheter took 13 weeks to block with encrustation (Mathur et al., 2006a). It 
could be the case that the Pr. mirabilis strain was a poor urease producer and not 
capable of generating the alkaline conditions necessary for rapid encrustation. The 
results presented in Figure 3.61 however, demonstrate that in the laboratory model 
this organism was perfectly capable of raising the urinary pH to 8.3 and blocking 
catheters in 25 h. In the presence of the Ent. faecalis the rate of encrustation was 
reduced and the catheters took significantly longer to block (25 h vs 55 h) (P=0.037). 
Although Ent. faecalis had little effect on the growth of Pr. mirabilis (Figure 3.62) 
and there was no significant difference between the mean urinary pHs at blockage 
(P=0.27) it did appear that the rise in urinary pH in the mixed community was slower
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than in the pure culture of Pr. mirabilis. It is possible therefore that the Ent. faecalis 
in some way inhibited the production or activity of the Pr. mirabilis urease enzyme.
Consideration of some important clinical factors makes it difficult to accept that the 
delay in catheter blockage by Ent. faecalis observed in these experiments could 
explain the observation that in the patient the catheter took 13 weeks to block. The 
patient concerned was a 101 year old woman who was fitted with a percutaneous 
endoscopic gastronomy tube after a stroke. The pHv of her urine was consistently 
high (7.5 -  8.0) throughout the lifetime of the catheter, testimony to the urease 
activity of the Pr. mirabilis. The pHn of her urine however was even higher, 
fluctuating around pH 9. The probable reason for such dilute urine (unusual in an 
elderly catheterised patient) was that being fed with a gastronomy tube ensured a good 
fluid intake. It seems likely therefore that in the case of patient 6, the dilute urine with 
its high pHn was the main reason for the very slow rate of catheter encrustation.
Patient 9 had urine which was colonized by Pr. mirabilis, E. coli, K. pneumoniae and 
Ent. faecalis. This patient did not experience catheter blockage for the duration of the 
study period (14 weeks) (Mathur, 2007). Control models inoculated with the Pr. 
mirabilis isolate alone quickly blocked (mean 35 h) demonstrating its ability to 
generate alkaline urine and form crystalline biofilm (Figure 3.63a). There was no 
significant difference between the mean blockage times of catheters in models 
inoculated with the Pr. mirabilis isolate alone (35 h) and the community (40 h) 
(P=0.643). The presence of other species of bacteria appeared to have little effect on 
the growth of the Pr. mirabilis or its production of urease. Conversely the numbers of
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both the E. coli and K. pneumoniae isolates present were reduced from their initial 
population by the end of the experiment (Figure 3.63b).
Given the lack of an observable effect by the community in reducing the rate of 
encrustation by Pr. mirabilis in the model it seems unlikely that the isolates present in 
the community from this patient are linked to the lack of encrustation seen on the 
patients catheters. The pHv of this patient’s urine varied from pH 6 to 7.5 although it 
was generally around pH 7. The pHn of the urine varied from pH 7 to 8.5 and was 
consistently higher than the pHv, with the pHn usually 1 -  2 pH units higher than the 
pHv. This elevated pHn is most likely to be due to relatively dilute urine. Patient 9 
was living in her own home during this study, implying that she was relatively 
competent. As a result it may be reasonable to assume that she was able to provide 
herself with sufficient fluid to maintain dilute urine during the study.
Patient 19 did not experience catheter blockage during the study (13 weeks) (Mathur 
et al., 2006a). His urine was colonized by Pr. mirabilis, Ps. aeruginosa, E. coli, and 
K. oxytoca for the majority of the study. While the Pr. mirabilis isolate was able to 
quickly block catheters in the model when tested alone (mean 40 h), only one of the 
models infected with the entire community had sufficient crystalline biofilm to cause 
catheter blockage (after 147 h) with neither of the remaining catheters blocking after 
168 h. The urine pH in the control models was significantly higher than that of the 
test models after 24 h (iM).021) and this corresponded to a reduction in the numbers 
of Pr. mirabilis present in the test models (Figures 3.64 & 3.65). While the numbers 
of Pr. mirabilis were reduced the urine pH remained below 7.0 in the test models. 
When Pr. mirabilis was able to recover back to the numbers present at the start of the
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experiment in one of the test models the urinary pH rose and blockage quickly 
occurred (Figures 3.64 & 3.65). The other members of the community appeared to be 
able to inhibit the growth of Pr. mirabilis effectively while growing well themselves 
for the majority of the experiment (Figure 3.65). It should be noted that in the patient 
19 test catheters through which urine flowed freely for 168 h some encrustation was 
present despite the reduction in Pr. mirabilis numbers (Figure 3.67). The biofilm 
present on the unblocked catheters after 168 h had an unusual form which was distinct 
from any of those seen previously in this study, appearing to consist of both 
crystalline and mucoid material (Figure 3.66).
Patient 19 was able to maintain a wide safety margin between urinary pHv and pHn for 
the duration of the study, in common with patients 6 & 9. While patients 6 & 9 had 
urinary pHvs that were in the range 6.5 -  7.5, as might be expected in the case of a Pr. 
mirabilis infection, the urinary pHv from patient 19 had a mean value of 4.77. This 
would suggest that the Pr. mirabilis isolate was having very little effect on urinary 
pH. Since this isolate had no problems in raising urinary pH and causing catheter 
blockage in the laboratory model it seems reasonable to assume that the effect seen in 
the models infected with the community may be occurring in the urine of this patient, 
with a restriction of the growth of Pr. mirabilis by the other species.
Bacterial interference with non-pathogenic bacteria has shown some success in 
preventing the establishment of infection by pathogenic strains. Darouiche et al. 
(2005) found that the deliberate establishment of a non-pathogenic E. coli strain on 
patient’s catheters reduced the occurrence of the development of symptomatic UTI 
during the subsequent year by half. Unfortunately a subsequent trial found that the
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presence of Proteus sp. in a patients urine had a deleterious effect on the E. coli 
biofilm and significantly reduced the numbers of E. coli present, indicating that the 
use of E. coli in this way would be unlikely to be effective against encrustation by 
Proteus sp. (Trautner et al., 2007).
The communities from patients 9 & 19 involve several similar organisms. Both have 
an E. coli isolate and a Klebsiella sp. isolate (K. pneumoniae for patient 9 and K. 
oxytoca for patient 19). In addition the patient 19 community also has a Ps. 
aeruginosa isolate. The presence of the Ps. aeruginosa isolate would appear to be the 
main difference between the communities from these two patients. Ps. aeruginosa 
isolates, in common with both K. pneumoniae and K. oxytoca, have been observed to 
form unusually thick mucoid biofilms in previous experiments (Section 4.1), with 
those formed by Ps. aeruginosa being slightly more extensive than either Klebsiella 
sp. It seems likely that some property of the Ps. aeruginosa biofilm phenotype is 
affecting the growth of the Pr. mirabilis isolate, while not affecting the growth of the 
other two species which show consistently high numbers in all three replicates (Figure 
3.65).
Sabbuba et al. (2002) noted the effectiveness of Ps. aeruginosa in reducing the 
swarming of Pr. mirabilis over sections of urinary catheter. It is possible that the 
apparent inhibition of Pr. mirabilis seen in the patient 19 community is due to the 
same or a related mechanism to the inhibition of swarming by Ps. aeruginosa. It is 
interesting to note that the species other than Pr. mirabilis from the communities 
reconstituted from patients 9 and 19 which were tested along with Ps. aeruginosa by
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Sabbuba et al. (2002) (E. coli, K. pneumoniae and Ent. faecalis) had little or no effect 
on the swarming of Pr. mirabilis.
It would be useful to test the patient 19 Ps. aeruginosa, E. coli and K. oxytoca isolates 
individually against the Pr. mirabilis isolate to determine if the inhibitory effect is due 
to the actions of the community or a particular isolate. After determining the source 
of the inhibition the isolate(s) could then be tested against other Pr. mirabilis isolates 
and additional isolates of the same species tested for their activity against Pr. 
mirabilis. Prospective studies similar to that conducted by Mathur et al. (2006a) 
which searched specifically for patients with Proteus infection who do not experience 
catheter blockage would also be useful in identifying other candidates for use in this 
type of bacterial interference.
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5. General Discussion and Future Work.
Pr. mirabilis has been consistently identified as the species responsible for the 
majority of episodes of catheter blockage by crystalline biofilm (Mobley and Warren, 
1987; Kunin, 1989; Stickler et al. 1993b; Stickler et al., 1998a). Although this study 
demonstrates that Pr. vulgaris and Pv. rettgeri are capable of causing rapid 
encrustation in the bladder model, both of these species occur relatively infrequently 
in the catheterised urinary tract (Mobley and Warren, 1987; Kunin, 1989). Species 
identified as slow encrusters (M morganii, Staph, aureus and Staph, saprophyticus) 
are also only likely to cause encrustation in a minority of patients whose urine has a 
low pHn. As a result strategies to combat catheter encrustation must focus on Pr. 
mirabilis since resolving problems caused by this species would benefit the vast 
majority of patients affected.
Biofilms cause problems in a wide variety of situations, from implanted devices to the 
hulls of ships. A number of attempts have been made to produce materials which 
inhibit the initial adhesion of bacteria to surfaces. In implanted devices a major 
problem with this strategy is that the device often becomes coated by serum proteins, 
providing an ideal surface for bacterial adherence and biofilm formation (Gristina, 
1987). Surfaces which antibacterial agents are either attached to or released from 
have been widely utilised to combat biofilm associated infection in implanted devices 
including heart valves, prosthetic joint replacements and venous catheters. Silver has 
been commonly used in this role, with varying effectiveness (Darouiche, 1999; 
Kjaergard et al., 1999). Antoci et al. (2007) found that covalently bonding 
vancomycin to the surface of a titanium alloy was effective at preventing bacterial
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colonization of the surface by Staph, aureus in vitro. It remains to be seen whether 
this approach will be sufficient to overcome the problem of coating by serum proteins 
in vivo. Antifouling surfaces or coatings have been used to prevent the growth of 
organisms on ships hulls since the Napoleonic wars, where copper was used to 
prevent fouling on warships. Many of the strategies used were highly toxic but 
recently legislation has required the use of minimally or non-toxic (to the marine 
environment) coatings (Wigglesworth-Cooksey et al., 2007). This has lead to the 
development of alternative methods for the prevention of fouling including the 
adaptation of antifouling strategies used by marine organisms. The most interesting 
of these is the use of halogenated furanones from the red alga Delisea pulchra (de Nys 
et al., 1995). Synthetic halogenated furanones have been shown to be effective in 
disrupting biofilm formation in Ps. aeruginosa by interfering with quorum sensing 
(Hentzer et al., 2002). This disruption is due to the furanones competing with the 
AHLs used by Gram-negative bacteria in cell to cell communication. Unfortunately 
due to their high reactivity these halogenated furanones are likely to be too toxic for 
use in humans (Hentzer and Givskov, 2003). They do however highlight the potential 
of this approach in disrupting biofilm formation on implanted devices.
Although these strategies might prove effective against most biofilm associated 
problems, the formation of catheter encrustation by Pr. mirabilis presents a different 
challenge. It is a physically and chemically driven process where the contribution of 
Pr. mirabilis is mainly to produce urease which raises the urinary pH and causes the 
precipitation of calcium and magnesium phosphates. Once the urinary pHv exceeds 
the pHn crystal formation occurs in the urine. These crystals aggregate with Pr. 
mirabilis and are deposited on the catheter surface, eventually causing blockage of the
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catheter lumen. As a result in order to prevent catheter blockage by Pr. mirabilis the 
urinary pHn must be maintained above the pHv. There are two ways in which this 
may be accomplished. Restricting either the growth or urease production of Pr. 
mirabilis would prevent the rise in urinary pHv. This can be achieved by the use of 
antimicrobials released into the urine, as shown by the use of triclosan (Jones et al., 
2005; Jones et al., 2006), or by urease inhibitors (Morris and Stickler, 1998b). 
Resveratrol, a naturally occurring polyphenol found in red wine, grapes and peanuts 
has been found to inhibit urease production and swarming as well as several other 
virulence factors in Pr. mirabilis (Wang et al., 2006). Studies on the cytotoxicity of 
resveratrol have found that it may be suitable for use clinically, unlike other urease 
inhibitors such as acetohydroxamic acid (Babich et al., 2000). The second option is 
to raise urinary pHn to levels where it exceeds the pHv caused by Pr. mirabilis 
infection. This can be achieved by increasing the fluid and intake of citrate, a metal 
ion chelator, which dilutes the urine and raises the urinary pHn (Suller et a l, 2005; 
Stickler and Morgan, 2006).
The simple cellulose acetate / bromothymol blue sensor developed by Stickler et al. 
(2006a; 2006c) provides a constant indication of urinary pH in the catheter bag. The 
placement of the sensor at the catheter / drainage tube junction would allow direct 
monitoring of urinary pHv. This might improve the specificity of the signal, since the 
urine in the collection bag may have elevated urinary pH relative to the pHv due to the 
action of urease while the urine is stored in the bag. The development of an 
inexpensive sensor able to detect both urinary pHv and pHn would be extremely useful 
in the management of catheter blockage. This would give heath care staff and patients
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warning of imminent blockage and allow the targeted application of the triclosan or 
any other moderation strategy.
Experiments examining the response of the sensor to urease producing species other 
than rapid encrusters found that while the sensor performed well in predicting 
blockage by slow encrusting species a number of false positive signals were observed 
with non-encrusting species. Although this was not reflected by the clinical data 
(Stickler et al., 2006c) it may be that the placement of the sensor at the catheter / 
drainage tube junction might improve the specificity of the sensor under these 
circumstances. This could be determined in experiments in the laboratory model.
The intrinsic resistance of Pv. rettgeri to triclosan, while not likely to be a problem 
initially due to its infrequent occurrence, may become a significant problem if the use 
of the triclosan strategy clinically causes its selection. As a result it would be prudent 
to investigate the possibility of using a similar method to deliver antimicrobials to 
which Pv. rettgeri is sensitive to the catheterised urinary tract using the bladder 
model. A combination of triclosan with any agents found to be effective against Pv. 
rettgeri would provide a strategy effective against all of the bacterial species capable 
of causing rapid encrustation. Williams (2006) found that nalidixic acid was able to 
diffuse from the catheter balloon in sufficient quantities to significantly extend the 
mean time to blockage of catheters by Pr. mirabilis. Unfortunately there is wide 
variation in the activity of this drug against Pv. rettgeri, the MIC ranging from 2 -  
256 pg/ml (Hawkey and Hawkey, 1984). Research into agents more consistently 
active against Pv. rettgeri which are deliverable via the catheter balloon should be 
conducted.
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The use of nitric oxide by Carlsson et al. (2005), while not found to be effective in the 
bladder model, is an interesting attempt to use a component of the human immune 
response to combat CAUTI. The production of NO in the catheter balloon did 
initially reduce the turbidity of the urine in the bladder model, suggesting that it can 
affect the growth of Pr. mirabilis. The short duration of the NO release however 
meant that it did not reduce the time to blockage of the catheters. It would be 
interesting to test the ability of a NO producing solution able to release NO over a 
longer period of time to extend catheter lifespan in the bladder model.
An alternative use for NO may be in combining it with the triclosan strategy. 
Triclosan does not immediately diffuse from the catheter balloon after inflation, 
taking up to 4 h to reach maximum levels (Jones, 2005). The quick release of NO by 
the solution used by Carlsson et al. (2005) might be able to cover this gap, with a 
combined solution providing consistent antimicrobial activity in the urine. This could 
be tested in principle in the bladder model.
The use of antimicrobial strategies to eliminate Pr. mirabilis colonization of the 
catheterised urinary tract raises the question of what happens next. Will Pr. mirabilis 
inevitably re-colonize the urine of these patients after successful elimination? 
Sabbuba et al. (2004) found that infection stones from the bladders of long-term 
catheterised patients experiencing catheter encrustation contained the same strain of 
Pr. mirabilis as in the catheter encrustation. It is possible that bacteria in these stones 
may be protected from the action of antimicrobials that were effective in eliminating 
Pr. mirabilis from the catheter and urine. Preventing the rapid reoccurrence of Pr. 
mirabilis colonization may as a result require the removal of these stones. Any
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studies into the effectiveness of antimicrobial strategies in eliminating Pr. mirabilis 
would need to take this into account when considering the long-term management of 
patients.
Although the use of antibacterial agents does show promise in controlling the 
formation of encrustation it would be far better in the long-term to find ways of 
reducing encrustation by other means. This would avoid the problems of resistance to 
the antimicrobial, important given the relatively small numbers of new antimicrobials 
coming into clinical use, and also any adverse reactions to the antimicrobial that 
might be experienced by the patient. Mathur et al. (2006a) observed that patients with 
a high urinary pHn were far less likely to experience catheter blockage by 
encrustation. Stickler and Morgan (2006) demonstrated that the dilution of urine and 
addition of citrate combine to raise the pHn of urine significantly. This strategy 
avoids the use of antimicrobials and so bypasses the problem of resistance. It is a 
strategy which should be effective against all of the urease producing species since it 
raises the pHn, thereby blocking a fundamental part of the bacterially induced 
encrustation process. Stickler and Morgan (2006) showed that this strategy was 
effective against Pr. mirabilis. Experiments in the bladder model would confirm its 
effectiveness against other bacterial species capable of causing encrustation. 
Increasing fluid intake is a simple measure that could be used effectively on the 
majority of patients and it would be interesting to see its effect on the occurrence of 
catheter encrustation in a clinical trial.
Some patients are chronically colonized by Pr. mirabilis while others are not. This 
raises the question of why this should be. Is there a reason other than that they have
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not been exposed to it? Mathur et al. (2005) found that the isolate of .Pr. mirabilis 
colonizing the catheterised urinary tract is often identical to that found in the patients 
gut microflora. It would be interesting to examine the extent to which catheterised 
patients without Pr. mirabilis as part of their urinary flora have it as a part of their gut 
microflora. It may be that for some patients with an already established community 
colonizing their urine that this community serves to prevent the establishment of other 
species such as Pr. mirabilis. This also could be tested in experiments in the bladder 
model.
A recent study by Laube et al. (2007) found that a diamond-like carbon coating 
(DLC) was effective in preventing the formation of encrustation on ureteral stents in 
patients who had previously experienced problems with stent encrustation. This 
material has the additional advantage of being relatively low friction, which may 
mean that its inclusion in urinary catheters would cause less trauma to the urethral 
mucosa on insertion. Unfortunately Pr. mirabilis was not one of the bacteria isolated 
from patients during this study so its effectiveness against this species is unknown. It 
would be interesting to examine the effect of urinary catheters coated with DLC on 
the formation of crystalline biofilm by Pr. mirabilis in the bladder model.
The data presented on the effect of catheter communities on the formation of 
encrustation shows the potential for bacterial interference in combating catheter 
blockage. Bacterial interference using a non-pathogenic strain of E. coli has shown 
some success in reducing the occurrence of symptomatic UTI (Darouiche et al., 
2005). Unfortunately the use of this strain was not effective against Proteus sp. 
(Trautner et al., 2007). Trautner et al. (2005b) demonstrated that a colicin expressing
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strain of E. coli was able to prevent the establishment of a colicin susceptible strain of 
E. coli on catheters in vitro. They proposed that the creation of a non-pathogenic 
bacterial strain able to produce a broad spectrum of bacteriocins active against 
uropathogens would potentially be effective in preventing the establishment of these 
species on urinary catheters when used in the manner of Darouiche et al. (2005). This 
is an interesting application of bacterial interference although the use of genetically 
modified organisms in a medical context may face strong opposition from regulatory 
authorities. The experiences of Darouiche et al. (2005) and Trautner et al. (2007) 
show that it is possible, at least in E. coli, to use a non-pathogenic strain to prevent or 
restrict the establishment of pathogenic strains. It would be interesting to see if this 
approach could be effective for Pr. mirabilis. Different strains of Pr. mirabilis are 
quite antagonistic towards each other when swarming and this is the basis of Dienes 
typing. Laboratory experiments could be performed to determine whether the 
presence of an established urease-negative strain of Pr. mirabilis might be effective in 
preventing the colonization of catheters by urease-positive strains of Pr. mirabilis of 
different Dienes type.
The inhibitory effect of the catheter community (from patient 19) on the formation of 
encrustation by Pr. mirabilis requires more study. It is necessary to identify whether 
one of the species present in this community is responsible for the inhibition of Pr. 
mirabilis or if the effect is due to the whole community. Once the source of the 
inhibition is identified it may be possible to determine the specific factors responsible. 
This could potentially lead to the use of a bacterial strain in the manner of Darouiche 
et al. (2005) but targeted specifically at preventing Pr. mirabilis colonization. 
Clinical studies similar to that performed by Mathur et al. (2006a) looking
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specifically for patients with Proteus infection but with a low urinary pH who are not 
experiencing catheter blockage might produce further suitable candidate communities 
for bacterial interference studies. In addition the collection of communities from 
patients without Proteus infection would allow their testing in vitro to determine if the 
communities were preventing the establishment of Proteus on their catheters.
It is important that any strategy used for the control of encrustation does not have 
serious side effects. If antimicrobial strategies such as using triclosan are unable to 
completely eliminate Pr. mirabilis from the urinary tract then may be necessary to 
extend their use as a long-term moderator rather than just for short-term crisis 
management. Strategies involving alteration of urinary composition such as the use 
of high citrate drinks are inherently long-term since they do not attempt to remove the 
Pr. mirabilis colonization. The use of either of these methodologies would need to be 
closely monitored in order to detect potential problems.
The insight we now have about the mechanisms of catheter encrustation make it very 
clear that we have to be more ingenious than simply putting antimicrobials in 
catheters if we are to solve this problem that complicates the care of so many elderly 
and disabled people.
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6. Conclusions
1. Three species {Pr. mirabilis, Pr. vulgaris and Pv. rettgeri) were identified as rapid 
catheter encrusters. They were able to raise the urinary pH in the model to > 8, 
causing the formation of encrustation and blockage. Assays of urease activity showed 
that these species were able to cause far more urea hydrolysis than the majority of 
urease producing species tested. As Pr. vulgaris and Pv. rettgeri are rarely found in 
the catheterised urinary tract, strategies to control the formation of catheter 
encrustation should focus on Pr. mirabilis.
2. M. morganii, Staph, aureus and Staph, saprophyticus are able to raise the mean 
urinary pH from 6.1 to 6.89 -  7.39 over 96 h and cause the slow formation of 
crystalline biofilm on urinary catheters. Crystalline biofilm is only likely to be 
formed by these species in a minority of cases in patients whose urine has a 
consistently low pHn.
3. A number of commonly occurring species identified as urease positive in standard 
diagnostic tests were found to be non-encrusting in the model {Pv. stuartii, Ps. 
aeruginosa, K. pneumoniae, K. oxytoca, Ser. marcescens, Enterobacter cloacae, C. 
freundii and C. koseri). These species were not able to raise the mean urinary pH 
above mean levels of 6.45 and did not form crystalline biofilm. Urease assays on 
these species in artificial urine found that they were unable to cause the hydrolysis of 
significantly more urea than the urease negative controls. These species are not 
appropriate targets for control strategies.
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4. Comparison of the effectiveness of antibacterial catheters (silver-hydrogel and 
nitrofurazone) with all-silicone controls showed no significant differences in time to 
blockage, mean urinary pH or bacterial populations when challenged by Pr. mirabilis, 
Pr. vulgaris or Pv. rettgeri. These antibacterial catheters are thus vulnerable to 
encrustation by crystalline biofilm.
5. The use of a 3 mg/ml triclosan in 0.1 M sodium carbonate solution to inflate 
catheter balloons was effective in preventing catheter blockage by Pr. mirabilis and 
Pr. vulgaris for > 168 h in the model. Both Proteus sp. tested had MICs of triclosan 
of < 0.2 pg/ml. This strategy was not effective against Pv. rettgeri, which showed no 
significant difference in mean blockage time between the test and control catheters. 
The MIC of triclosan of Pv. rettgeri isolates was 64 pg/ml.
6. The sensor / modulator strategy in which the cellulose acetate -  bromothymol blue 
sensor signals that the urinary pH has risen and that the catheter balloon should be 
inflated with triclosan, was successful in preventing catheter blockage by Pr. 
mirabilis and Pr. vulgaris but not Pv. rettgeri. The change in the sensor from yellow 
to blue signals that encrustation has started to build up on the catheter. When 
triclosan at 3 mg/ml in 0.1 M sodium carbonate is then introduced into the balloon the 
further development of the crystalline biofilm is arrested and the catheter drains 
freely.
7. The pH sensor was effective in providing early warning of blockage by the slow 
encrusting species M. morganii and Staph, saprophyticus. For Staph, aureus however 
the reaction of the sensor was less clear-cut.
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8. Experiments examining the reaction of the sensor to non-encrusting species in the 
model system showed that while it generally remained negative, some false positive 
signals were observed for Ps. aeruginosa and Pv. stuartii.
9. Inflation of the catheter balloon with a nitric oxide producing solution was not 
effective in preventing encrustation and blockage of catheters in the model by Pr. 
mirabilis. There was no significant difference between the mean catheter blockage 
times in the test and control models.
10. Organisms present with Pr. mirabilis in the mixed urinary flora of the 
catheterised urinary tract can have an inhibitory effect on the ability of the Pr. 
mirabilis strain to encrust catheters.
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